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Abstract
Prescription drug abuse is a significant problem in the United States with huge societal and
financial cost. The 2010 National Survey on Drug Use and Health indicated that in 2009 there
were 12.4 million non-medical users of prescription opioids, indicating a 10% increase from
2002. According to the Drug Enforcement Administration (DEA), the financial cost of
prescription drug diversion is approximately $72 billion per year. According to the Department
of Justice, doctor shopping is the primary method of diversion of prescription drugs. Doctor
shopping occurs when patients visit numerous prescribers and pharmacies to obtain prescriptions
for controlled drugs for illicit use, such as opiates, stimulants and benzodiazepines for illicit use
or sale. In many cases females are noted to be doctor shoppers, perhaps because they are
perceived more sympathetically by prescribers. The purpose of this study was to examine the
experiences of female doctor shoppers through a phenomenological study guided by the
philosophy of Merleau-Ponty. Participants were recruited through a flyer placed at a location
where a Narcotics Anonymous group met, as well as by personal invitation of the researcher.
The sample included 14 women ranging in age from 27 to 51. Participants were asked to share
their experience of doctor shopping. Data from the interviews was coded and thematically
analyzed. A thematic structure of the meaning of doctor shopping was developed which
encompassed four themes: (1) “feeding the addiction” (2) “networking with addicts” (3)
“playing the system” and (4) ”baiting the doctors.” Recommendations for future research
include instrument development to measure doctor shopping and prescribing behaviors,
intervention development for the treatment and support of women who engage in doctor
shopping and interventions to increase responsible prescribing. Recommendations for
v

systematic changes include improved methods to determine patients identity and insurance
status, eliminating cash payments for controlled drug prescriptions and visits, advanced use of
the prescription drug monitoring system, developing advanced assessment instruments and tests,
and an external auditing program to ensure responsible prescribing.
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Chapter 1
Introduction
The use of substances to achieve a psychoactive effect such as a feeling of euphoria or of
being “high” has been recorded since early civilizations. Initially the discovery of fermentation
led to the use of alcohol to achieve a psychoactive effect. Other natural substances such as cocoa
beans, peyote and mescaline have also been used (Naegle, 1988b). Psychoactive substances,
including medications, are regulated in this country by the Drug Enforcement Administration
(DEA). Some psychoactive substances used for abuse are illegal or illicit such as cocaine and
heroin. Other psychoactive substances are used legally to treat conditions such as pain, anxiety,
or attention deficit disorder and require a prescription. Some people abuse psychoactive
prescription drugs by obtaining them through methods of diversion, including theft, forgery, and
doctor shopping. This study focuses on the diversion method of doctor shopping as a means of
obtaining prescription drugs for abuse.
Prescription drug abuse is a serious and significant problem in the United States (Worley,
2012b). The United States Department of Health and Human Services (2012) lists reducing nonmedical use of prescription drugs as a priority in the Healthy People 2020 report. Doctor
shopping has been identified as a primary source of prescription drug diversion and occurs when
patients visit numerous prescribers for prescriptions of controlled drugs and have them filled at
numerous pharmacies. Few research studies have been done on the phenomenon of doctor
shopping. No instruments have been developed to measure doctor shopping or prescriber
experiences and decision making when prescribing controlled drugs. Additionally no
interventions have been developed for prescribers or patients to reduce the incidence of doctor
shopping. Differences in gender have been noted between men and women in studies on illicit
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and prescription drug abuse as well as in tactics and sources of diversion. To date, no research
study has been done specifically with women related to prescription drug diversion or doctor
shopping. In order to understand the experience of doctor shopping for women, a
phenomenological study was proposed.
A greater understanding of doctor shoppers will help prescribers, including advanced
practice nurses (APNs), to make more appropriate decisions when prescribing controlled drugs.
This information may also guide in the development of instruments and interventions to measure
and improve appropriate prescribing decision making.
Scope of the Problem
In 2009, seven million Americans age 12 and older used prescription drugs nonmedically (Drug Enforcement Administration, n.d.). Prescription drugs are diverted for illicit
use through a variety of methods such as theft, forgery, and doctor shopping (Wang & Christo,
2009). Several studies have confirmed that diversion of controlled substances for non-medical
use often involves doctor shopping (Pradel, Delga, Rouby, Micallef, & Lapeyre-Mestre, 2010;
Wilsey et al., 2010; Wilsey et al., 2011). Diversion of prescription drugs by doctor shopping is a
major contributor to prescription drug abuse (United States Government Accountability Office,
2011). The United States National Drug Intelligence Center (2004) defines doctor shopping as
occurring when individuals visit numerous doctors in an attempt to obtain multiple prescriptions
for drugs, often falsify or exaggerate symptoms in order to receive these prescriptions, and
typically have their prescriptions filled at multiple pharmacies in order to avoid detection.
A 2008 report by the Government Accountability Office (GAO) found that 170,000
Medicare beneficiaries engaged in doctor shopping at a cost of $148 million (United States
Government Accountability Office, 2011). Another study conducted in 2008, found that 65,000
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Medicaid recipients from just four states engaged in doctor shopping at a cost of $63 million
(Civic Federation, 2009). Despite the increasing incidence of doctor shopping, prescribing rates
of controlled drugs have increased dramatically, 127% between 1997 and 2006 (Manchikanti &
Singh, 2008). This increase has occurred despite the development of prescription drug
monitoring programs (PDMPs), which are electronic databases run by individual states so that
prescribers can access information on controlled drug prescription histories of patients (Worley,
2012b).
The financial cost of prescription drug diversion has been estimated at $72 billion per
year (United States Department of Justice, 2009). This reflects overall healthcare and law
enforcement costs. A study evaluating claims data found that the societal cost of abuse,
dependence and misuse of one type of prescription pain reliever: opioids, was estimated to be
$55.7 billion in 2007 which included workplace, healthcare and criminal justice costs (Birnbaum
et al., 2011). Further evidence of the seriousness of the problem is the fact that deaths from
opioid poisoning or overdoses have tripled from 1997 to 2007 (United States Center for Disease
Control Morbidity and Mortality Weekly Reports, 2010). Another study found that people who
engage in doctor shopping had twice the odds of a drug related death (Pierce, Smith, Abate &
Halverson, 2012). Additionally, the proportion of substance abuse treatment admissions in
people age 12 and older who reported prescription pain reliever abuse increased more than
fourfold between 1998 and 2008 from 2.2% to 9.8% (Treatment Episode Data Set Report, 2010).
From 1999 to 2006 hospitalizations from poisonings by prescription opioids, sedatives and
tranquilizers increased a total of 65% (Coben et al. 2010).
Few studies have been done on prescription drug diversion and doctor shopping.
Consistently in research conducted with people who abuse prescription drugs, doctor shopping is
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stated as one of the primary methods by which the drugs are obtained (Cicero et al., 2011;
Inciardi et al., 2009; Rigg, Kurtz & Surratt, 2012). Tactics described by buyers and sellers of
prescription drugs in London when obtaining prescriptions from health care professionals
included feigning symptoms, gaining sympathy, and exaggerating (Fountain, Griffiths, Farrell,
Gossop, & Strang, 1998). Other studies have found that people who sell prescription drugs often
visit numerous clinics to obtain large amounts of prescription drugs, sponsor others to obtain
prescription drugs, and buy prescription drugs from vulnerable people such as veterans, the
elderly, people on Medicare or Medicaid, or those with HIV/AIDS (Inciardi et al., 2009; Rigg,
Kurtz, & Surratt, 2012).
Philosophical Basis for the Study
Existential Phenomenology of Merleau-Ponty
Philosophy can be described as the search for origins and foundations (Schrag, 1985).
This study will be conducted using the existential phenomenology lens of Merleau-Ponty.
Existentialism is a form of philosophy that focuses on who we are and how we come to live
authentically (Thomas & Pollio, 2002). The study focuses on experience as seen through the
participants’ eyes in order to discover their perceptions of their lived experience (Thomas, 2005).
According to Merleau-Ponty, figural aspects of perceived things are only understood against the
backdrop of existential grounds, which include: body, time, other people and the world (Thomas,
2005; Thomas & Pollio, 2002). This view describes human experience on its own terms through
perception, which reveals interconnectedness between ourselves and the world in the situational
context of personhood and being in the world (Thomas & Pollio, 2002). Our relationship to the
world we live and interact within plays an integral role in our experience. According to
Merleau-Ponty (1945/2005), “Truth does not ‘inhabit’ only ‘the inner man’, or more accurately,
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there is no inner man, man is in the world, and only in the world does he know himself” (p. 25).
Additionally he (1945/2005) states that man is “nothing but a view of the world” (p. 1413). This
existential phenomenology philosophy guides this study to provide an understanding of the
meaning of the participant’s experience of doctor shopping, relative to the world, time, their
body, and interactions with others.
Purpose of the Study
In this and the following sections I will detail the purpose of the study as well as the
research questions and key definitions. The purpose of this study was to describe the meaning of
the lived experience of women who engage in doctor shopping.
Research Question
The research question for this study was: what is the experience of female doctor
shoppers?
Definitions
Illicit Drug Abuse
Illicit drug abuse is defined as any use of drugs that have no accepted medical or legal
use as designated by the United States government.
Prescription Drug Abuse
Prescription drug abuse is defined as any non-medical use, misuse, or abuse, of controlled
prescription drugs (Worley, 2012a).
Controlled Prescription Drugs
Controlled prescription drugs are medications that have abuse potential and are classified
in the United States as Schedule I thru V with I being the most addicting or having the greatest
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abuse potential (U.S. Department of Justice Drug Enforcement Administration Office of
Diversion Control, n.d.; Worley, 2012b).
Prescription Drug Diversion
Prescription drug diversion is any diversion or deviation of prescription drugs from
medical use to the illegal market including: doctor shopping, illegal Internet pharmacies, drug
theft, prescription forgery, and illicit prescribing (Council of State Governments, 2004).
Prescription Drug Monitoring Programs
Prescription drug monitoring programs are electronic databases run by individual states
that collect data on controlled drug prescription substances so health care providers can access
the data and deter abuse, doctor shopping, and diversion (Worley, 2012b).
Prescriber
A healthcare professional who has legal authority to prescribe medication in the United
States, which includes APNs, dentists, ophthalmologists, physicians, physician assistants, and
podiatrists.
Doctor Shopping
Doctor shopping occurs when, a) a patient receives a prescription for the same or similar
controlled drug for illicit use, from more than one prescriber within a 30-day day period, b) from
three or more pharmacies, c) wherein the patient does not inform the prescriber of previous
controlled prescriptions or the prescriber is aware and unscrupulously prescribes, as well as or
when, d) a patient visits five or more prescribers within a one-year period for controlled drugs
for illicit use (Worley & Hall, 2012).
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Delimitations
My study focused on doctor shopping, which is a facet of prescription, rather than illicit
drug abuse. There are two key players in the act of doctor shopping, patients and prescribers.
This study focused on the experience of the patient. Specifically I am interested in the experience
of adult women who engage in doctor shopping. The participants self-identified as doctor
shoppers based on their common knowledge of the term and/or the definition provided when
they inquired about the study. I included women who were enrolled in outpatient substance
abuse in my study as well as those who were not in treatment. Women in the study may or may
not have had legal charges related to substance abuse and may or may not have been on
probation. Women who were current or former patients of the researcher were not included in
the study.
Assumptions
Assumptions for this study were: a) substance abuse is a complex psycho-social problem,
b) prescription drugs are a source of substance abuse, c) prescribers are a source of controlled
drugs for doctor shoppers, whether through ignorance, complacency, or collusion.
Significance of the Study
In these sections on the significance of the study I will focus on the overall significance
of the study for the nursing profession and for women. Prescription drug abuse results in the
tragedy of lost lives and huge societal costs. Through doctor shopping, patients are obtaining
prescription drugs to abuse or sell. Patients, through clever tactics or fraudulent methods, are
able to deceive and manipulate prescribers to prescribe medication that is being misused. Since
APNs are prescribers in this country and nurses in many fields interact with patients who abuse
prescription drugs regularly, this topic is significant to nursing. Research has shown women’s
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experience of prescription drug abuse and diversion differs from men’s. For this reason, it is
important to understand women’s experience of doctor shopping.
Significance of the Problem for Nursing
Nurse practitioners, nurse anesthetists, nurse midwives, and clinical nurse specialists are
nursing professionals with advanced education who are designated as APNs (American Nurse
Association, 2012). The majority of APNs are nurse practitioners, who comprise a significant
percentage of prescribers in the United States. Nurse practitioners are registered nurses with
advanced degrees who are prepared through advanced graduate courses to provide health care
services including the diagnosis and treatment of medical conditions, which includes prescribing
medication (American College of Nurse Practitioners, n.d.). Nurse practitioners must hold a
master’s or doctoral degree and be board certified by a national accrediting agency. Certification
is achieved through taking a national exam in their specialty area. Specialty areas for nurse
practitioners include family practice, pediatrics, geriatrics, women’s health and psychiatry.
The Kaiser Family Foundation (2011) reported in 2010 there were 167,857 nurse
practitioners in the United States. During the same year, the American Medical Association
(2010) reported there were 638,661 physicians in office based practice. Prescribers have a legal
and ethical obligation to prescribe medication responsibly. Legitimate reasons for prescribing
controlled drugs must exist according to the American Nurses’ Association (2001) Code of
Ethics. The DEA also designates that a prescription is only lawful when issued for legitimate
medical purposes and that willfully not doing so subjects prescribers to penalties (U.S.
Department of Justice, n.d.).
In addition to being significant to APNs, the problem of prescription drug abuse, which
often involves doctor shopping, is significant to nurses in many specialty areas. People who
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abuse substances interact with nurses in the healthcare system at all levels including substance
abuse treatment centers, mental health clinics, family practice, obstetrics, public health, and
inpatient psychiatry units. Nurses are often on the forefront of providing screening and
implementing treatment for patients who abuse prescription drugs. While APNs may be the ones
writing the prescriptions, office nurses are often the first people that doctor shoppers interact
with when they call or are received for an appointment. Nurses play a crucial role in partnering
with prescribers to detect and intervene when doctor shopping is suspected.
Significance of the Problem for Women
Historically, controlled prescription drugs have been targeted at women for conditions
such as menopause and stress, which will be covered more in depth in Chapter Two. Gender
differences have been identified in research on people who abuse prescription drugs and engage
in diversion tactics. For example, studies have shown that when compared to men, women have
a greater incidence of mental health problems associated with illicit and prescription drug abuse
(Back, Payne, Simpson & Brady; 2010, Grella & Lovinger, 2012; Jamison, Butler, Budman,
Edwards, & Wasan, 2010; Pant & Bagrodia, 2003), a greater incidence of physical health
problems (Grella & Lovinger, 2012), a greater incidence of a history of being physically or
sexually abused (Jamison et al., 2010; McCauley, 2009; Tracy, et al., 2012), and a greater
incidence of polysubstance abuse (Back, et al., 2010; Green, Grimes-Serrano, Licari, Budman, &
Butler, 2009; McCauley, 2009). There are also differences between men and women in regards
to the tactics and means of diversion of prescription drugs. Studies have found that women are
more likely to use doctors’ prescriptions for abuse (Cicero et al., 2011) and/or engage in doctor
shopping than men (Hall et al., 2008).
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This study may help shed light on why women engage in doctor shopping, for instance
for abuse due to an addiction, for recreational use, or to sell the drugs for profit. It may be that
women are more likely to engage in doctor shopping because they are perceived more
sympathetically by prescribers. If this is the case, this study may uncover the fact that women
are in some way being coerced by others to obtain medications. In addition, interventions may
be developed based on the results of this study, which may help women who engage in doctor
shopping to improve coping skills and adopt healthier lifestyles that do not include prescription
drug abuse.
Personal Interest in the Study
Having worked as a family nurse practitioner for 10 years and then as a psychiatric nurse
practitioner for close to 10 years, I have repeatedly seen patients who are drug seeking. My
experience has been that in family practice, opioid narcotic pain medications are primarily
sought, followed by benzodiazepines for anxiety. In psychiatry, benzodiazepines and stimulants
used to treat attention deficit disorder are sought. I have listened to numerous suspicious stories
and requests for controlled drugs and have been concerned about potential prescription drug
abuse. With the onset of a PDMP, I have been able to confirm doctor shopping in close to 100
patients. Often a patient's PDMP reports are several pages long, indicating many controlled drugs
prescribed and filled. While certain prescribers are known for overprescribing, I believe that
most would not willingly prescribe controlled drugs to people who are doctor shopping. I have
wondered why prescribers are not using the PDMP or verifying patients’ information through
other methods. I have been very concerned and surprised that so many patients are able to obtain
so many controlled drugs from so many prescribers.
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I have also seen the damaging effects of prescription drug abuse in patients who have told
me that the drugs have ruined their lives. Routinely I see teenagers who report they have taken
prescription drugs from their parents or other family members’ medicine cabinets, some of
whom are known to engage in doctor shopping. I see many patients whose lives have been
detrimentally affected by prescription drug abuse including those who have gone through
treatment numerous times, to no avail. Several months after I started on my path researching this
topic, one of my patients died unexpectedly of a prescription drug overdose. Her PDMP report
revealed she had gotten numerous prescriptions from numerous prescribers filled at numerous
pharmacies in the days before her death.
Summary
Doctor shopping is a problem of epidemic proportions in the United States which often
involves patients engaging in doctor shopping to divert controlled prescription drugs which are
then abused or sold for profit. Little is known about doctor shoppers. Women have unique
differences from men in regard to prescription drug abuse and doctor shopping. Currently there
are no instruments to measure doctor shopping or prescriber decision making when prescribing
controlled drugs and no interventions to decrease its incidence. There is no understanding of the
motives or uses of the prescription drugs that are obtained. It is not known if doctor shoppers
primarily act independently or if other people are involved in the act of doctor shopping.
Specific tactics of doctor shoppers are not understood, and there are many questions, such as if
and how certain prescribers are targeted for doctor shopping. An understanding of the
experience of doctor shopping can be used to help prescribers make better decisions about
prescribing. This understanding can also lead to the development of a theory of doctor shopping
as well as instruments and interventions to decrease its incidence. The needs of women who
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engage in doctor shopping may be identified and used to develop interventions to decrease the
incidence of their prescription drug abuse.
Doctor shopping is a problem for patients, as it has the potential to ruin lives. Doctor
shopping is also a significant problem for prescribers who have an ethical and legal obligation to
prescribe controlled drugs responsibly. This proposed research on the experience of doctor
shoppers can be used to help prevent or reduce the incidence of doctor shopping. The results of
this study can be used for benefit for the people engaging in doctor shopping and the prescribers
who care for them.
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Chapter 2
Review of the Literature
In this section I provide a historical perspective of substance abuse in the United States as
well as pertinent laws pertaining to the regulation of substances. I also discuss historical aspect
of substance abuse in the lives of women. This is followed by an examination of theoretical
frameworks that have been used to examine substance abuse as well as noted leaders and
researchers in the field of substance abuse. The new construct of doctor shopping is discussed as
well as a historical perspective of prescription drug monitoring programs. This chapter
concludes with a thorough review of the empirical literature on doctor shopping.
Historical Perspective of Substance Abuse
In order to understand and appreciate the current phenomenon of prescription drug abuse,
it is important to reflect on a historical perspective of substance abuse. Substances have been
abused to achieve a psychoactive effect for centuries. Use of psychoactive substances causes an
alteration in a person’s mental status such as a feeling of calm, relaxation, euphoria, excitement,
or dulled sensation. Large amounts of psychoactive substances can lead to the impairment of
functioning of speech, motor skills, memory and judgment. The physiological effect of drug
abuse is hypothesized to occur in the mesolimbic dopamine pathway in the brain which is
considered the “pleasure center” (Stahl, 2008). Other activities such as intellectual
accomplishments or sport participation can increase the brains natural pleasurable
neurotransmitters. This has been referred to as a “natural high.” When drugs are abused, they
bypass the brain’s own neurotransmitters and stimulate the brain’s receptors in the mesolimbic
reward system which results in the release of dopamine resulting in an “artificial high” (Stahl,
2008).
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Initially, in early civilizations, there was the discovery of the process of fermentation led
to alcohol consumption, which can be abused in large amounts. Some psychoactive drugs are
derived from naturally occurring substances such as cocaine from cocoa beans, and opium or
heroin from poppy plants. Other natural substance such as peyote, certain mushrooms and
mescaline can also cause mind altering effects (Naegle, 1988b). Some substances used for other
purposes can be abused such as glue, certain cleaning fluids, and canned aerosolized products
which can be inhaled. Medications that are sold over the counter and do not require
prescriptions such as Sudafed, which is a decongestant, and some cough syrups can be abused in
large quantities or used to make other illegal substances.
Drug abuse in the United States can be traced back over 150 years to the Opium Wars in
the early 19th century (Kandall, 2010). At that time immigrants from China resorted to smoking
opium in the United States to alleviate difficult living conditions. This drug use subsequently
infiltrated into the general U.S. population. Cocaine and heroin became drugs of abuse at the
end of the 19th century. At that time it was legal to distribute opiates such as morphine and
opium in medications, including those available without prescriptions, and in food products. The
Federal Pure Food and Drug Act was passed in 1906 which required medicines and foods
containing opiates to be labeled as such. The Harrison Anti-Narcotic Act was passed in 1914
which criminalized illicit drug use (Kandall, 2010). Drugs classified as illicit drugs are those
that have no recognized medical use such as heroin and cocaine. In the 1950s, potentially
addictive psychoactive prescription medications grew in favor such as tranquilizers, sedatives
and stimulants. Prescription medications with abuse potential were designated as controlled
drugs in 1970 by the Controlled Substance Act (National Conference of Commissioners on
Uniform State Laws, 2012). Despite laws regulating controlled prescription drugs and use of
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illicit drugs which include stiff penalties, substance abuse has continued to be an epidemic in this
country with huge financial, societal and personal cost. The U.S. Department of Health and
Human Services (2009) estimates the total cost of all substance use disorders, including
prescription and illicit use, at $180 billion per year. This cost includes medical treatment, law
enforcement, and all other associated costs.
Historical Perspective of Women and Substance Abuse
Substance abuse has played a pivotal role in the lives of many women. In this section I
will summarize a historical perspective of women and substance abuse. From the beginning,
women have been no strangers to substance abuse (Worley, 2012a). As early as the mid-to late
19th century, two-thirds to three-quarters of the opium addicts as well as cocaine, chloroform
and cannabis abusers in the United States were women (Kandall, 2010). As cited by Ogur
(1986), Terry and Pellens reported that in 1924 there were approximately 66,000 women
addicted to narcotics in the United States. During that time, many of the medications that legally
contained opiates and cocaine were targeted at women for conditions such as menstrual and
menopause symptoms, as well as what were described as “nervous disorders” (Kandall, 2010).
Many women became addicted to illicit or prescription drugs. Elite women who became
addicted to drugs were treated in private clinics as early as 1892. Approximately 15,000 women
were admitted to substance abuse programs between 1941 and 1965, which was 18% of all
admissions. Women without means were sometimes forced into prostitution and crime to support
their habits (Kandall, 2010). Later, methadone clinics sprung up as an alternative to illicit drug
use. Methadone is a controlled prescription drug prescribed to heroin and opiate addicts as an
alternative to street drugs. Ten thousand women were treated in federally funded methadone
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clinics from 1969 to 1973 which was about 25% of all cases. The percentage rose to 35% from
1992 to 2005 (Kandall, 2010).
In the 1950s and 1970s there was an increase in psychoactive prescription drugs targeted
at women. These medications, known as “mother’s little helpers,” were recommended for
motherhood and singlehood as a means for women to get through the day (Metzi, 2003).
Released in 1956, Miltown was the first drug to hit the market targeted at middle class women
for anxiety. This drug was heavily marketed to physicians and the public and as cited by Metzi
(2003), in 1956 Consumer Reports found that one in twenty Americans was taking Miltown or
another tranquilizer in a given month. In 1960, Carter Products, the maker of Miltown and
Equinal, which both contained the active ingredient meprobamate, was charged with having
monopolized the market in mild tranquilizers (Ranzal, 1960). In 1965 meprobamate was
removed from the list of tranquilizers when experts ruled it was a sedative instead. In 1967 it
was listed as a controlled substance due to causing physical and psychological dependence (New
York Times, 1967). In the 1960s Valium and other benzodiazepines became the drugs of choice
prescribed to women for a variety of ailments such as anxiety, stress from motherhood or being a
housewife, frigidity, a bride’s uncertainty and a wife’s infidelity (Metzi, 2003).
A study done on data in the 1970’s by Cooperstock (as cited by Hughes, 1989, p. 329)
found that substantially greater numbers of women than men used prescription drugs. In a
secondary data analysis of a longitudinal study from 1979 (n = 12,686) to 1984 (n = 12,069),
gender differences in prescription drug use were not significant. However, more women than
men reported lifetime use of prescription tranquilizers and rates of past month use of
tranquilizers for white women were more than twice that reported for white men (Hughes, Day,
Marcantonio & Torpy, 1997). In 1993 there were four million women abusing drugs, including
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illicit and prescription abuse in the United States (National Institute on Drug Abuse, 1994).
According to the Substance Abuse Mental Health Administration (2010), in 2009 the rate of
illicit and prescription drugs in females age 12 and up was 6.6%, which is less than the male rate
of 10.8% but remains significant, affecting millions of women.
Overview of Theoretical Frameworks Used to Examine Substance Abuse
In order to identify the cause as well as explain and describe the phenomenon of
substance abuse, an abundance of theories have been proposed. An overview of theoretical
frameworks and models will be discussed in this section. The major categories for theories on
substance abuse and addiction are biological, personality, cognitive, behavioral and social
theories. In early times, substance abuse was viewed as deviant behavior and addicts were
imprisoned, rejected by their families and subjected to punitive medical interventions (Naegle,
1988b). Early theories of drug addiction explained drug use in terms of being weak-willed or
morally inferior. These are often defined as moral models of addiction which have lost favor as
far as accurately portraying drug abusers (Room, 2005). Other early theories were developed
from Freudian views including that substance abuse occurred due to a disorder within
psychological structures. Drugs were viewed as a substitute for gratification of oral and genital
needs (Vetter, 1985).
Cooperstock (1971) proposed a model to explain sex differences in the use of moodmodifying drugs. According to this model, society at that time permitted a greater expression of
feelings among women who also had an increased perception of emotional problems in self.
Women then sought care from physicians for emotional problems, and physicians had greater
expectations of women than men of that expressiveness. This led to an increase in the
physician’s expectation of the female patient’s need of mood-modifying drugs. It does not
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appear that this model has ever been tested or used in research or practice, therefore its relevance
in today’s society is not clear.
Several biological models of addiction have been proposed. The disease model of
addiction came into favor in the early 20th century. According to this theory, addiction fits the
definition of a medical disorder which can be diagnosed and treated. Addiction as a disease
involves an abnormality of structure or function in the central nervous system (CNS) that results
in impairment (West, 2005). Genetic theories postulate that an innate genetic predisposition is
related to addiction. Several scientific human studies have supported a substantial genetic
vulnerability to substance abuse (Uhl, Elmer, LaBuda, & Pickens, 2000).
Personality theories include those that describe an addictive personality where drug use
fulfills a purpose and holds benefits despite negative consequences (Sutker & Allain, 1988).
Five factor theory includes the concept that personality traits are biologically influenced and
stable (McRae & Costa, 2003). Studies based on this framework have shown that people who
abuse opioids have higher levels of the personality trait of neuroticism and lower rates of
extroversion (Korner & Nordvik, 2007). Neuroticism has also been identified as a predictor of
relapse to substance abuse following treatment (Fisher, Elias, & Ritz, 1998).
Impulse control as a facet of the personality has also been implicated in theories related
to substance abuse, such as the inhibition dysregulation theory. In this theory the inhibitory
system involved in aspects of response inhibition and selection underlies drug addiction
(Lubman, Yucel & Pantelis, 2004). Self-regulation theory has been applied to substance abuse.
According to proponents of this theory, addiction results from impaired control or compulsion.
This impairment is defined as an inability to self-regulate (West, 2005).
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Cognitive models to explain drug abuse include the theory of drug urges, where cravings
for drugs involve a feeling of urgent need linked with fear of withdrawal symptoms as well as
from the expectation of pleasure from the activity (Tiffany, 1990). Other cognitive models can
be classified as rational addiction theories, where addiction is viewed as a choice. In these
theories there is a belief that people do things because they expect a benefit despite knowing
about and accepting any adverse consequences (West, 2005). These theories debunk the notion
that drug addiction is a disease because loss of control is not considered valid. The selfmedication model of addiction also involves the choice of individuals who intentionally uses
drugs to treat psychological symptoms they suffer from (Gelkop, Levitt, & Bleich, 2002).
Several social theories have been formulated or used to explain substance abuse. Social
learning theory states that socially deviant or criminal behavior, including substance abuse, is
learned from intimate groups. For this to occur there must be exogenous or social conditions,
such as the influence of friends, as well as endogenous conditions, such as physiological or
psychological precursors to substance abuse. This theory has been used in studies of drug use
with adolescents and college students (Peralta & Steele, 2010). Another social theory used to
explain addiction is social disorganization theory. This theory stems from ecological theories
and focuses on group adaptations to social processes such as urbanization and shifting patterns of
economic growth. The focus is on the community or external influences in the environment
rather than on the individual. According to this theory, disorganized communities lead some
residents to no longer submit to normative social controls (Rose & Clear, 1998). Another theory
that has been used in research on substance abuse which also takes into consideration social
influence, is the theory of planned behavior, which assumes that attitudes, subjective norms and
perceived behavioral control influence intention and predict behavior (Ajzen, 1991).

19

Particularly in nursing, the Rogerian model has been used to describe substance abuse as
well as to guide research. Martha Rogers (as cited by Compton, 1988, p. 98) was a nurse theorist
who conceptualized a human as a unitary, four-dimensional energy field phenomenon. The
unitary human and dimensions must be understood in totality and include the concept of
developmental diversity with patterns of changes (Naegle, 1988b). Manifestations of substance
abuse can be understood through the lens of this theory and are seen as part of a continuous
whole. This view shifts assessment from the focus on the explanation of substance abuse to the
assessment of patterns (Naegle, 1988b). In light of this theory, drug use can be seen as a means
to increase one’s awareness of the four dimensional nature of reality. Addiction is seen to arise
out of the mutual processes that occur between human and environmental fields (Compton,
1988).
Solomon developed an opponent process theory of motivation which has been used to
describe addiction (Solomon & Corbit, 1978). According to this theory, drug addiction occurs
when the pleasure of using drugs is opposed by the emotional symptoms of drug withdrawal.
When a person first begins to use drugs the pleasure they feel with drug use outweighs the
withdrawal symptoms, but over time the withdrawal symptoms increase and the person is then
motivated to use drugs to treat the withdrawal symptoms to a greater extent than for the pleasure
of doing it.
Flagler, Hughes, and Kovalesky (1997) proposed using Brickman’s models of helping
and coping where four models are used to describe addiction; the moral model, medical model,
enlightenment model, and compensatory models. The moral and medical models have
previously been discussed. The enlightenment model shares the perspective of the medical
model, but in this model a person needs to accept responsibility for the problem and must
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surrender personal control to a higher power to change one’s behavior. This perspective or
philosophy is espoused by 12-step programs such as Narcotics Anonymous (NA), which are
popular support groups for people with substance abuse problems. The compensatory model
views addiction similarly to social theories and describes it as occurring as a result of
multidimensional factors beyond a person’s control, but for which a person can compensate
(Flagler et al., 1997). When these models are applied to Brickman’s models of helping and
coping, they are classified as whether or not the substance abusing person is responsible for the
problem as well as if they are responsible for the solution. In the moral model, the person is
responsible for the problem and the solution. In the medical model, the person is not responsible
for the problem or the solution. In the enlightenment model, the person is responsible for the
problem, but not the solution. In the compensatory model, the person is not responsible for the
problem, but is responsible for the solution (Flagler et al., 1997).
Conflicting perspectives are noted in the different theories related to substance abuse.
Views, values and attitudes of healthcare professionals, researchers, and the public are
influenced by a number of factors, including religious background, familial influences, education
and training, and personal or professional experience (Hughes, 1989). Theoretical perspectives
play a role in influencing research and treatment of substance abuse. Additionally,
misapplication of theoretical models held by those in a position to help people who abuse
substances may lead to ineffective helping strategies (Hughes, 1989).
Noted Leaders and Researchers in the Field of Substance Abuse
Throughout the years, there has been considerable research in the general phenomenon of
substance abuse. In this section, I will provide information about noted nursing and psychology
researchers in the field of substance abuse. Although a lack of nurse researchers in the field of

21

substance abuse theory and research has been noted, there are several nurses who include
substance abuse in their area of focus, some of whose works are referenced in this paper.
Florence Nightingale is likely one of the first nurses to focus her attention on the
phenomenon of substance abuse in her work with soldiers related to their alcohol use in the
1800s. Nightingale (as cited by Naegle, 1991, p. 124) recognized that the soldiers resorted to
alcohol when they lacked emotional supports and activities. In addition she recognized that
acute alcohol intoxication was life-threatening and had a negative impact on wellness. In her
writings, she discussed measures she implemented to decrease alcohol use including opening
reading and recreation rooms. After realizing the men drank away their pay due to
dissatisfaction with how their funds were otherwise handled, she intervened and developed a
method for which the men could send money home rather than use it to purchase alcohol. Due to
her influence British soldiers were no longer characterized as drunken intractable brutes
(Woodham-Smith, 1991).
Margaret Compton of UCLA School of Nursing is a researcher and neuroscientist with a
research focus on the characterization and pharmacological management of opioid-induced
hyperalgesia in opioid addicts and behavioral indicators of addiction in chronic pain patients.
She was a postdoctoral fellow at the National Institutes of Drug Addiction Research Center
where she studied pain and addiction responses in opioid addicts. She has co-authored several
articles including ones on substitution pharmacotherapies for opioid addiction and other topics
related to the treatment of opioid addiction and dependence (Ling, Rawson, & Compton, 1994;
Ling, Rawson, & Compton, 2003). Another important work of Margaret Compton is her article
on the Rogerian view of drug abuse with implications for nursing (Compton, 1988).
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Madeline Naegle is a nurse researcher in the field of substance abuse from New York
University. She focuses on chemically impaired nurses and nursing education in the prevention
and treatment of substance abuse disorders. She has been a champion for increased substance
abuse education in nursing. She authored an article about substance abuse issues in women in
1988 (Naegle, 1988a). There has not been another similar work since then. Her article
“Theoretical Perspectives on the Etiology of Substance Abuse” (1988b) is unique and notable
among early nursing research on substance abuse.
Tonda Hughes of the University of Illinois Chicago School of Nursing has been
instrumental in developing the field of knowledge on substance abuse in lesbian women. Her
research has included numerous studies on substance and alcohol abuse in lesbian, gay, bisexual
and transgender populations (Hughes & Eliason, 2002; Hughes, Johnson, Wilsnack & Szalacha,
2007). She has also done research and published on chemically dependent nurses (Hughes,
Howard & Henry, 2002; Hughes, Smith & Howard, 1998). She co-authored an important work,
“Toward an Understanding of Addiction” (Flagner et al. 1997) which outlines issues and major
perspectives on substance abuse. She authored an early significant paper, “Models and
Perspectives of Addiction: Implications for Treatment” (1989). In 1997 she co-authored the
results of a large secondary data analysis from survey results in 1984 on gender differences in
alcohol and drug use among young adults (Hughes et al., 1997).
Carol Boyd of the University of Michigan School of Nursing is the only nurse researcher
identified who focuses on the phenomenon of prescription drug abuse, in which she studies
adolescents and college age students. Her work has included studies on prevalence, motives, and
diversion of illicit use of prescription stimulants in undergraduate and middle school students
(Teter, McCabe, & Boyd, 2003; Teter, McCabe, LaGrange, Cranford, & Boyd, 2006) and opioid
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and ecstasy use among college students (Boyd & McCabe, 2003; McCabe, Teter, Boyd, Knight,
& Welschler, 2005).
Nurse researcher Mary R. Boyd from the University of South Carolina has a research
specialty of alcohol and drug disorders in rural women. Her numerous publications include
those on studies predicting substance abuse, psychiatric assessment, and alcohol abuse in rural
women (Boyd & Hauenstein, 1997; Boyd, 2000; Boyd & Mackey, 2000).
William Miller is a PhD psychologist and is a professor emeritus in the department of
psychology and psychiatry at the University of New Mexico. He has written over 40 books and
400 articles related to addictions and focuses on the development, testing, and dissemination of
treatments for addictions (Miller, 2012). He is interested in the psychology of change and his
research foci include behavioral self-control training, cross-cultural research, health care and
brief intervention, motivational interviewing, relapse research, and spirituality and health. He is
credited with introducing new ways of viewing substance abuse treatment. His randomized
controlled clinical research on confrontation demonstrated that confrontation leads to resistance
and denial (Miller, Benefield, & Tonigan, 1993). He favors motivational interviewing over
confrontation as an approach with people who abuse substances.
Another noted psychologist who has done considerable research in the area of substance
abuse is Kathleen Carroll from Yale University. She has authored numerous publications on
issues related to substance abuse, including evidenced based practice, neural effects of behavior
therapy, outcomes in drug dependence treatment, and other randomized clinical trials (Martino,
Carroll, Nich & Rounsaville, 2006; Sofuoglu, Sugarman, & Carroll, 2010; Zhiru et al., 2011) .
She is also known for developing a computer-assisted training in cognitive-behavioral therapy
for people who abuse substances (Yale School of Medicine, n.d.)
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While this review has revealed the contributions of several noted researchers in the area
of substance abuse, there are numerous gaps in knowledge, especially considering the magnitude
of the problem. Few research studies have been conducted on the phenomenon of prescription
drug abuse, none of which have focused specifically on doctor shopping, which highlights the
necessity and importance of the findings from this study. A greater understanding of what
constitutes doctor shopping as well as the experiences surrounding it is of paramount importance
in order to make strides in reducing its incidence.
New Construct of Doctor Shopping
In order to answer questions about what doctor shopping is and what specifically
constitutes doctor shopping, an in-depth discussion and concept analysis of the term doctor
shopping is included in this section. The term doctor shopping is a commonly accepted term in
the United States denoting patients visiting numerous health care professionals for multiple
prescriptions of controlled drugs. Often the term is used in research without providing a
definition. Dictionary definitions include the practice of getting prescriptions for a single drug
from more than one provider at the same time (Dictionary.com, n.d.) and the practice of going
from doctor to doctor to obtain prescriptions for pharmaceuticals (Webster’s Online Dictionary,
n.d.). USLegal.com (2011) defines doctor shopping as the practice of a patient requesting
simultaneous care from multiple provider physicians without efforts to coordinate care or
information the physicians of the multiple caregiving. Individual state laws have also been
enacted to address doctor shopping. For instance, Connecticut has a statute which states:
“no person who, in the course of treatment, is supplied with controlled substances or a
prescriptions thereof by one practitioner shall, knowingly, without disclosing such fact,
accept during such treatment controlled substances or a prescription therefore from
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another practitioner with intent to obtain a quantity of controlled substances for abuse of
such substances” (USLegal.com, n.d.).
Tennessee has a doctor shopping bill that states, “a patient must disclose to a prescriber
(physician, nurse practitioner, dentist, podiatrist, or optometrist) that he/she has received the
same controlled substance or one with similar therapeutic use from another practitioner within 30
days” (Tennessee Medical Association, 2010). In Texas, it is a felony for patients to receive a
prescription for a controlled drug without disclosing they are already receiving controlled
substances from another practitioner (Texas Legislature Online, 2011).
The United States National Drug Intelligence Center (2004) defines doctor shopping as
occurring when individuals visit numerous doctors in an attempt to obtain multiple prescriptions
for drugs, often falsify or exaggerate symptoms in order to receive these prescriptions, and
typically have their prescriptions filled at multiple pharmacies in order to prevent detection.
According to the Drug Enforcement Administration (DEA), doctor shopping can be defined as
visits by an individual – who may or may not have legitimate medical needs – to several doctors,
each of whom writes a prescription for controlled substances (U.S. Drug Enforcement
Administration, 2006).
Further criteria for doctor shopping include the number of prescribers an individual visits
in the course of one year to obtain prescriptions for controlled drugs. This is significant because
patients may only be able to secure one or two prescriptions for controlled drug from one
prescriber so they move on to other prescribers throughout the year. Legitimate reasons for
receiving controlled drugs from more than one prescriber within one year include when
prescribers work in large practices patients; may be seen by more than one prescriber if their
prescriber is not working that day. Also patients may see different prescribers for different
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classes of medications such as seeing a dentist and getting a prescription for a small amount of
pain medication after a tooth extraction, seeing a psychiatric prescriber for medication for
anxiety, and seeing a primary care provider for pain management for another cause. However,
five or more prescribers within one year is likely excessive and would constitute doctor shopping
if the prescriptions are obtained for non-medical use.
The United States government as well as other researchers have used the criterion of five
or more medical practitioners in one year as criterion for doctor shopping (U.S. Government
Accountability Office, 2011; Hall, et. al., 2008). The term “overlapping” prescriptions is used in
some studies to define doctor shopping (Cepeda, Fife, Chow, Mastrogiovanni, & Henderson,
2012a; Pradel et al., 2010;). The standard of care when prescribing controlled drugs is to write
them for a 30-day supply, therefore overlapping prescriptions are equivalent to prescriptions
filled within a 30-day period. Multiple pharmacy use to fill multiple prescriptions for controlled
drugs is also a criterion used to define doctor shopping. This is done in order to avoid detection.
A large study of 65% of all retail pharmacy sales in the United States found that overlapping
prescriptions by more than one prescriber filled at three or more pharmacies per year was
indicative of shopping behavior (Cepeda, Fife, Chow, Mastrogiovanni, & Henderson, 2012b).
In the United States, several types of healthcare professionals have legal authority to
prescribe medications including APNs, dentists, physicians, physician assistants,
ophthalmologists, and podiatrists. The term doctor shopping is well known and routinely used
by the media, the government, healthcare professionals, law enforcement and the public. This
term is heavily ingrained in the U.S. culture and is known to refer to patients obtaining
prescriptions for controlled drugs from any prescriber, not solely physicians.
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The term prescriber accurately reflects health care professionals with legal authority to
prescribe medications. Other terms such as health care provider or practitioner are problematic
because one could be a health care provider, such as a physical therapist, and not be able to
prescribe medication. The term prescriber is used in a U.S. Government report on doctor
shopping (United States National Prescription Drug Abuse Prevention Strategy, 2009) as well as
laws pertaining to doctor shopping. For the purposes of this paper, the term prescriber will be
used to describe healthcare professionals who prescribe medication.
A concept analysis of doctor shopping, based on the literature, defines doctor shopping
as: a) when a patient visits more than one prescriber in a 30-day period to obtain controlled drugs
for non-medical uses, b) patients do not disclose to prescribers previous prescriptions for a same
or similar controlled drug, or the prescriber is aware and unscrupulously prescribes the drug
anyway, c) patients fill prescriptions for controlled drugs at three or more pharmacies per year,
and d) patients obtain prescriptions for controlled drugs from five or more prescribers for illicit
use within a one-year period (Worley & Hall, 2012).
Unscrupulous prescribing occurs in doctor shopping when prescribers are aware patients
are seeking prescription drugs illicitly yet choose to prescribe them anyway. Illegal prescribing
by unscrupulous physicians is a significant source of diverted pharmaceuticals (U.S. National
Drug Intelligence Center, 2004). Reasons for this include profiting from numerous patients
receiving prescriptions for controlled drugs, in which case they are referred to as “script doctors”
(Cicero et al., 2011; Inciardi et al., 2009), as well as under the table payments, exchange for
illicit drugs, and sexual favors (Rigg et al., 2012).
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Historical Perspective of Prescription Drug Monitoring Programs
Certain measures have been implemented in an effort to reduce the incidence of
prescription drug abuse including the advent of PDMPs. In this section I will outline and discuss
a historical perspective of PDMPs as well as issues pertaining to their use. Prescription drug
monitoring programs are electronic databases started in 2003 to provide a way for healthcare
professionals who prescribe medication to look up which prescriptions their patients have had
prescribed in order to detect doctor shopping (Worley, 2012b). Prescription drug monitoring
programs have been shown to deter doctor shopping (National Alliance for Model State Drug
Laws, 2011). Currently 49 states have laws providing for PDMPs, 44 states have active
programs and 5 states have programs that are not operational either due to being in the process of
implementation or lack of funding (National Alliance of Model State Drug Laws, 2013). Most
programs are reactive, meaning that prescribers must log on to the system in order to retrieve
information. Currently only seven states have laws mandating prescribers or pharmacists to
check the database in certain circumstances (National Alliance of Model State Drug Laws,
2012b). Enforcing prescribers checking PDMPs is problematic and currently there is no
nationwide PDMP so patients can cross state lines to prevent detection. Less commonly, some
states have more elaborate and expensive reactive programs that notify prescribers of suspected
doctor shopping behavior.
Research is lacking on prescribers’ use and barriers to use of PDMPs. Two older survey
studies done with pharmacists and physicians on older now extinct pilot reactive PDMPs found
that barriers to PDMP use included lack of time, lack of knowledge, perceived government
oversight, information not viewed as necessary, and lack of Internet access (Barret & Watson,
2005; Ulbrich, Dula-Clark, Green, Porter, & Bennett, 2010).
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Review of Empirical Literature
In order to determine the state of the science related to prescription drug abuse, this
section details a thorough review of literature related to this phenomenon. Despite the enormity
of the prescription drug abuse epidemic, a search of databases CINAHL, PubMed, and
PsycINFO revealed there have been relatively few research studies in this area done with
women, and even fewer on the phenomenon of doctor shopping. In order to review the literature
on women and substance abuse, searches were done using the terms women and drug abuse,
women and substance abuse, and women and drug addiction. Studies focusing on illicit as well
as prescription drug abuse related to women have been included. All studies located by doing a
search for prescription drug abuse, prescription drug diversion, and doctor shopping are
included.
In this section I first summarize the findings of illicit drug abuse in studies done with
women or those that include gender differences. The focus areas that were identified in these
articles are comorbidity of mental illness, physical illness, and history of abuse. In addition, a
summary of other significant research findings in this literature is included. Next, articles related
to prescription drug abuse in women or those that focus on gender differences is summarized in
the areas of comorbidity of mental illness, history of abuse, and polysubstance abuse.
Additionally sections are included on reasons for prescription drug abuse, method of obtaining
prescription drugs, treatment for prescription drug abuse and other findings in studies on
prescription drug abuse. This is followed by a comparison of findings between studies on illicit
and prescription drug abuse. A section reviewing the literature on patterns and tactics of
prescription drug diversion is then included. Finally, the research articles on doctor shopping is
summarized and includes the topics of doctor shopping rates for benzodiazepines, doctor
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shopping related deaths, and scope and magnitude of doctor shopping. Identified gaps in the
literature are then discussed.
The majority of research in the field of substance abuse has been conducted in the field of
psychology. In PsycINFO the first study on women and drug abuse was by Hall (1938) who
conducted a study with women ‘drug addicts’ in a reformatory. For the next few decades,
studies with women were scarce and focused on alcohol abuse rather than drugs. Studies
including women with drug abuse began to appear with more regularity in the 1980s. These
predominantly have focused on specific populations of women such as pregnant women, those
HIV positive, or those who are incarcerated. Initially studies in the field of substance abuse
focused on those abusing illicit drugs, followed by prescription drug abuse and more recently,
doctor shopping. Because I am interested in the general phenomenon of doctor shopping, for
this review I am including studies done including women with substance abuse in general, and
not those in specific populations.
Comorbidity of Mental Illness and Illicit Drug Use
Several studies identified a co-occurring mental health diagnosis in participants with
illicit drug abuse. Gender differences in an aging cohort of people with a history of heroin
dependence were studied by Grella and Lovinger (2012). In this study the Medical Outcomes
Study 36-item Short-Form Health Survey, the Symptom Checklist and Beck Depression
Inventory were used with no reliability or validity data provided. Participants in this study were
sampled from a methadone clinic in the 1970s and completed follow up interviews between 2005
and 2009. Results of this study include that at a younger age women had more chronic mental
health problems than men.
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Another gender comparative study was done in India by Pant and Bagrodia (2003) with
15 men and 15 women from a residential drug rehabilitation program in order to identify
psychosocial factors related to substance abuse. Data were gathered by using the Personal data
sheet which is a semi-structured questionnaire, and the Bell’s Adjustment Inventory. Specific
information and reliability and validity of these instruments were not provided. A large
percentage of the women in the study (60%) reported using drugs to escape from immediate
stress and difficulties. The researchers examined home, health, social, and emotional adjustment
and found that women had very unsatisfactory home adjustment.
In order to determine the relationship between victimization, psychological distress and
high risk behavior among women who abuse substances, Golder and Logan (2011) collected data
from 149 sexually active crack-using women who had participated in an AIDS prevention
program. In this study trained interviewers asked questions which were adapted from several
measures. For psychological distress four measures were operationalized and measured by the
Global Severity Index derived from the Brief Symptom Inventory. Analysis of these measures
was not provided. The overall level of psychological distress in the women who abused illicit
drugs was found to be well above that of female psychiatric patients. Loneliness was measured
by the Loneliness Scale described as being reliable based on alpha = .90. In the participants,
loneliness was found to be predictive of crack and alcohol use.
Hutchinson (1986) conducted an early qualitative grounded theory study with chemically
dependent nurses, and found that the base psychological problem was emotional pain. In this
study participants described abusing drugs in order to survive day-to-day life and to feel better
during stressful times. The researchers concluded that participants attempted to resolve or
obliterate psychological pain through the ingestion of chemicals.
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Shinebourne and Smith (2011) used images of addiction and recovery in an interpretive
phenomenological analysis. The researchers studied six female participants who were asked to
bring artwork made earlier in their recovery to an interview in addition to being asked to draw
during their interview. The authors discuss the results from one of those participants and
highlight her emotional experience of substance abuse. Analysis was made of both the artwork
and the transcript from the interview. Three themes emerged from the artwork and interview
with the featured participant; ‘I see things through different eyes now’, ‘I couldn’t see anything
on the horizon’, and ‘I’m trying to figure out who and where I am’. In the theme ‘I see thing
through different eyes now’, the participant relates to representation of recovery at present which
is evident in her drawings of an idyllic landscape, described as an oasis, or in the image of a bird
or dolphin associated with freedom. In the drawing of the dolphin and bird there was an
absence of ground, which may signify she is adrift or as a reminder of the need to stay vigilant.
In the ‘I couldn’t see anything on the horizon’ theme, her drawings reflected wastelands, desolate
landscapes, and a punishing sun which may reflect resentment, ambivalence, and isolation. In
the ‘I’m trying to figure out who and where I am’ theme, the participant drew handprints, an
addiction eye that does not see, and a black serpent, which allude to struggling to figure things
out, renewal, and fear.
Engagement was the focus of a qualitative semi-structured interview study by Godlaski
Butler, Heron, Debord, and Cauvin (2009). Twelve rural women in substance abuse treatment
were interviewed about their state of mind before entering treatment, what experiences caused
them discomfort in treatment, and changes they would recommend in treatment in order to
understand factors that might influence comfort and engagement with treatment. Significant
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characteristics of the women in the study included that nine of the 12 women stated they were
either extremely or considerably troubled by emotional problems.
Twelve women participated in a qualitative semi-structured interview study by Aston
(2009), to understand how rural women with addictions are hailed into identities of self-asaddict, through the interpretive lens of interpellation. Facets of hailing as a process were
identified in the transcripts of the interviews, including that it took time for the women to come
to terms with seeing themselves as addicts. The interviews were also analyzed to provide insight
into the readiness of the women to be hailed as addicts. The women reported they had suffered
enough and came to a turning point where eventually they became ready and willing to accept
themselves as addicts. The participants’ responses in relation to their perception of hailing a
failed performance were discussed, including that multiple authorities worked unknowingly
together to hail them as addicts. The authors concluded that women with addictions are hailed
by the addiction services and supports they encounter to accept or reject an identity of self-asaddict. Hailers included friends, health care professionals, police, parents, employers and the
media. These hailing encounters had a cumulative negative effect on the women.
To understand the changes that take place in social environments that enable individuals
suffering from an addictive disorder to break the cycle and achieve recovery, Watson and Parke
(2011) conducted several semi-structured interviews with five heroin addicts which were then
analyzed through what is described as an interpretive phenomenological analysis. Three themes
emerged from the data: childhood experience, psychological symptoms and perceptions of
recovery. In the theme of childhood experience, relationships and rejection was a subtheme and
participants’ described themselves as ‘outsiders’ and ‘black sheep’. Death and loss was also a
subtheme in childhood experiences, and the women recounted experiences and memories of
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deaths of family members or friends. Manifestations described in the psychological effects theme
included depression, panic attacks, and paranoia. In the perceptions of recovery theme, lost
childhood and ‘my rock bottom was fear’ were the subthemes. Participants described themselves
as deviating from normality, and fear was intricately involved in recovery. The authors of this
study concluded that fractures in the mother-daughter relationship were evident in all the
narratives, which generated feelings of rejection and isolation, and impacted the daughters’
identity and ability to build relationships.
A life history study conducted with 26 women in treatment for substance abuse by
Woodhouse (1990) included the data collection methods of life line exercises, focus groups,
interviews, and written segment exercises in order to understand and highlight women’s
experiences within the context of their worlds. A common theme among the participants was
their experience of motherhood. All the mothers in the study expressed feeling great
psychological pain related to the negative effect their substance abuse had on their children.
It is clear from the results of studies done with women who abuse illicit substances that
this use is associated with mental health problems. Prior losses and other difficulties were noted
in many of their childhoods and their substance abuse also negatively affected other people in
their lives, such as their children.
Comorbidity of Physical Illness and Illicit Drug Use
Nurses in the qualitative study previously described by Hutchinson (1986) reported using
drugs to self-medicate physical pain in addition to psychological pain. Participants described
painful physical conditions associated with drug abuse such as backaches and migraines. In
studying the aging heroin users, Grella and Lovinger (2012) measured health conditions based on
the respondents’ self-report of having any of 16 chronic health conditions. They found that at a
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younger age, women had more chronic physical health problems than men, including heart
disease, diabetes and liver disease.
In a phenomenological representative case method study done by Furrer (1991)
psychological testing, as well as semi-structured interviews, were conducted to study six women
who abused either heroin or cocaine. In that study, all of the women reported acute adverse
physical reactions to drugs including hospitalization, but none reported lasting effects other than
sinus problems or high blood pressure.
These studies highlight a relationship between physical health problems and substance
abuse. This is a significant finding as physical health problems have a profound impact on the
quality and longevity of an individual and highlight the serious longstanding effects of substance
abuse.
Comorbidity of History of Abuse and Illicit Drug Use
A history of physical or sexual abuse is a common finding in research on women who
abuse substances. In the study done in India by Pant and Bagrodia, (2003) which used semistructured questionnaires, 79% of the women addicts began using drugs due to the influence of
their husbands including beatings and coercion to use drugs. Data about victimization were
obtained in structured interviews and were reported in 94% of the crack-using women in the
previously mentioned study by Golder and Logan (2011). Intimate partner violence was noted
by 84% of the participants. Interpersonal violence predicted crack use, and childhood
victimization and psychological interpersonal violence predicted psychological distress in
multivariate models. In the qualitative study by Godlaski et al. (2009), six of the 12 women in
substance abuse treatment had a history of physical abuse and six had a history of sexual abuse.
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Victimization was also a theme identified in the qualitative study by Watson and Parke (2011)
which used semi-structured interviews to examine addiction and recovery in heroin addicts.
In the life history study by Woodhouse (1990) with 26 women, half of them had been
raped or sexually abused and described medicating their emotional pain with drugs.

In another

life history study by Etherington (2006), one woman’s story from the United Kingdom was
analyzed. Her childhood was chaotic and violent. She lived with an abusive aunt who also
abused substances. She had an abortion at age 14 and then lived with an abusive boyfriend
starting at age 15. She became pregnant again at that age and was physically abused and took
drugs throughout her pregnancy. In the study by Furrer (1991) four of the six women had been
sexually abused as children and 50% were physically abused. Four of the six women also
reported being battered in relationships as teens or adults.
These studies provide evidence that a history of being physically or sexually abused in
childhood is associated with substance abuse in later life. Victimization from interpersonal
violence as an adult is also associated with abuse of substances.
Other Research Findings Related to Illicit Drug Use
In the previously mentioned gender comparison study done in India, 79% of the women
addicts began using drugs due to the influence of their spouses (Pant & Bagrodia, 2003).
Another difference between men and women in this study was the reason for seeking treatment.
The women sought treatment because they were unable to care for their families, whereas the
men more often sought treatment because they were forced to do so. In the life history study
previously mentioned by Woodhouse (1990), the women participants saw themselves as not
having an identity without men and as being dependent on men. Additionally, they reported
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being introduced to drugs by a man, they shared a commonality of not purchasing the drugs they
abused, and they described themselves as being functional in their lives.
The findings from these few studies suggest that men may often or sometimes play a role
in initiation into substance abuse for women. Additionally, women who abuse substances may
face issues of dependence or reliance on men.
Comorbid Mental Illness and Prescription Drug Abuse
In order to determine psychiatric and pain characteristics of prescription drug abusers,
Passik, Hays, Eisner, and Kirsh (2006) collected both quantitative and qualitative data in a study
of both males and females entering drug rehabilitation. The Structured Clinical Interview for
DSM-IV was used to assess substance use disorders, mood disorders and psychotic disorders.
Interrater reliability for this instrument is described as having a weighted kappas of 0.61 for
current disorders and 0.68 for lifetime disorders. In this study there was no statistical difference
between males and females for mental health diagnosis. Fifteen percent of participants (n = 109)
met criteria for an additional mental health diagnosis such as mood disorder.
Gender differences related to risk of opioid misuse among chronic pain patients were
studied by Jamison et al. (2010) previously mentioned, who performed a longitudinal predictive
study of 275 males and 335 females. The participants completed several questionnaires,
including the Prescription Drug Use Questionnaire which includes information on psychiatric
history. Reliability and validity information for this measure were not provided. Gender
differences were identified in this study in that women identified more emotional issues and
affective distress related to their prescription drug use than did men. Women were more likely
to admit to a history of psychiatric problems than men. The authors state that their study
suggests this puts women at greater risk to misuse prescription opioids. Women with a history of
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depression or anxiety also tended to do less well in managing prescription opioids and had a
tendency to self-medicate.
Gender differences were also examined by Back et al. (2010) in an analysis of findings
from the National Survey on Drug Use and Health. In that study women’s, but not men’s,
prescription opioid abuse was also associated with serious psychological distress. In another
study by Back, Lawson, Singleton, and Brady (2011), researchers examined gender differences
in a group of 12 men and 12 women, recruited via newspapers and flyers, who were not in
treatment. The findings suggested that women were more likely to use prescription opioids in
order to cope with interpersonal stress and less likely to use them for physical pain.
Quality of life (QOL) was studied among women in substance abuse treatment by Tracy,
et al. (2012). A theoretical framework was not listed as being used in this study. A quality of
life measure developed by the World Health Organization was used in this study using
instruments stated to have excellent psychometric properties and moderate to high reliability as
evidenced by a Cronbach alpha for each domain ranging from .642 to .806. The Trauma
Symptom Checklist was also used with a Cronbach alpha .931 for the total scale. The Social
Support for Recovery Scale was used along with the Friend’s Support for Abstinence Scale both
with alphas of .881 and .717 respectively. These instruments were used to assess physical,
psychological, social and emotional characteristics of 240 women enrolled in substance abuse
treatment at one and six months post treatment intake. Non-African American status was
associated with lower psychological quality of life. Additionally, the number of mental disorders
was negatively associated with all QOL domains except the environmental domain. Social
support was positively correlated with all four QOL domains.
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As part of a large ethnographic study on marijuana use funded by the National Institute
on Drug Abuse, researchers Bardhi, Sifaneck, Johnson, and Dunlap (2007) identified a small
subpopulation of 12 college educated upper middle class White or Asian women who abused
prescription drugs. These women participated in a qualitative study using semi-structured
interviews developed by the researchers. The questions focused on their past and present history
of prescription drug abuse. Initiation into prescription drug use varied among the participants,
with three of the women reporting initiation for pain relief, four began using out of boredom, and
three for anxiety or depression. Other findings in this study included that there were shifting
patterns of prescription drug use among the participants from legal to quasi-legal to recreational
users.
Another study was done to study prescription drug misuse in adults, both men and
women, who were prescribed anxiolytics and sedatives, which include benzodiazepines. In this
cross-sectional study by McLarnon, Monaghan, Stewart, and Barrett (2011) which did not
specify a theoretical framework, 67 adults who had a current prescription for anxiolytic or
sedative drugs completed a drug list, substance abuse and dependence scale, and substance use
risk questionnaires as well as a structured polysubstance interview adapted from an existing
measure. Specific reliability and validity measures for the instruments used in this study were
not provided other than the authors state the instruments are ‘validated.’ Misuse of prescriptions
was reported by 54% of the participants. Misuse included exceeding their drugs recommended
dosage (42%), and taking the medication for nontherapeutic purposes (21%). Multiple logistic
regression results determined that generalized anxiety disorder and the personality dimensions of
hopelessness and impulsivity were predictive of anxiolytic or sedative diversion. Statistical
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significance was not found in the relationship between psychiatric conditions and prescription
drug misuse. Gender differences were not examined.
Findings from these studies highlight the fact that women who abuse prescription drugs
often have a greater incidence of mental health problems than men. However, two studies did
not find a statistical difference in psychiatric disorders between men and women.
Comorbidity of History of Abuse and Prescription Drug Abuse
In a gender differences study by Jamison et al. (2010), several instruments were used
including the Screener and Opioid Assessment for Pain Patients which is described as having a
test-retest reliability of 0.71 with a coefficient alpha of 0.74. Differences between the men and
women participant results included that women who abused prescription opioids were more
likely to admit to a history of sexual or physical abuse than men. A secondary analysis of data
from the National Household Survey on Drug Abuse which used computer assisted telephone
interviewing to collect data by McCauley (2009) resulted in findings that non-medical use of
prescription drugs was significantly higher in women who had been victims of drug or alcohol
facilitated rape. In the quality of life study of women by Tracy et al. (2012) the Trauma
Symptom Checklist was used, described as having a Cronbach alpha of .931. Findings from this
study included that a history of trauma was associated with lower quality of life in all domains.
Similar to the studies of women who abuse illicit drugs, studies of women who abuse
prescription drugs showed a relationship between a history of physical or sexual abuse and
substance abuse.
Reasons for Prescription Drug Abuse
Male and female participants in the study by Passik et al. (2006) were studied to examine
psychiatric and pain characteristics of prescription drug abusers entering drug rehabilitation.
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One of their measures was the Prescription Opioid Abuse Survey which included qualitative
data. Specific questions that were asked and reliability or validity of the measure were not
provided. Qualitative data gathered in this study included that participants described various
reasons for taking drugs such as increasing energy level, achieving a good feeling, and creating
euphoria. In a mixed methods study done by Daniulaityte, Falck, and Carlson (2012), 51 men
and women were studied including analysis of demographics and prescription drug use variables
such as method and frequency of administration. Qualitative data were collected using
structured interviews. The participants reported they abused prescription drugs to get high, to
self-medicate, or to not abuse other opioids. In the qualitative study of middle class women who
abused prescription drugs by Bardhi et al. (2007), respondents reported they took the medication
for a perceived medical reason such as to relax or to stay up all night to study as well as to get
high.
The results of these studies which examined reasons for prescription drug abuse are
particularly helpful and informative in providing insight into the phenomenon of prescription
drug abuse because they examine underlying causes of use from the participant perspective in
their own words. The varied findings suggest complexity and individual differences in the
reasons for prescription drug abuse.
Comorbidity of Polysubstance Abuse
McCabe, Cranford and West (2008) examined prescription drug abuse and co-occurrence
with other substance use disorders in men and women by analyzing the findings of two national
surveys. The National Longitudinal Alcohol Epidemiological Survey and the National
Epidemiological Survey on Alcohol and Related Conditions were used to assess data on alcohol
use, non-medical use of prescription drugs and substance use disorders along with demographic
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and background characteristics. The findings from this study include that the majority of
individuals with a past-year prescription drug abuse disorder for both time frames studied also
met criteria for another substance abuse disorder such as alcohol, marijuana, or cocaine. In the
study by Passik et al. (2006) with men and women, polysubstance abuse was found in 31% of
people who abused prescription drugs. In addition, all the patients met criteria for a diagnosis of
opioid abuse or dependence. The Bardhi et al. (2007) qualitative study previously mentioned
included excerpts from the participants about their experiences with using prescription drugs
along with illicit drugs such as cocaine, indicating polysubstance abuse.
A secondary data analysis was conducted by Green et al. (2009) using the Addiction
Severity Index-Multimedia Version. Reliability and validity of this instrument was not
provided. This survey was administered to 29,906 people entering substance abuse treatment to
determine the characteristics of women as compared to men who abused prescription opioids.
Unlike men, women’s opioid use was associated with problem drinking. In the study by Back et
al. (2010), illicit drug use was associated with prescription opioid abuse and dependence in
women but not men. In the previously mentioned study by McCauley (2009), non-medical use
of prescription drugs was significantly higher in women with past year illicit drug use or binge
drinking. In the study by McLarnon et al. (2011) participants co-administered their anxiolytics
with alcohol (37%), cannabis (24%), cocaine (9%) and amphetamine (18%). These studies show
polysubstance abuse is common in women who abuse prescription drugs.
Method of Obtaining Prescription Drugs
In the study done with men and women by Passik et al. (2006), 91% had purchased
opioids from a street dealer, 36% had stolen someone else’s medication, 43% had sold
prescription drugs, 43% stole money to buy drugs, and 17% admitted to obtaining their
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prescription drugs by doctor shopping. In the gender differences study by Back et al. (2010),
differences were found in how men and women obtained their prescription opioids. Women
were less likely to obtain prescriptions from family or friends or to purchase them from a drug
dealer.
In the qualitative study by Bardhi et al. (2007), all participants demonstrated one of three
patterns of prescription drug use and shifts were noted among these patterns. The pattern of
legal medical users included women who obtain legitimate prescriptions for controlled drugs but
report nothing wrong with diverting them either through giving the pills to friends or selling
them to others. The quasi-medical user pattern includes women who do not have prescriptions
for the prescription pills they use, but obtain them for free from a friend or family member or by
purchasing them from others. Reasons for taking the medication included a perceived medical
reason such as to relax or to stay up all night to study. The final pattern is recreational users who
obtain their prescription pills from friends or family or purchase them from others to get high or
as an adjunct to illegal drugs to counteract the side effects.
How prescription drugs were obtained was a theme found in a case study undertaken to
understand the issues of prescription drug abuse in the elderly. One family’s experience was
examined by Morgan and Brosi (2007) using human ecological theory as a guiding framework.
The researchers studied 12 mother-adult dyads and reported findings from one of the cases. The
featured caregiving daughter was interviewed about the care system and arrangement and
experience of providing care to an elderly parent. The mother was interviewed about the care
arrangement to understand the history of care in the family, perceptions of care over time, and
beliefs about filial responsibility. The 80-year-old mother in this case was addicted to
prescription drugs. The daughter spoke of her experiences taking her mother to prescribers and
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how she may have unknowingly contributed to her mother’s drug-seeking behavior. Later she
fought to educate prescribers about her mother’s prescription drug abuse which caused conflict.
The mother in the case study did not talk about her daughter’s involvement in her drug seeking.
Both women talked about how caregiving had changed and strained their relationship. The
daughter spoke of the relief she felt when her mother was placed in an assisted living facility and
could no longer go to prescribers to try to obtain prescriptions. The authors in this study created
a human ecology model applied to the mother and daughter participants and made
recommendations such as improved training of healthcare professionals to recognize and treat
prescription drug abuse in the elderly.
These studies show that women who abuse prescription drugs do report obtaining
prescriptions from numerous prescribers. One of the studies showed that women were less likely
than men to obtain their prescriptions from dealers or friends or family. Another study showed
that women who abused prescription drugs obtained the drugs for free from family or friends or
purchased them from others.
Treatment for Prescription Drug Abuse
In the study of both men and women prescription drug abusers by McCabe et al. (2008),
the majority of individuals with past-year prescription drug abuse had not utilized substance
abuse treatment in the past 12 months. Fewer women than men had received alcohol or drug
abuse treatment in the study by Back et al. (2010). These findings may indicate a lack of
treatment options or the presence of barriers to treatment for women.
Other Research Findings Related to Prescription Drug Abuse
Chronic pain was identified as being present in 61% of the men and women who abused
prescription drugs in the Passik et al. (2006) study. However, in the gender differences study by
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Green et al. (2009), women who abused prescription drugs were less likely to report
experiencing pain than men, but more likely to report other medical problems. In the qualitative
study by Bardhi et al. (2007) three of the 12 women reported initiating prescription drug abuse
due to pain. In the Green at al. (2009) study, women’s prescription drug abuse was associated
with a history of overdose. The majority of men and women in the study by Back et al. (2011)
reported being first introduced to prescription opioids through a prescription from a physician for
legitimate pain. In the large survey by Cicero et al. (2011), women over age 45 years with
insurance and of higher socioeconomic status were more likely to use doctors’ prescriptions as a
source of abusing controlled prescription drugs.
Bardhi et al. (2007) reported that most of the women in their study claimed to avoid
dependence on their prescription drug use, believed obtaining prescription drugs from others was
acceptable, used prescription drugs in conjunction with other drugs, and obtained prescription
drugs relatively easily. General practitioners were perceived as being more willing to write
prescriptions for controlled drugs than those in psychiatry. McLarnon et al. (2011) reported
misuse of their prescriptions for benzodiazepines in 54% of the participants. In addition, 52%
reported diverting their medications by either giving it away or selling it to others.
Comparing Findings Between Illicit and Prescription Drug Abuse
In the majority of studies that have examined mental health in women as compared with
men with both illicit and prescription drug abuse, women struggle to a greater degree with
mental health problems and distress related to both illicit and prescription drug abuse. Women
tend to abuse both illicit and prescription drugs to self-medicate and cope with painful emotions.
In addition, women who abuse both illicit and prescription drugs had higher rates of being
victimized by sexual or physical abuse including rape. This abuse was identified as a precursor

46

to illicit and prescription drug abuse. In these cases, drugs were abused to medicate the
emotionally painful sequelae of past abuse.
Patterns and Tactics of Prescription Drug Diversion
The nature, scope and magnitude of prescription drug diversion was studied by Cicero et
al. (2011) through the results of a survey of opioid dependent patients entering treatment (n =
1,983) and focused interviews using standardized instruments with opioid abusers in South
Florida (n = 782). Demographic information was collected along with illicit and prescription
drug use history and methods to obtain each diverted prescription drug they misused in the last
90 days. Diversion methods included getting prescriptions from doctors who were described as
‘script doctors’ working at pain clinics where narcotic pain medications were readily dispensed,
known as ‘pill mills’, doctor shopping, regular doctor, pharmacist, theft, dealer, sharing or
trading, family, transport from another country, or internet purchase. In the survey sample,
dealers were the primary source of diversion (>50%). A doctor’s prescription, either regular
doctor or doctor shopping, accounted for 25% of the means of diversion. Women were
significantly less likely to use dealers and significantly more likely to use doctors’ prescriptions.
Respondents age 45 years or older were three times more likely to use a medical source for their
prescriptions. Respondents of higher socioeconomic class and those abusing hydrocodone or
methadone were also more likely to use a doctor’s prescription.
In the South Florida sample the researchers did not examine gender differences. The
majority of the participants obtained their prescriptions using dealers (66.6%) followed by
sharing or trading with family (54.6%) and only 13.8% reported obtaining through doctor
shopping or regular doctor. In both samples, participants with higher income and health
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insurance were more likely to obtain prescriptions from doctors. In both samples oxycontin was
the most commonly abused drug followed by hydrocodone.
In another study by Inciardi et al. (2009) with an aim to determine patterns of prescription
drug diversion, data were collected from a diversion and addiction surveillance system, the
National Survey of Drug Use and Health, and other surveys. Additional qualitative data were
analyzed from focus groups with prescription drug abusers in the Miami club culture as well as a
rapid assessment which included in-depth interviews with three prescription drug dealers, and
two prescription pill brokers. Results from six focus groups consisting of patients in residential
treatment programs were also included. The authors sought to gain an understanding of what
they described as the ‘black box’, which is the unknown circumstances surrounding diversion.
Findings from a nationwide survey of police and regulatory agency personnel, who based their
responses on data entered in a diversion system, included that three-quarters of the survey
participants considered doctor shopping (39.4%) and prescription theft or forgery (35%) to be the
main source of diversion. Results from 346 participants entering substance abuse treatment from
a methadone treatment center showed that 75% reported obtaining opioids from drug dealers,
39% from friends or relatives, and 20% from a doctor’s prescription.
Also included in the study by Inciardi et al. (2009) was a survey of 1,472 patients referred
from substance abuse treatment specialists showed that the majority got their prescriptions from
dealers (65%), followed by friends and relatives (64%), doctor’s prescriptions (59%), emergency
rooms (22%), and forged prescriptions (21%). In the 2007 National Survey of Drug Use and
Health, 21,335,000 people reported non-medical use of prescription opioids. The majority of
these respondents obtained their prescriptions from friends or relatives for free (57%) followed
by prescriptions from one doctor (18%), friend or relative for purchase (9%), friend or relative

48

stolen (5%), and dealers (4%). Street sex workers were also surveyed and only a small
percentage reported prescription drug abuse (12.2%) as opposed to illicit use (80.4%). These
participants reported obtaining prescription drugs most often from friends or relatives (68.1%),
street buys (30.6%), clients or other sex workers (4.2%), script doctors (4.2%), and theft (1.4%).
Doctor shopping was not identified as a means to obtain prescriptions in this population. In a
survey of 515 club drug users, all of them reported using prescription drugs for recreational
purposes during the past 90 days. The most common drug abused was alprazolam, a
benzodiazepine, followed by oxycodone and hydrocodone, both narcotic opioids. These
participants obtained their drugs from local drug dealers (75%), sharing or trading with friends
(<50%), or from family members (25%). Only 3% of these participants reported engaging in
doctor shopping.
Focus groups were done with 27 ethnically diverse men and women connected to the club
scene. A common theme in the focus groups was Medicare and Medicaid fraud as mechanisms
for obtaining prescription drugs. Situations described included people selling their prescriptions
in order to obtain illicit drugs, and young people paying elderly people to obtain prescription
drugs which they then sold. Eight drug dealers described methods of obtaining prescriptions
which included buying drugs brought in from Mexico, and purchasing from other dealers.
Results from the rapid assessment focus groups included that members of the elderly
population in that community were in the business of duping their physicians with complaints of
pain in order to obtain prescriptions for pain medication to sell for economic reasons. Some sold
their prescriptions themselves or to dealers. Another finding was patients with legitimate pain
often sold part of their prescriptions for profit or in exchange for illicit drugs. Pill brokers,
dealers and sellers often congregated in open air drug markets such as strip malls and pharmacy
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parking lots, and outside methadone clinics to buy, sell, or trade prescriptions. Less commonly,
doctor shopping was identified by the focus group participants as a source of diversion (Inciardi
et al., 2009).
A qualitative study was conducted in London during 1995 and 1996 by Fountain et al.,
(1998) with buyers and sellers of prescription drugs to understand the tactics used to obtain
prescription drugs which were then resold. In this study, qualitative research techniques,
described as observation, conversation, and unstructured interviews surrounding the issue of
diversion, were used with an unstated number of participants recruited from over 100 drug users.
Diversion techniques included: a) multiple scripting by obtaining more than one prescription
from different treatment services, b) overscripting by obtaining a surplus of drugs to sell, c)
exaggerating a habit by telling prescribers they were taking more medications than they actually
were to get a prescription for a higher quantity of pills, d) bargaining with prescribers by telling
prescribers they were having to commit crimes to obtain illicit drugs in order to be prescribed a
prescription such as methadone, e) false identities used with different prescribers to obtain
prescriptions, f) gaining sympathy by telling prescribers “sob stories” to obtain prescriptions, g)
feigning addiction to obtain prescriptions such as methadone or benzodiazepines for withdrawal
symptoms, h) becoming a temporary resident by traveling miles to different localities to visit
prescribers, i) forgery after having stolen or bought blank prescriptions, j) feigning symptoms
such as pain, insomnia or attention deficit disorder (ADHD) in order to obtain prescriptions, k)
pretending to be an injector in order to obtain injectable methadone, l) one off tactics by claiming
liquid medication was dropped, or pills were lost or stolen, j) and enjoying the game by
experiencing enjoyment from outwitting prescribers.
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Rigg et al. (2012) conducted semi-structured interviews with 50 prescription drug sellers
in South Florida to understand patterns of prescription medication diversion among drug dealers.
The ethnically diverse sample included 36 men and 14 women ranging in age from 20 to 53
years old (mean = 33 years). Six themes were identified in the interview transcripts: a) the
omnipresence of opioids, b) pain clinic shopping, c) sponsorship, d) buying scripts, e) using a
‘connect’, and f) healthcare fraud. Sellers in this study obtained the majority of their prescription
drugs from pain management clinics. Opioids and benzodiazepines were obtained by presenting
a magnetic resonance imaging (MRI) report and complaints of pain to a pain doctor. In some
cases special arrangements were made with pain doctors including recruiting additional patients,
sexual favors, exchanging illicit drugs or under the table cash payments. Doctor shopping was
described as the ‘norm’ among dealers who reported visiting pain clinics for prescriptions, at
times 10 or more pain clinics a month, to obtain prescriptions for large quantities, up to 240 pills
or more for one drug.
Sponsorship was also reported among the sellers which involved subsidizing someone
else’s trip to pain clinics, the cost of the visit, the cost of the prescription, transportation costs,
and the cost of a MRI. In return, the dealer required 50-75% of the medication obtained, often
from 16 to 50 people per month. Dealers who bought prescriptions from others typically did so
from veterans, Medicare and Medicaid recipients, crack or heroin addicts, or HIV/AIDS patients.
Connects are described as people with connections or access to prescription drugs such as those
who work at healthcare facilities including pharmacies, medical offices or hospitals, in addition
to those with access to blank prescription pads. Healthcare fraud was committed with fake
MRIs, fake prescriptions and billing Medicare or Medicaid for costs of prescriptions that were
sold for profit.
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Using mixed methods, Green et al. (2013) studied 195 participants were studied to assess
collaboration and coercion in partnering to divert prescription opioids as part of a rapid
assessment and response process in Connecticut and Rhode Island. Key informant interviews
were conducted with 143 participants as well as 52 anonymous brief intercept surveys. The
interviews were recorded and the transcriptions analyzed using a coding scheme for themes, one
of which was partnership as a pattern of prescription opioid diversion. In some cases this was
collaborative, involving situations where both partners benefited from the diversion such as by
sharing rides in exchange for pills. Exploitive partnering was also noted in some instances where
one member took advantage of the other to get access to prescription opioids such as when
elderly or disabled persons were coerced into going to doctors to obtain prescriptions.
These studies show a wide variety of diversion tactics including doctor shopping are used
as methods of obtaining prescription drugs for abuse. Working together or purchasing pills from
other addicts was also noted in these studies.
Doctor Shopping for Benzodiazepines
Pradel et al. (2010) studied the abuse potential of benzodiazepines, a class of controlled
drugs used to treat anxiety, using doctor shopping as an indicator through a secondary data
analysis of health insurance claims from a region of France. All prescriptions for
benzodiazepines reimbursed for a one-year period were assessed. Benzodiazepines were
classified for their abuse potential from very high to low. The researchers calculated a doctor
shopping indicator, defined as the overlap between prescriptions from different prescribers.
During the study period, 12% of the population received at least one prescription for a
benzodiazepine. Doctor shopping indicators were calculated for 14 benzodiazepine medications.
The range of doctor shopping indicators was 0.3% to 42.8%. Through statistical analysis the
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authors concluded that the expected doctor shopping indicator for all benzodiazepines combined
was 2.6% but the observed doctor shopping indicator found was 3.6%, which was 38% greater
than expected, accounting for 361,428 daily doses.
Hospitalizations for Poisoning by Prescription Drugs
Nationwide data of unintentional poisoning by prescription opioids, sedatives, and
tranquilizers examined by Coben et al. (2010) found that the rate of hospitalizations for these
poisonings increased by 65% from 1999 to 2006. The largest increase in poisonings was
involved benzodiazepines. When compared to other hospitalizations for poisoning, women over
the age of 34 were more likely hospitalized for poisoning by opioids, sedatives and tranquilizers
and presented at rural or urban nonteaching hospitals.
Prescription Drug Related Deaths
A secondary data analysis of a forensic drug database was conducted to examine
characteristics of all alprazolam-related deaths in West Virginia between 2005 and 2007
including demographics, toxicology and comorbidity information. Shah et al. (2012) found that
alprazolam, a benzodiazepine, contributed to 17% of all the drug-related deaths during that time
frame and at least one other drug, predominantly an opioid, was identified in 97.5% of the
alprazolam cases. An alprazolam prescription existed in 52.5% of the alprazolam deaths and a
prescription for all drugs identified existed in 77.6% of the cases. In several cases, two
benzodiazepines were detected on autopsy and in 63% of those cases, prescriptions for both were
noted. Since concomitant use of two benzodiazepines such as alprazolam and diazepam is not
recommended, the researchers determined that inappropriate prescribing, doctor shopping, and
inconsistent use of PDMPs occurred. The number of prescribers was not evaluated in this study.

53

The results of the study included that alprazolam was a contributing cause of death in a
substantial and increasing number of drug-related deaths.
Doctor Shopping Related Deaths
A secondary data analysis using a case-control design was conducted using controlled
substance prescription data from the West Virginia Controlled Substance Monitoring Program.
Drug-related death data from the Forensic Drug Database over a two-year period was analyzed
by Peirce et al. (2012) to identify factors related to the odds of drug-related death and for the
incidence of doctor and pharmacy shopping. The researchers compared subjects who were
dispensed a controlled substance who were living (control) with those who were in the drugrelated death group (case). Approximately one quarter of the deceased group were doctor
shoppers compared with 3.6% of the living group. Pharmacy shopping was noted in 17.5% of
the deceased group compared to 1.3% of the living group. In addition, a significantly greater
proportion of doctor shoppers were also pharmacy shoppers when compared to non-doctor
shoppers (20.23% vs. 0.60%). Using logistic regression, it was determined that subjects who
were older had less odds, and subjects with the greatest number of prescriptions dispensed had
greater odds of drug-related death. Doctor shoppers had twice the odds of drug-related death.
Subjects who filled a prescription for an opioid or a benzodiazepine had significantly greater
odds of drug-related death. A relationship between doctor and pharmacy shopping was found
although one was noted to occur without the other. In this study 80% of doctor shoppers were
not pharmacy shoppers and 44% of pharmacy shoppers were not doctor shoppers. The authors
conclude that both shopping behaviors impact medication safety among patients.
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Scope and Magnitude of Doctor Shopping
Cepeda et al. (2012b) conducted a large secondary data analysis was done on opioid
shopping behavior using 65% of all retail pharmacy prescription records in the United States.
The authors do not use the term ‘doctor shopping’ but instead define opioid shopping as at least
one day of overlapping dispensing of opioids written by two or more different prescribers. They
also studied filling prescriptions at multiple pharmacies. Rates of opioid shopping were
compared to overlapping prescriptions for benzodiazepines and diuretics. Diuretics are not
known to have abuse potential. Findings from this study include that 13.1% of all prescriptions
during 18 months of follow-up involved an overlapping prescription for opioids by at least two
prescribers, 9.8% occurring in prescriptions benzodiazepines, and 13.8 for diuretics. With the
additional criteria of filling prescriptions at three or more pharmacies, opioid shopping occurred
in 0.18% of cases, 0.10% of benzodiazepines and only .03% of diuretics.

The authors conclude

that having overlapping prescriptions by two or more prescribers filled at three or more
pharmacies clearly distinguished opioids and benzodiazepines from diuretics and is predictive of
shopping behavior.
Gaps in the Literature
There is a paucity of research on the phenomenon of doctor shopping. Predominantly, the
available studies have been done with specific populations such as drug dealers, street sex
workers, and those from the club scene in South Florida. These studies reveal a heavy reliance
on obtaining prescription opioid from pain clinics or pill mills. At that time, Florida was widely
known for having a problem with an abundance of pill mills, but since that time Florida has
implemented a PDMP, as well as strict laws regulating pain clinics in an effort to combat and
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shut down pill mills. More studies are needed on doctor shopping in general populations because
findings may be different from specific populations.
Qualitative studies done on prescription drug diversion have been done using structured
or semi-structured interviews or focus groups. Additional qualitative studies are needed using
other qualitative methods in the area of prescription drug diversion and doctor shopping with
many populations, including women to increase understanding which would provide additional
information to develop instruments and interventions. At present there is a complete lack of
research on prescribers’ experiences or decision making when prescribing controlled drugs.
Studies are also needed on prescriber use of PDMPs and perceived barriers to their use. There is
a lack of quantitative studies to measure doctor shopping because instruments have not been
developed. Interventional studies to reduce the incidence of doctor shopping are also lacking.
This qualitative study on the experience of female doctor shoppers will be a significant
contribution to the literature in that it provides an avenue toward a better understanding of the
phenomenon of doctor shopping related to prescription drug abuse. Since people who engage in
doctor shopping have not previously been interviewed by researchers using the method of
existential phenomenology, themes identified in the research findings may suggest new
directions for scholarly investigation and clinical intervention.
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Chapter III
Methodology
The purpose of this study is to examine the experiences of female doctor shoppers. In
this chapter I explain the method I used in this qualitative study on the experiences of women
who engage in doctor shopping. In this section I further elaborate on the existential
phenomenology of Merleau-Ponty. I describe the method used in purposive sampling, and
collecting data. I describe the University of Tennessee Knoxville (UTK) method of
phenomenology (Thomas & Pollio, 2002) which was used in this study. Finally, study rigor and
threats to rigor is addressed.
Qualitative Research Design
A qualitative approach was appropriate for this study due to the paucity of research
available on the phenomenon of doctor shopping. The qualitative study method was useful to aid
in the discovery of insight and meaning (Sandelowski, 2008). Findings of qualitative studies can
contribute to concept and theory development as well as interventions, changes in health care
policies, and in the development of quantitative instruments (Kearney, 2001; Morse, 2012;
Sandelowski, 2008). I chose to explore the experience of women who engage in doctor
shopping using a phenomenological approach. This approach was appropriate when studying the
experience and perception of the person within the environment. This understanding is
important and involves a relationship between the patient and their environment, which includes
the prescriber, with subtleties and complexities that can be captured through a phenomenology
study (King, 2006).
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Historical Perspective of Existential Phenomenology
Existentialism can been described as the search and journey for true self and true personal
meaning in life. Key assumptions in existentialism include that humans have a special existence
that points beyond itself which cannot be assimilated to the mode of existence of nonhuman
things and that it is possible to overcome the error of conceiving of ourselves as estranged from
the world by revealing the dependence of a significant world upon human meaning-bestowing
practices (Shand, 2010).
Soren Kierkegaard was a Danish Christian philosopher (1813 – 1855) who is considered
the first existentialist. Kierkegaard was born into a wealthy Danish family and his life was
influences by a broken engagement. He studied theology, philosophy and religion at the
University of Copenhagen. He was a prolific writer of several essays and kept journals that were
often published under pseudonyms. He studied how one lives as a single individual giving
priority to concrete human reality over abstract thinking highlighted by the importance of
personal choice. He explored emotions and feelings related to choices. He believed life is
experienced in distinct stages: a) aesthetic, concerned with experience and materialism which
leads to boredom, which gives way to b) ethics, and then to c) religion (Stanford Encyclopedia of
Philosophy, 1996).
German born Edmund Husserl (1858 – 1938) became known as the founder of
phenomenology. Husserl received his PhD in mathematics and became interested in and studied
philosophy. His first publication was on the philosophical foundations of mathematics in 1887.
He later became a professor of the University of Germany. He was greatly affected by the
serious injuries and eventual death of one of his sons who fought in World War I, as well as by
the Nazi movement. His philosophy focused on how objective knowledge arises in and for a
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person through experience (Drummond, 2008). He sought to focus on a phenomenon without
any presuppositions, focusing on what is known, not how it is known (Tameri Guide for Writers,
2010).
Martin Heidegger (1879 – 1976) studied under Husserl and is readily associated with
existentialism and phenomenology. Although he rejected Husserl’s views focusing on
consciousness, he eventually took over a teaching position vacated by Husserl. He published an
acclaimed philosophical book titled Being and Time in 1927. Heidegger was controversial
because he joined the Nazi party, but his work is significant in regards to existential
phenomenology because of his focus on the meaning and experience of being (Stanford
Encyclopedia of Philosophy, 2011). Jean Paul Sartre (1905 – 1980), another well-known French
novelist is famous for his defense of atheistic existential philosophy which focused on the human
experience of being. He believed in two kinds of being: being in itself, having no reason for its
being, it just “is” and being for itself; both of which corresponds to human consciousness. He
also characterized human existence by “nothingness” (Stanford Encyclopedia of Philosophy,
2004).
Phenomenology of Merleau-Ponty
The French philosopher Merleau-Ponty (1908-1961) was influenced by the works of
Husserl, Sartre, and Heidegger (Thomas, 2005). His early life was touched by tragedy when he
lost his father in a battle in World War I. He studied philosophy in Paris and later taught in
various universities (Thomas, 2005). Merleau-Ponty further developed Husserl’s and
Heidegger’s phenomenological thinking about ‘being’ and suggested that phenomenology is the
rigorous science of the search for essences. He authored books on the structure of behavior and
the phenomenology of behavior which focused on the lived experience of being in the world
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which supersedes the notion of consciousness (Sadala & Adorno, 2003). I have chosen to use
Merleau-Ponty’s existential philosophy as my guiding philosophy because it is a holistic,
positive, all-encompassing approach to the study of experience, incorporating both Husserl’s
focus on consciousness as well as Heidegger’s emphasis on the state of being.
Merleau-Ponty describes a sense experience as vital communication with the world
making it present as a familiar setting in a person’s life (Merleau-Ponty, 1945/2005). From the
existential phenomenology view, perceived things have figures or forms against background.
Figures and ground co-create each other in human experience (Thomas, 2005). Rather than a
literal approach to science and a view of the world, meaning is derived through perception of a
persons’ experiences, in relation to existential grounds. According to Merleau-Ponty
(1945/2005) “we must therefore rediscover, after the natural world, the social world, not as an
object or sum of objects, but as a permanent field or dimension of existence” (p. 1269). In this
sense there is a more fluid illuminating interaction between a person, their world, time, their
body, and others. The experience and response to others, body, time and the world is an
individual and unique experience. These unique experiences however, can share common
threads and themes. These themes and their structure can help increase understanding of a
phenomenon and can be used to describe the meaning of it. Other tenets of the existential
phenomenology method which relate to its applicability in nursing research are intentionality or
relatedness to the world, embodiment wherein the body is a fundamental category of human
existence, and connectedness with others, which is seen by Merleau-Ponty in a positive
beneficial light (Thomas, 2005). These existential grounds of world, body, time and others, are
avenues toward which perception of experience occurs and from which meaning is derived.
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Nurses along with other disciplines have increasingly used existential phenomenology to
conduct research. Early researchers in nursing used the phenomenological method in the 1970’s
and 1980’s (Oiler, 1982; Parse, 1981; Paterson & Zderad, 1976). This approach allows an indepth examination of human experiences which provides a greater opportunity to gain new
perspectives and knowledge insights. When researchers investigate a phenomenon from the
perspective of the experience of the participant, the essence of that experience can be realized
(Sadala & Adorno, 2002). This view differs from traditional research methods which
predominate in the medical as well as other health professional fields where subjects under study
are viewed scientifically as malfunctioning or with complaints or problems that need treatment.
Phenomenological research is useful for my study because I want to listen to the participants and
understand their experience in regard to their perception. Commonalities in their individual
experiences will provide insight and understanding of the meaning of the phenomenon of doctor
shopping.
Ethical Considerations
Institutional Review Board (IRB) approval was obtained from the University of
Tennessee (UT). Participants were informed of the study, both in writing, in the consent form,
and verbally, by the researcher (Appendix A). Participation was voluntary, with no
consequences to subjects who declined to participate or withdrew from the study. A digital
recorder was used to record the interviews which were then sent electronically as a file through
an encrypted password protected program to the transcriptionist who then returned the typed
transcription of the interview through the same program to the researcher. The digital recordings
were destroyed at the completion of the study. The transcriptionist and members of the
interdisciplinary interpretive group signed a confidentiality agreement (Appendix B). Following
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the interview participants were asked to complete demographic questions about age, race, marital
status, education level and occupation (Appendix C). Consideration was taken that describing
events surrounding the experience of doctor shopping could be distressing to participants,
therefore a referral for counseling, or other treatment was offered as stated in the consent form.
However no follow up needs were identified or requested. To protect the rights and minimize
risks to the participants of the study, confidentiality of all interviews and transcripts was
maintained. Pseudonyms were used for any identifying information in the transcripts and no
identifying information was kept with the interviews, recordings or transcripts. All transcripts,
and informed consent forms were kept in a locked file at the office of the researcher during the
study and the consents were then placed in the office of the dissertation chair for a period of
three years.
Bracketing Interview
Initially a bracketing interview was conducted with the researcher using the same
interview questions asked of the participants to highlight the researcher’s pre-understanding.
This was done to increase the researcher’s awareness of prejudgments and biases to facilitate an
open nonjudgmental attitude. The bracketing interview was recorded and transcribed and a
portion of the results were read by the interpretive interdisciplinary phenomenology group at the
University of Tennessee. This facilitated bracketing because the bracketing interview results
were available for reference by the group throughout the data analysis process, as needed, in the
event that issues arose related to interpreting the participants’ transcripts. Insights gleaned from
the bracketing interview included that the researcher would be a need to refrain from taking a
therapeutic approach with the participants during the interviews and that she should avoid
focusing on whether information the participants provided would be factual or not.
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Participant Recruitment
Participants were recruited through a flyer placed in the foyer of a location where
substance abuse support groups are held as well as on a Narcotics Anonymous (NA) bulletin
board in one of the rooms where that group met in the building. A snowballing approach was
used where people who saw or heard of the study were encouraged to refer women who met
study criteria to participate. Flyers included a phone number to schedule an appointment.
Additionally, I attended approximately 15 NA meetings, each time introducing the study, staying
for the meetings and then staying after to talk. This was the method through which most of the
participants were recruited. The study was explained to participants in person or during a
telephone call initiated by the potential participant. An explanation of the inclusion criteria was
provided. Inclusion criteria included age 21 or older, English speaking and self-identifying as
having engaged in doctor shopping. A definition was provided to them based on the concept
analysis previously discussed. Exclusion criteria included being a current or former patient of
the researcher and no current or former patients of the researcher volunteered for the study.
Additionally it was decided that participants who presented for their interview appearing to be
acutely intoxicated would be excluded from the study, but this did not occur. Participants were
invited to set up an appointment for an interview at their convenience. Participants were
permitted to reschedule their appointments if necessary. Participants were given a $25 gift card
following their interview.
Participant Interviews
Informed consent was obtained from each participant prior to the interview. The
questions that were asked were, “Tell me what your experience has been doctor shopping” and
“Is there anything that stands out for you about your experience doctor shopping?” These
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questions were followed by further open-ended questions with an aim to facilitate the
participant’s elaboration of their experience. An effort was maintained to avoid any leading
questions or statements. There was no set time frame for the interviews. The average length of
the interviews was 45 minutes. Field notes were recorded following each interview to provide
impressions of the interviews which were transcribed and referred to as needed during the data
analysis process. Field notes included information on the setting of the interviews, as well as any
observations and insights about the participants.
Participant Characteristics
The study sample consisted of 14 women who were English speaking ranging in age from
27 to 51, who identified themselves as having engaged in doctor shopping. All names used in
this report are pseudonyms chosen by the participants. Twelve of the women were Caucasian
and two were African-American which is representative of the geographic area in which the
study was conducted in the Southeast United States. The majority of participants were not
currently employed: four were disabled, three unemployed and one described her occupation as a
homemaker. Six participants listed their occupations which included working as a hairdresser,
cosmetologist, construction worker, medical assistant, nursing assistant, and factory worker.
Eleven of the participants listed some college as their level of education, two graduated high
school and one listed having obtained a GED. An equal number of participants were married,
single or divorced (4) and two participants listed their marital status as single. The sample size n
= 14 was determined by saturation of the data through ongoing analysis of the transcripts,
including input from the multidisciplinary interpretive phenomenology group at the University of
Tennessee Knoxville (UTK). The sample size was congruent with the estimated sample size to
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reach saturation in qualitative research as approximately six to twelve participants (Guest,
Bunce, & Johnson, 2006).

Table 1: Participant Demographic Characteristics
Name
Sue
Summer
Tammi
Jane
Melissa
Flo
Becky
Victorious
Mya
Londie
Desiree
Rebecca
Susan
Samantha

Age
29
30
27
33
29
28
29
31
34
39
51
48
36
30

Marital
Status
Separated
Single
Divorced
Divorced
Divorced
Married
Single
Divorced
Married
Single
Married
Separated
Married
Single

Education
Level
Some College
Some College
Some College
Some College
Some College
High School
Some College
Some College
Some College
Some College
Some College
GED
High School
Some College

Occupation
Disabled
Nursing Assistant
Cosmetologist
Hair Dresser
Unemployed
Homemaker
Construction
Disabled
Medical Assistant
Disabled
Unemployed
Disabled
Unemployed
Factory

Six interviews took place at a private office, two took place at a secluded location outside
at a picnic table near the building where the substance abuse support groups met, and six took
place at the participant’s place of residence, which included the participant’s apartment and a
half-way house for women.
Data Analysis
Following the interviews, the transcripts were professionally transcribed. The transcripts
were read at least twice. Meaning units were identified as short phrases, ideas, or key concepts
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that emerged. Code labels were assigned to identify categories which were then analyzed for
the presence of themes and interrelationships. Initially themes were identified as patterns of
descriptions and then as experiential patterns in diverse situations. Global themes were then
developed across interviews followed by the development of a thematic structure which included
the themes and their relationships. The Thomas & Pollio (2002) rule for determining a global
theme was used which specifies that a global theme is present in every interview or at least not
contradicted in any interview. Portions of the transcripts were taken to the interdisciplinary
group and read and analyzed. The group offered thoughtful comments, challenges, and
alternative interpretation of the data. Themes were named with terms closely aligned to
participants’ own words and identified themes were supported with verbatim quotes from
participants (Thomas & Pollio, 2002). Finally, textural and structural descriptions were
incorporated into a composite description in order to summarize the essence of the women who
engage in doctor shopping.
Study Rigor
The bracketing interview as previously described, was used in this study to add rigor of
the findings by clarifying and reducing researcher bias (Brink & Wood, 1998). According to
Lincoln and Guba (as cited by Polit and Beck, 2009, p. 492) trustworthiness of qualitative studies
can be developed using four criteria: credibility, dependability, confirmability and transferability.
The findings of the study were validated as the results contain convincing evidence and
plausible, illuminating findings (Thomas & Pollio, 2002). Confirmability is achieved when there
is agreement from more than one person about the meaning of the data which is free of
researcher bias. In order to provide a realistic assessment of the phenomenon of interest, peer
review and debriefing was conducted among the researchers (Creswell, 2012). In this study,
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members of the interdisciplinary phenomenology group were consulted during data analysis and
provided valuable input regarding data interpretation including determination of meaning units,
themes, the final thematic structure and data saturation. Dependability of the data is achieved as
the themes are replicated across the interviews despite variability in each participant’s
experience. Transferability or generalization of the findings to other groups is considered
plausible since the themes were overwhelmingly present in the participant’s experience. The
results from this study are generalizable as evidenced by repeated variation in the findings which
adequately describe the structure of the experience, and additionally by readers of the findings
(Thomas & Pollio, 2002). Therefore, credibility was established in this study as it was carried
out in a way that meets the highest standards for qualitative research through the aforementioned
methods.
Threats to Study Rigor
When beginning this research, I had no personal knowledge of the experience of doctor
shopping. I do, however, have extensive experience dealing with patients engaging in doctor
shopping. Any threat this posed to the study rigor was reduced through bracketing, peer review,
and the interpretive group.
Summary
This phenomenology study based on the existential philosophy of Merleau-Ponty was an
appropriate method to study the experience of doctor shopping in women. An exhaustive
literature review revealed that there is a paucity of research on the phenomenon of doctor
shopping. In addition previous research showed that women have unique characteristics related
to prescription drug abuse. Therefore, findings of the present study contribute new knowledge
about the phenomenon of doctor shopping. These findings are presented in the next chapter.
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Chapter 4
Findings
It’s dark out as I drive up to the building and park in the back parking lot. Several older
cars are already parked there and a few people stand outside smoking near the heavy metal door
that leads to the basement room I am about to enter. I walk into the basement room which has no
windows and is lit by fluorescent lighting. The room is stark. There is a long rectangular table
in the center of the cramped room surrounded by chairs. Against the walls around the table are
chairs, an old couch and a few ratty loveseats. Several people of all ages, mostly men, are seated
around the room, mostly alone but some are conversing quietly. There is an old coffee maker on
a metal stand against the wall in the center of the room and several people get cups of coffee to
drink. Several plastic coated sheets of paper lay in the middle of the table which are either
passed out by the leader or different people take one to read. At precisely 7 pm the leader, the
man who sits at the head of the table, starts the meeting announcing that for all the addicts out
there who are still suffering there will be a few minutes of silence. Then the Serenity Prayer is
said out loud in unison. The leader then reads a list of rules, including that people talk for no
more than five minutes and that cross talk or talking between attendees is not allowed. He asks
if there are any announcements. A basket is passed around for donations to help pay for the use
of the space and coffee. Visitors are asked not to donate. He looks at me and asks me to
introduce myself and tell why I am there. I explain my research study and say I will be around
after the meeting if anyone wants to talk about it.
Then the people with the papers read them one by one. The first is “who is an addict”
which is written in first tense using the words “we are addicts.” The next reading is “why are we
here” followed by “how it works.” Next the 12 traditions of NA are read followed by the daily
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reading from the NA daily meditation book. This takes 15 minutes. After attending several
meetings I already know them by heart. It seems they are read out loud each time to drill it into
the minds of the reader and those listening. Spoken words have power. During the reading, the
listeners seem uninterested and look either away or down. Some people talk softly to each other
during the reading and a few stragglers enter the room. After all the sheets and the daily
meditation are read the leader says the meeting is open for anyone to talk. Silence sets in. I
glance around and see that as usual no one is looking up or at each other. Finally someone starts
to talk.
When someone talks, a variety of things are said, such as trouble they are going through,
how they are able to stay clean, conflicts with family, loved ones who don’t understand, legal
problems, and relapsing. More than once someone cries when they talk. All the while no one
responds or looks up. Eye contact is rare. When someone finishes talking they say, “that’s all I
got.” After the monologue several in the room respond by saying “glad you’re here” or “keep
coming back.” Silence again. Sometimes the silence lasts several minutes and seems to lurk on
awkwardly forever. No one looks up, everyone’s expression is blank. Then someone else will
talk, again in monologue fashion, sometimes dramatically pontificating, sometimes bragging,
sometimes broken and distraught, followed by saying “that’s’ all I got.” Afterwards the response
again is “glad you’re here” and “keep coming back.”
Close to ten minutes before the hour the leader asks for the final reading which is “just
for today.” At that time someone takes charge of a bunch of different colored key tags and reads
off what length of sobriety each color represents starting with two years and working down to 30
days. After each color and length of time sober is stated, attendees are asked to come forward
and claim a tag if they have achieved that length of sobriety. After each one is read the attendees
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say in unison “keep coming back.” The last key tag is for someone rededicating their life or
starting at day one. Afterwards the entire group stands and forms a large circle and puts their
arms on each other’s shoulders. Looking down, everyone says “God, take my will and my life,
guide me in my recovery and show me how to live clean. Keep coming back, it works if you
work it!”
Immediately following the meeting I sit back down in a chair and wait to see if anyone
will approach me about the study. Usually there are only a few women present at the meetings.
If no one approaches me I go outside and stand around and mingle with the attendees while they
smoke. Often people want to know more about me and why I am doing the study and express
concerns about confidentiality because they don’t want to get in trouble. Sometimes if someone
is interested I schedule the interview then; this way, they don’t have to call since they are
reluctant for me to know their phone number.
This experience of attending the meetings in order to recruit participants led to a greater
understanding of the lives of people suffering from substance abuse. Often they would talk in
the meeting about “doctor day” and the temptation they felt when it was a day they would
normally go to the doctor to get medication to abuse. Several times attendees talked about how
they had been misdiagnosed and treated for a variety of mental health illnesses which were in
reality all caused by their substance abuse. Several attendees talked of losing their children and
being estranged from their families. Many times it was mentioned with a great amount of pain
that loved ones had given up on them and written them off. A few times someone came to a
meeting admitting to using drugs that day or recently prior to that day. Relapses were frequently
discussed as well as the number of days of sobriety. I was struck by the lack of eye contact and
verbal interchange amongst the people who attended the group. The lack of interaction felt
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isolating, disconnecting and unsupportive. I wondered if this one reason why so few women
attended.
Nonetheless a sense of community among the people who attended was noted before and
after the meetings. They all seemed to know each other and stayed around afterwards to talk.
Occasionally it was announced that the group would be holding a social gathering such as
meeting for dinner at a restaurant. There were also “speaker nights” which were held to
celebrate someone achieving a significant time frame for being sober which was referred to as
their birthday, such as one year or five years. It was often standing room only for speaker nights.
Frequently prior to the meetings starting attendees would talk about these birthdays and how they
would be celebrated. Reports of frequent relapses in sobriety seemed common. I attended
numerous meetings and only rarely did someone come forward for a sobriety tag but the few
who did were only for the 30 day and one day tag. This corresponds to the evidence that relapse
rates for drug addiction are estimated to be between 40 and 60% (National Institute on Drug
Abuse, 2008). Periods of sobriety often related to inpatient detox programs or longer
rehabilitation stays followed by relapses back into drug abuse reflects a common repetitive
pattern or cycle in those who abuse drugs. Addiction was the focus of the meetings and a
relationship with other addicts was noted, both of which emerged as being significant in the
encompassing thematic structure of the meaning of doctor shopping in this study.
Existential Grounds
When analyzing the data, a particular emphasis was taken to consider the existential
grounds of world, time, body and others of the participant’s experience of doctor shopping.
According to Merleau-Ponty, meaning is understood through our experiences of these grounds
(1945/2005), “But if we rediscover time beneath the subject, and if we relate to the paradox of
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time those of the body, the world, the thing, and others, we shall understand that beyond these
there is nothing to understand” (p. 1280). Thomas and Pollio (2002) also described existential
grounds as playing a vital role in experience.

For the participants, the world is the setting in

which the experience of doctor shopping takes place in regards to a physical location or
environment. The existential ground of time encompasses themes of change and continuity,
limits and choices, capturing time, and tempo (Thomas & Pollio, 2002). The existential ground
of body human involves the human experience of body including a physical and interpersonal
meaning. The existential ground of others includes those who are present or notably missing in
the experience. The experience of others involves relationship, comparison, and benefit.
The world of visiting prescribers and pharmacies is the contextual ground within the
experience of doctor shopping takes place. This often involves traveling to distant locations and
requires careful planning to elude detection. The participants’ world consists of going to new
places when constantly seeking new sources for prescription drugs. This is a complicated
process, often involving a calendar to keep track of their appointments and is perceived as
stressful and hard work. Because the entire focus of the participants is visiting prescribers and
pharmacies, the participants’ world in the experience of doctor shopping is a limited and
restricted one. No mention is made of interaction with nature or recreational settings or other
locations as would be found in most people’s descriptions of their world. Additionally the entire
focus described by the participants involved the acquisition of drugs with little mention of the
use of the drugs. This could be explained by Solomon’s opponent process theory of motivation.
The withdrawal symptoms seemed to outweigh the pleasurable effects of the drugs and therefore
served as the primary motivation to use.
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The existential ground of time for the participants is driven by their need for drugs, which
prompts them to use most of their waking hours to engage in doctor shopping. This engulfment
leaves little extra time for other activities in life. The participant’s energy and time are entirely
focused around fulfilling their addiction which limits time to expend in other areas of their life.
The participants choose to focus their time on doctor shopping as a result of their addiction
which is overpowering them. If they choose not to seek and use drugs they will become
physically ill. This causes an urgency to doctor shop in a short time period, to prevent drug
withdrawals. The time devoted to doctor shopping is often great, involving traveling far
distances to different locations. Additionally the participants described tediously long periods
spent sitting in waiting rooms waiting see prescribers or waiting to have prescriptions filled.
Time spent in addiction seems to pass at a rapid pace and for prolonged periods for the
participants. The participants described many years living in addiction involving time spent in
jail or hospitals or rehab.
The participants engage in this world of doctor shopping in the healthcare arena which is
very time consuming because of their experience of their body as being associated with
addiction. They experience cravings for the substances they abuse as well as severe withdrawal
symptoms when they do not have them. This abuse results in the experience of the need for
feeding the addiction. The participants’ experience of engaging in doctor shopping when
traveling to numerous prescribers and pharmacies was described as stressful and hard work.
Additionally they report physical symptoms of boredom when sitting in waiting room and fear of
being detected. Other adverse effects of addiction on their body include seizures and overdoses.
Some participants stated they had almost died due to their drug use, yet they continued in their
addiction. They ignored their bodily risk signifying that the risk was not significant to them.
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Conversely, when the participants successfully manipulated prescribers they experienced joy.
The discussion of the adverse effect on their body was mentioned in a detached manner. The
participants describe their body as a tool, or mechanism by which to feed their addiction, with
little regard to the damage being done to it. The interpersonal meaning of the body in the
participants’ experience of doctor shopping centered on its existence as a vessel to doctor shop
and an empty vessel that needs to be filled with drugs.
Interaction with fellow addicts and with prescribers is grounded in the experience of
others. The participants report a tightly knit ‘network’ or ‘circle’ of addicts who work together
to share information which enables them to doctor shop. Additionally the participants report
networking with addicts by helping each other in the actual act of doctor shopping including
sharing transportation and paying for visits and medication for others in exchange for pills. A
central component to the relationship between the addicts is that it involves benefit to the
participants. Other addicts are merely seen as a mechanism to obtain drugs with little regard to
their well-being or value as human beings. Comments about other addicts getting caught or
dying from overdoses are referred to in a matter of fact manner, without emotion or regard.
Prescribers are viewed as easy targets by participants. Interaction with prescribers
involves conning and manipulating them for prescriptions which involves complacency and
collaboration of prescribers in the act of doctor shopping. The relationship participants had with
prescribers was based on falsehoods and deception. Success at manipulating prescribers is
perceived as being easy, thrilling, and satisfying. The prescribers were viewed as a means to
obtaining drugs. When relationships with prescribers were terminated when doctor shopping
was suspected or detected, the participants seemed unaffected and merely moved on to another
target. When the relationship between the participant and prescriber involved collaboration, this
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entailed mutual benefit. Prescribers were compared and categorized as being either ‘writers’
who were sometimes referred to as ‘pill doctors’ or those who were ‘not writers.’ The sole value
of the prescriber as a person was centered on whether or not they would write prescriptions for
controlled drugs. Expressions of caring and concern are not a part of the participants’
experience of others in regards to other addicts or prescribers.
Notably missing from the experience of the participants related to the existential ground
of others in this study were significant others who would normally be a part of a person’s world.
Relationships in the experience of doctor shopping primarily focused on other addicts and
prescribers. The relationships that took place between addicts were tenuous and dependent on
the pursuit and use of drugs. The participants stated that relationships ended when they were no
longer using or in possession of drugs. Very little mention was made about significant others
who would normally be part of the world of others such as spouses, partners, children, or friends.
On the rare occasions when participants mentioned their children, it was to state that they had
been removed from their custody due to drugs and this was spoken about in a way that reflected
little emotion.
Figural Themes
The meaning of doctor shopping was comprised of four themes for the participants in this
study: (1) “feeding the addiction”; (2) “networking with addicts”; (3) “playing the system” and
(4) “baiting the doctors.” The participants were driven to engage in doctor shopping because of
their ongoing need for feeding their addiction. They networked with addicts to obtain
information and in the act of doctor shopping, which involved work and was at times scary.
Playing the system enabled them to be successful in obtaining prescription drugs which they
accomplished through baiting the doctors. Conning and manipulating prescribers was easy and
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sometimes thrilling and often involved complacency or collaboration on the part of the
prescriber.
Theme One: “Feeding the addiction”
A central theme of this study arising from the existential ground of the body is feeding
the addiction. The participants perceive their addiction as the driving force to engage in doctor
shopping. They experienced physical cravings for drugs as well as painful physical withdrawal
symptoms when they did not have drugs. Addiction is sometimes reported almost as it if were an
external being which directs the participants’ actions. This addiction is a controlling force which
they perceived as though they were powerless to go against. Addiction was all encompassing for
the participants leaving the rest of their world empty and vacant. Their experience is that their
bodies are hollow empty shells or vessels which need constant feeding with drugs.
The driver of the behavior of engaging in doctor shopping for all the participants is
addiction. The participants were either addicted to the medications they got prescriptions for
through doctor shopping, or they sold the controlled drugs they obtained from doctor shopping to
buy other drugs to abuse. The severity of the addiction was noted in that all but two of the
participants reported using drugs intravenously. The process of addiction led to doctor shopping,
which fueled the addiction, which in turn led to more doctor shopping. This process is described
as a cycle. The cycle of doctor shopping in the participants’ lives is perceived as all
encompassing, leaving little time or energy for any other normal activity or relationships in life.
Little emotion was expressed concerning the ravaging effects of addiction in the participants’
lives or on others in their lives. The participants expressed being overcome or controlled by the
force and control of their addiction which they were powerless to stop.
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Tammi, who was the youngest participant at age 27, is divorced, with some college
education, and employed as a cosmetologist. She stated the first time she used IV drugs was
when she was age 14. She ran a sophisticated sponsoring operation while doctor shopping. She
reported her addiction to prescription drugs had resulted in many losses and problems in her life.
Her IV drug use affected her health adversely in the past resulting in a hospitalization for a life
threatening blood infection. At the time of the interview she was trying to detox herself from IV
opiates. She was trying to get off drugs because she regretted at times taken her children with
her to doctor shop. She stated that recently she had become destitute and after having sold all
her furniture, she found herself alone in her apartment in the dark because her utilities had been
shut off for nonpayment, sitting on the floor shooting up morphine.

My whole life with everything that was going on I was powerless. I felt like I couldn’t
do anything to stop. I was in a cycle. (Tammi).

Even when participants suffered great significant consequences due to their addiction to
drugs, they continued on that path. When describing the effects of addiction as miserable or bad,
they showed little emotion. Consequences such as health problems, legal problems or losing
custody of their children were perceived by the participants in a matter of fact way as if they
were just a normal aspect of life they had to go through. They experienced themselves as being
powerless to break the magnetic pull of their addiction and rather than fight it or take steps to
stop it, they willingly gave in to it. Even when they recognized retrospectively the adverse
effects of their addiction on their lives, this was expressed in a nonchalant detached manner.
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Londie, age 39, is single, listed some college education, and is on disability for physical
problems. She had legitimate health problems but falsified her pain in order to obtain
prescriptions for pain medications which she snorted. She stated she had a history of IV heroin
abuse and although she abused pain pills, she described her drugs of choice as alcohol and crack,
which she smoked. She also sold her prescription pain pills in order to get money to buy crack.
She had been in rehab more than once, had legal problems and had lost custody of her children
more than once due to her drug use. She also described her experience of doctor shopping as a
cycle.

Yeah, I would have to go buy some from this dealer I knew and he would supply to
me. He’ll give me a discount because I normally sold to him. Yep, it’s a vicious cycle.
You know, it was bad and my family was pleading with me to get help and I knew
I needed help but I just couldn’t bring myself to get that help. Know it was hard on them.
It was hard on me because I was miserable. I couldn’t think clear. Just couldn’t think
straight at all. It was a nightmare I couldn’t wake up from. (Londie).

Participants referred to themselves as ‘full blown addicts’ with a need to feed their
addiction. The addiction dictated the behavior of doctor shopping wherein the participants were
pulled to feed their addiction, despite fear and dire consequences. This need for drugs was
described as the driving force behind doctor shopping. In a detached manner they described
what they went through including lying to and manipulating prescribers which was
acknowledged as being illegal, and involving risk. Going from one prescriber to another to
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obtain prescriptions was part of their normal every day experience because of their continued
need to feed their addiction.
Melissa, age 29, is divorced with two years of college education, and was unemployed at
the time of the interview. She was in a court ordered outpatient substance abuse treatment
program and was a user of IV opiates. She had a legitimate health problem but falsified
symptoms related to that condition to obtain prescription pain medications from more than one
prescriber, including a relative. Often she was not able to obtain prescriptions for morphine,
which was her drug of choice, so she would trade the hydrocodone pills she got for morphine
with other addicts. She also described her addiction as something that needed to be fed.

I would have a prescription and go to another one, another doctor, knowing I already
had it, wanting to get more, just to feed my addiction (Melissa)

The participants perceived their experience of having to feed their addiction in a detached
manner and without normal emotions that one would expect when discussing a force in one’s life
that is all consuming and that involved such great risk. Rather than experiencing distress, guilt,
sorrow, anger or fear about the hold the addiction had on them, the participants perceived
feeding the addiction as merely something they did as part of their everyday life with seemingly
little thought or emotion connected to it.
Mya, age 34, is married with some college and employed as a medical assistant. She had
a sophisticated understanding of ways to obtain medications from prescribers, including using
different names and filling the prescriptions in rapid succession of one another so that there
would not be enough time for them to show on the PDMP. She also forged urine drug tests for
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other addicts while she was employed at a physician’s office. She described several overdoses.
She smoked methamphetamine in addition to taking several prescription pain pills, alprazolam,
and the muscle relaxer carisoprodol, which is a controlled drug, throughout the day. She stated
she had used IV drugs in the past but this was not her primary method of administration. Her
addiction had resulted in legal problems as well as losing custody of her children. She went to
great lengths to obtain prescription drugs to abuse.

I don’t know, it’s not fun, it’s not enjoyable, but you do what you do to feed that
addiction (Mya).

At times addiction was referenced as if it was an entity outside of or separate
from the participant themselves. The addiction held a level of control over them and influenced
their actions. The participants were driven to satisfy the addiction despite their stated desire not
to do so.
Samantha age 30, is single, had two years of college, and was employed in a factory.
After obtaining prescriptions from doctor shopping she used opioid pain meds intravenously and
snorted or took alprazolam orally. Her drug use resulted in going to jail which caused her to lose
her apartment and her belongings. Additionally she described several episodes of becoming
physically sick when she did not have drugs. She often drove for more than an hour out of town
to visit prescribers in numerous locations and described her experience as ‘the insanity of
addiction.’ Her addiction was also described as a separate entity that spoke to her.

That’s what my addiction was telling me, that I had to have them. I wasn’t
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thinking about anything besides getting more. (Samantha).

Reports of painful withdrawal symptoms which are described as being experienced when
drugs could not be obtained were also reported. These withdrawal symptoms caused severe
body aches, nausea, vomiting and diarrhea and resulted in an urgency to obtain more drugs to
stop the sickness. The physical pain of drug withdrawals also reinforced their need for pain
medication wherein the pain was not organic in nature but due to withdrawing from the
substance. The withdrawal symptoms are described by participants as being ‘pill sick,’ meaning
that they were sick from not taking pills.

Again, the response to the physical bodily

consequences is met without resistance. Rather, it was met with the participants further
succumbing to the addiction by continuing to pursue and use drugs.
Becky, age 29, is single with some college and listed her occupation as working in
construction. She, along with other participants, described herself as a “pill head” who used IV
opiates and sponsored others to doctor shop. She stated she had been using drugs since age 17
and described several methods to get around pill counts and urine drug tests. She described how
painful her withdrawal symptoms were when she was unable to get drugs. Becky described
being so desperate for drugs that she would crush and snort her Xanax at a red light after leaving
a pharmacy or pull her car over on the side of the road after leaving a pharmacy to shoot up her
opioids.

Cause you were like going to get sick or whatever if you didn’t. Being pill sick is
not fun. It’s no fun at all. (Becky).
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Becoming physically sick when the participants did not have drugs is perceived as a
normal part of their everyday life and they accept it. They sought pain medications under false
pretenses from prescribers to abuse, which then in turn ended up resulting in their experiencing
severe pain when they went without it. This pain reinforced to them their need for pain
medication, therefore they continued doctor shopping to avoid the pain of withdrawal.
Jane, age 33 is divorced, listed some college as her level of education and was currently
employed as a hair dresser. She described a long history of IV drug use resulting in her children
being removed from her custody. She reported overdosing several times and having had DUIs
related to drug use. She had several unnecessary surgeries for the sole purpose of obtaining
prescription pain medication and often visited emergency rooms to obtain opioids which she
used intravenously. She described severe physical pain when she was not taking drugs during
her addiction.

I was in pain from the pain medicine like when I wasn’t taking it. I thought I was
doomed for the rest of my life. I thoughts I had to take that stuff but it was really
weird how the pain medicine caused pain you know. (Jane).

Despite the variety of methods of administration of the drugs obtained through doctor
shopping, all the participants experienced adverse physical effects on their bodies. Some
participants related blood infections stemming from intravenous drug use. Others who snorted
pills did damage to their nasal passages resulting in congestion or bleeding. While only a few
participants did not use drugs intravenously, their health consequences were equally as great,
often involving overdoses.

The physical effects of drug use on their bodies were perceived in a
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detached manner and seemingly inconsequential. The addiction drove them despite disfiguration
including needle track marks, skin lesions, or weight loss.
Susan, age 36, is married with a high school education and unemployed. She stated
members of her family, including her adult children, also used drugs. She described going to
numerous prescribers to obtain pain medication for pain she did not have as well as often
working with others to obtain prescription drugs from prescribers. She described periods of
lapses in her memory, self-induced comas, weight loss and almost dying due to her drug use. She
denied intravenously drug use and stated she snorted her pills which also caused adverse physical
symptoms.

My nose would start bleeding and you know stay stopped up or it would run. When
I didn’t have anything my nose would run. (Susan)

She described becoming comatose after abusing prescription drugs as well as having
severe withdrawal symptoms.

Honey, you are deathly sick if you don’t have ‘em. Deathly sick. You will not get
out of the bathroom for days, trust me. Yeah, it makes you very sick. (Susan).

Londie also described terrible physical symptoms she developed as a result of her drug
abuse.

I started blacking out and, you know, my pill addiction became heavier. I was snorting
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three and four pills at a time and just, you know, I had burnt off my fingertips. I still
have scars on my fingertips now from a month now where I burnt off the tips of my
fingers smoking crack just, you know, it was bad. I had blisters on my lips. My nose,
uh, the inside of my nose has scabs from sniffing pills. (Londie)

Theme Two: “Networking with Addicts”
Throughout the interviews all the participants described ways in which they worked with
other addicts when doctor shopping. The relationship between the addicts was referred to as a
‘network’ or ‘circle.’ The participants engaged in networking with addicts to secure drugs when
doctor shopping. The extent to which the participants described relying on other addicts to
obtain information about doctor shopping was significant. A sense of camaraderie with other
addicts which served as a source of support was noted amongst the participants’ expression of
their experience. The participants networked in two distinct ways which reflect two subthemes
within this overall theme: (1) getting information and (2) acting together.
While the addicts worked closely to network, these relationships lacked the emotional
connections that are commonly experienced with others. Other addicts were perceived by the
participants as tools or instruments to meet their needs or for their benefit to secure drugs to
abuse. When another addict was arrested and jailed or suffered a consequence of their addiction
such as illness or death, the participants expressed little regard or concern. Rather this was
mentioned in their characteristic unemotional, nonchalant manner. The relationships between
addicts were transient and tenuous, existing for the sole purpose of networking and thereby
feeding their addiction. When the need for information or drugs ended, so did the relationships,
endings which did not seem to have an effect on the participants one way or another.
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The participants did not perceive any culpability in networking with addicts to engage in
activities that were both illegal and life threatening. When they helped one another to doctor
shop, it did not matter if this resulted in someone going to jail, losing their children, or losing
their life. The addiction seemed to override any emotional response such as empathy or guilt.
The drive and focus on securing the drugs was foremost in their minds with little thought of
anything else. The use of drugs seemed to dull their emotions and regard for their own wellbeing as well as the well-being of others. A detached approach was taken when sharing
information or engaging in activities when doctor shopping, despite the risk of serious harm to
themselves or others.
The relationship that formed between the participants and other addicts and prescribers
was so all encompassing that it precluded the importance or existence of other relationships that
would normally be important such as those between loved ones in a family. Significant
relationships of value and importance to participants in their experience of doctor shopping were
primarily those with other addicts and with prescribers. Only infrequently and often with a lack
of emotion were others mentioned. People were compared and classified for the participants as
being either ‘addicts’ or ‘pill heads’ or not. Prescribers were compared and classified as being
either ‘writers’ or ‘pill doctors’ or not. This black and white categorization left no room for
others to be part of the experience of others in the lives of the participants.
Getting information
Others were used to benefit the participants as part of their experience of doctor
shopping. All the participants described how they listened to each other and found out
information about where to go to doctor shop and how to do it. Information was also shared
about which pharmacies were more likely to fill prescriptions they obtained through doctor
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shopping. Information about prescribers who were apt to prescribe controlled drugs was shared
along with prescribers who were not. Additionally information about what to say to prescribers,
sometimes specifically to one prescriber or another was also shared.
Sue is a 29 year old separated female with some college who is on disability for a variety
of physical illnesses including seizures she developed from drug withdrawals. She described
conflicted relationships with her family, many of whom were addicts. She experienced
numerous traumatic events in her life involving the loss of loved ones, and unlike the other
participants she talked about her daughter, and stated she was her main reason for living. She
stated she had abused prescription drugs intravenously for many years and at the time of her
interview was being prescribed suboxone, an opiate prescribed as maintenance therapy for opioid
addiction. Sue described sharing information with other addicts as part of her experience of
doctor shopping.

They spread it around, you know, “hey I know you can go to this doctor and get this.”
You just talk to people and they’ll say, you know, “I went to this doctor and he
wouldn’t give me nothing.” Addicts listen to each other, other addicts, that’s how
they find out their information and then that’s how you find out where you can doctor
shop. Addicts spread it around. (Sue).

Just as the participants used prescribers to manipulate to write them prescriptions for
controlled drugs to abuse, the participants used other addicts to obtain information. The
perception was that other addicts had something they needed and they took steps to get that
information from them. The relationships between addicts arose not necessarily out of friendship
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or companionship, but instead often for the sole purpose of obtaining information. The
participants perceived a need to manipulate other addicts to divulge information which could
then be used to secure drugs to abuse for themselves.
Summer is 30 years old and single. She reported some college education and her
occupation as a nursing assistant. She stated she gained friends from doctor shopping and also
dated a doctor who was prescribing her controlled drugs which she used intravenously.
Additionally she said she had an addiction to doctor shopping and described it as her drug of
choice. She related going to jail, going to rehab, having seizures, and overdosing several times
due to prescription drug abuse. In addition to making friends through doctor shopping she
described how other addicts helped her gain information.
I got some people talking about where they were going and I made appointments there.
I would get tips on what to say. I listened to people that were doctor shopping.
(Summer).

Sharing information between addicts was described as part of the norm in the ‘network’
or ‘circle.’ They counted on and depended on information from other addicts. This sharing of
information was perceived by the participants as a camaraderie and necessity related to doctor
shopping. For the participants, the social support they received from others was not focused on
enjoying or having an affinity for another person or sharing in each other’s company, but rather
for the sole purpose of furthering their addiction. Characteristics or qualities of people in the
network seemed inconsequential; all that mattered was what benefits could be gained from them.
Rebecca, is age 48, separated, has a GED and is on disability. She primarily doctor
shopped for benzodiazepines and the sleeping mediation zolpidem (Ambien), which she took so
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that she could sleep long periods, often days at a time in an attempt to deal with depression. In
addition to taking more than the prescribed amount of benzodiazepines to cope with stress, she
also hoarded prescription drugs to use in suicide attempts by overdose. She did not use IV drugs
and stated her primary addiction was to alcohol. She often used information from other addicts
when doctor shopping.

I knew somebody that was doing it and he was giving me the name of another doctor in
another town that I could go to and they would give drugs out freely. I mean, because
this is passed around to all of us. We pass it around who gives drugs out, you know, and
who doesn’t. (Rebecca).

Susan also used information she got from other addicts to determine where to doctor shop
and what to say when she did it.

I mean, people told me how to do it to get them. I told the doctor which pain clinic
I wanted him to refer me to because I knew people who went there. You know
somebody and they’re going to know somebody else. (Susan).

Samantha, as well, talked about part of her experience doctor shopping including
networking with other addicts to obtain information.

People would be like “oh, uh, this is a good doctor. He’ll write” or “she’ll write”
you know. I went to a doctor’s office because I had heard he’d write and he did. Yeah,
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that’s always a common thing you know, when anybody is just trying to go get whatever
they can, whether to do or sell, whatever. They’d be like “hey man, where’s a good
doctor?” Everybody asks for what you know and they say, “hey I heard,” you know, or
something. (Samantha).

Acting together
Not only did the participants in the study discuss networking with other addicts to obtain
information, acting together was also integral to the participants’ perception of doctor shopping.
Relationships with other addicts were used to benefit the participants in their efforts to secure
drugs. This was done in a variety of ways such as sharing rides, paying for others’ appointments,
borrowing pills for pill counts, providing urine for urine drug screens, and borrowing MRIs.
Many of the participants sponsored others to doctor shop or were sponsored by others.
Sponsoring involves one person paying for another person to doctor shop, including money for
gas or providing transportation, paying for the visit, the MRI, and/or the medication, and then the
medication is shared.. The participants who were sponsored by others did so when they lacked
funds to obtain the medication. Some of the participants sponsored others to doctor shop, which
proved to be quite lucrative when excess medication could be sold for a profit.
The participants did not perceive regard for the well-being of another person as part of
their experience when acting together. When participants talked about recruiting others to
sponsor to doctor shop there was never a mention of any adverse effects this might have on them
such as getting arrested or furthering an addiction that could lead to death. The relationship
formed to act together when networking with addicts was based solely on need. It did not seem
to matter if that person shared any common characteristics or if they were congenial, all that
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mattered was that they were addicts and they shared the need for drugs. Unlike most social
relationships, the camaraderie when acting together was based solely on being together to doctor
shop. If the person they acted with to doctor shop experienced harm such as being arrested or
any form of suffering, this was not mentioned as being significant in the participant’s perception
of acting together.
Sue described a situation where someone else paid for her to have a tooth pulled and then
they shared the pain medication that was prescribed.

We both needed something for pain. This person was like, “well if you go in and get
it pulled, I’ll pay for it and I’ll pay for you to get ‘em filled and you know, I was like
‘we’ll split ‘em down the middle.’ (Sue).

Sometimes the problems of other addicts were perceived as an inconvenience for those
who sponsored others to doctor shop. This was a complication which was not welcomed and
rather than responding with empathy or concern, it was dealt with in a matter of fact fashion, as
just another step that had to be taken in stride. Putting others at risk or danger to doctor shop
through sponsorship was also financially beneficial and participants perceived other addicts as a
means to make money. Tammi ran a sophisticated sponsoring operation. At times she described
having to be the caretaker of her sponsors who would sometimes call her when they were sick
from withdrawals when they ran out of their pills. She also had to make sure they had enough
pills for pill counts if they were requested, as well as making sure they could pass their drug
tests.
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I sponsored people to go to the pain clinic. I paid for other people to go so I could
get half their pain medicine. I was sponsoring people to go to the pain clinic and they
were getting the same prescriptions I was so it’s kind of like a package deal. You meet
people who do ‘em when you’re buying ‘em or selling ‘em and offer to pay for them to
go to the doctor. I would pay for their visit and then I would get half of their
prescription. I would drive ‘em and take ‘em to the pharmacy. I had to make sure the
people I sponsored had what they needed in their system for drug tests. I’d make quite a
bit of money off ‘em and that paid for my habit. If someone got called for a pill count I
have to call somebody and try to borrow pills for a pill count. (Tammi).

Desiree, age 51, was the oldest participant in the study. She is married, has some college
education, worked as a medical receptionist in the past, but was unemployed at the time of her
interview. She described many years of doctor shopping which she described as being thrilling
and glamorous often in exchange for sexual favors. She reported going to numerous prescribers
in several states. She admitted to using drugs IV in the past but stated her primary method of
administration was snorting pills and taking them orally. Her drug use had resulted in her going
to jail and caused problems in her relationships with her family. Additionally she sponsored
others to doctor shop which she described as being part of her experience of doctor shopping.

I would get other people doctor shopping and I recruited as well. ‘You go see
Dr. so and so and I’ll pay for your visit, I’ll pay for your prescription and I’ll give
you half and gas money.’ It became a lucrative business after a while as well as
me using, so the cycle just snowballed and became larger than I even imagined.
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(Desiree).

The only relationships that the participants described as being part of their experience of
doctor shopping were ones that involved getting information or acting together with other
addicts. They went through whatever steps were necessary, often working in unison to secure
the drugs to abuse. Often it did not matter what drugs they got or how they used them, the focus
was on feeding the addiction, one way or another. This acting together often involved a
significant amount of planning to outwit prescribers. Using drugs together with other addicts
was also part of acting together. If the participants physically went together to secure drugs, they
would often use the drugs together. The central focus of being in each other’s presence was the
need to abuse drugs due to addiction
Flo, age 28, is married with 12 years education and listed her occupation as a
homemaker. She was enrolled in a court ordered outpatient substance abuse program at the time
of her interview due to a drug related legal charge from which she had lost her vehicle.

She

doctor shopped from prescribers in primary care, dentists and emergency rooms. She would
often sell the pills she got from doctor shopping in order to buy morphine which she used
intravenously, although sometimes she snorted the pills she got. She stated her mother also had a
substance abuse problem. She and her husband used drugs together as well as with other addicts.
Flo and her husband and a group of friends would take turns going to emergency rooms to obtain
drugs so that the emergency room staff would not become suspicious.

I used to go to the hospital, me and my friends would go and we would pick one of the
friends to go there and then we would switch out so we could get more medicine. We’d
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share the pills together. We would drive ‘em to the hospital you know, and they would
give us so much pills to do and we would just do ‘em together you know, like snort ‘em
or whatever. Whatever they did you know, if they snorted ‘em, we would snort ‘em, but
if they IV’d then we IV’d. (Flo).

Victorious is age 31, divorced, with some college, who is on disability. She had several
health problems for which she reported falsifying symptoms to obtain prescriptions for
controlled drugs which she used by snorting them or taking them orally. Her drug use had
resulted in several overdoses. She frequently went to emergency rooms in other towns and then
was referred to other doctors for follow up, from whom she got prescriptions. She described
trading things like milk or gas money for pills as well as going with other addicts to
appointments to doctor shop.

After so long without insurance it became so expensive so I would use pills with
the doctor shoppers. I can think of numerous people I have rode with to sit in the
doctor’s office waiting for them. I would go with ‘em and wait till that got filled
and then we’d get high. I would go with them every time and find them more
doctors. (Victorious).

Theme Three: “Playing the System.”
The worldly setting which the participants interacted with to feed their addiction is the
healthcare system, including doctors’ offices, pain clinics, hospitals, emergency rooms, and
pharmacies. The participants became skilled at playing the system to secure prescription drugs
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to abuse. The participants often used the term ‘doctor’ when describing prescribers; however, as
previously discussed, these professionals represent a variety of prescribers including physicians,
physician assistants, dentists, and nurse practitioners. Participants perceived healthcare
professionals as merely being people they needed to manipulate, fool, or con so that they could
secure drugs with little regard of their actual profession or credentials. The only regard voiced
for others in the system was whether or not they could be played. Playing the system had to be
done for the benefit of the participants despite any consequence to themselves or the people they
interacted with in the process.
The healthcare system is set up to thwart abuse through measures such as checking
patient’s identification and insurance companies not covering or pharmacies not filling duplicate
prescriptions. However, the participants reported sophisticated means and measures they would
take to play the system in order to elude detection. Safeguards employed by prescribers, such as
having patients bring in their medication bottles for pill counts to be sure they were not
overtaking them, as well as urine drug screens, were easily thwarted by participants. Other
objective testing used to verify the need for pain medication such as MRIs were shared or
borrowed, allowing the participants to deceive prescribers about the nature of their illness.

It really took me no time at all to figure out how to play the system. I really
learned to play that system too, to get lots of things. (Mya).

Although the participants perceived playing the system as being fairly easy to figure out,
the act of playing the system was at times described as being hard, exhausting, time consuming,
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and stressful, like a ‘full time job.’ There were several steps in the process to secure
prescriptions which involved planning and effort.

It’s a lot of work, doctors in different cities and pharmacies in different cities and pretty
consuming. It takes up a lot of time. You have to sell some just to pay for your other
visits and to be able to afford to go back for the gas money and the places are far away.
You don’t go in the same town that you live in and then most of the time they drug
test you so you’ve got to have the exact pain medicine in your system that you’re
supposed to have and that’s exhausting because you usually don’t, and trying to
remember what you get at where and it’s pretty ridiculous. That was all I did. That was
my full time job. (Tammi).

It was my job almost. I would travel as far as I needed to go. I had an appointment
book and I had the doctor’s names, you know, like he’ll be here this day and he’ll be here
that day. I was putting some thought into this. It was very stressful, hectic and
expensive. (Jane).

It became like a job. Its insanity, total insanity. I had 20, 25 or more doctors in
one specific area. (Desiree).

It’s hard work. You have to keep up with which doctor you have that week.
Sometimes I had two in one week, you know, so you had to keep a calendar. It’s
so much work to do all that. (Susan).
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Networking with addicts was a common strategy employed to play the system. Some
aspect of playing the system could not be done without the help of others. Becky described
borrowing pills for pill counts, borrowing MRIs, and paying cash rather than using her insurance
to play the system, or as she put it ‘fly under the radar.’

If they want a pill count, get on the phone with everybody you know to get the pills
and try to come up with them. You call everybody you know (laughs) and try to get
some together. You use other people’s MRI’s, “you let me use your MRI, I’ll give you
10 of ‘em.”

If you’re doctor shopping, you pay for the doctor and you let your

insurance fill your prescription or you can just pay for all of it and fly under the radar.
(Becky).

Several participants, including Becky, talked about fooling urine drug screens requested
by prescribers to either be sure the prescribed drugs were being taken or to be sure other
controlled drugs were not being taken along with what was being prescribed. Some of the
women would sneak other people’s urine in to use and others would put a small amount of the
actual medication in the urine itself.

You can cheat to pass a drug test, you can also cheat to fail one. If you need to, you
know, you can fix pee. I mean, I take somebody that doesn’t have anything in their
system and you can pull it up like you’re going to pull up a shot of the Roxy and
squirt it in the pee and it will show up perfect on a drug test, you just do like a
half of one and like a half Xanax and put it in the pee and it shows up perfect.
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You can take a pill bottle put clean pee in it and put aluminum foil
over the top of it and wrap black electric tape around it and put it up in you (motioning to
vaginal area). When you sit down to pee, you poke it open. The nurse has to officially
be in the room but they’re not watching you that close. (Becky).

Another way that several participants described playing the system was by
monitoring which prescribers were on duty in offices or emergency rooms and purposely waiting
for certain prescribers to visit who they felt were easier targets to prescribe them controlled
drugs.

I can think of a couple times that I have went to a certain ER at a certain time, you know,
because you knew that that doctor is there. (Victorious).

I traveled out of town an hour or two, four hours away from where I was living to
go to an emergency room. I made sure I got to know what doctors were on call. It
took work. It took ingenuity to do this. (Desiree).

The participants described other ways to prevent their doctor shopping from being
detected including going to more than one pharmacy, not using their insurance, paying cash and
using different names.

When I was going to both places to get the Xanax’s I would go to different pharmacies.
One was 45 minutes from the other one. I went there so I could pay for ‘em. I told
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‘em I didn’t have insurance. (Samantha),

I never went in my hometown and get ‘em filled because everybody knew me
there. The high dosage ones I always got filled way, way, away from home
and I used my insurance for them instead of cash. (Susan).

I had four pharmacies. You can get around the PDMP by using your maiden
name. I would use another ID, it doesn’t matter which photo ID. Instead of my whole
first name I would do a portion of my first name or I would use my middle name or
a different address. There were just tricks like that, go to two doctors on the same day
and the prescriptions don’t show up until I actually filled ‘em. (Mya).

Despite being successful at doctor shopping, many of the participants admitted
experiencing fear when playing the system. Disproportionately, they identified getting caught as
more of a cause for fear than other serious adverse consequences such as physical illness, death,
or losing their children.

I was just scared of going to jail more than anything. I remember being scared. I
was afraid, very afraid. (Sue)

I was really scared. It scared me. I was always afraid of being caught or being
embarrassed or um, going to jail. I’m like terrified of all that. Yeah, it scared me.
I was always afraid of getting caught. I didn’t want to go to jail. I have kids and
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that was always a big fear, but the benefit outweighed the risk. It scared me but
nothing ever stopped me from doing it though. I mean, I was never too stressed or scared
or anything. I mean, there’s a lot of crap that went along with it, but I really felt
obligated, like I had to do this. (Tammi).

I would go to one doctor and pay cash because if you use cash it don’t show up on
your insurance and stuff and the next one that I went to, I’d use my insurance so
I was getting ‘em all the time. I went to, I don’t know how many pharmacies I went
to, because I was afraid they’d get to noticing. (Susan).

When talking about being afraid when doctor shopping during their interviews, they
exhibited little emotion. Instead, they often laughed and seemed proud of themselves when
talking about their success at playing the system. Even though many times they did talk about
being afraid as part of their experience, this stated fear was never mentioned as a reason to
dissuade them from doctor shopping.

Theme Four: “Baiting the Doctors.”
Another central theme noted among the participant’s experiences was the act of conning
or manipulating prescribers to write prescriptions for controlled drugs which they abused or sold.
Baiting the doctors was accomplished by falsifying symptoms and denying or hiding the fact that
prescriptions had been obtained from previous prescribers. The focus of the participants is selffocused on meeting their needs through conning others. At times the participants played the role
of an actress by dramatically feigning symptoms of pain or anxiety. Other times they simply
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requested certain medications and the prescribers complied. Going through painful medical
procedures was another strategy used to manipulate prescribers into writing them prescriptions
for controlled drugs. Other times participants became loud and demanding. Overall the
participants described baiting the doctors to be easy, fun, and thrilling.
The primary method the participants perceived themselves as being successful at conning
prescribers was by eliciting sympathy through complaints of physical pain or distress. They
became ‘good actresses’ to make these complaints believable. Often dramatic scenes were
created full of moaning and groaning in pain and shedding real tears. The participants perceived
the discomfort of the prescribers when they expressed extreme distress and used this to their
advantage. They saw that the prescribers would rather write a prescription than listen to or
witness their extreme displays of emotion, so this became a common method employed.

Just hearing my sob self-pity story, they just fell into that and gave me all kinds of
narcotics due to that. They just fell into this sob story and I used that to bait them
doctors. (Summer).

I learned all the tricks. All the hard luck stories. Everybody’s got one, especially
addicts, we’ve got the best ones because we’re the best liars you know, that’s
just how it is. Once I was crying because I was hurting so bad from withdrawals but they
don’t know that. They just know that I’m in pain and this is what they gave me before
and that’s what got me to stop crying. They just want me to stop crying (laughing), ‘just
please stop crying in this office.’ (Mya).
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The manipulation is the key that anybody can turn (laughs). I was faking that
you know, faking the tears and how on an instant you know, I could cry or
yell out in pain and not really be hurting. I would milk it, milk it to the fullest
extent. (Melissa).

Some participants even went through painful experiences such as having teeth pulled or
surgeries in order get pain medication. Experiencing physical pain or disfigurement to their
bodies was taken in stride as part of what they considered necessary to get prescription drugs to
abuse.

I got so desperate I even would let them do surgery on me. I was so convincing
that I would convince the doctors. I’ve had so many surgeries for that. I guess
that’s part of being a con artist, part of being a manipulator. I can’t think of a time that
I had surgery that I really needed it in my life. I invented every one that I’ve ever had.
(Jane).

I would make up stuff. It didn’t matter. I would make up whatever. I could, like, have
a headache. I hurt my arm or my back, or whatever, and I called the dentist, some of
the dentists, and see what they would give, you know, if they would give Percocet’s,
hydros and say, ‘what do you give for pain?’ (Flo).

A skill that the participants described as having, which enabled them to bait the doctors,
was the ability to ‘read the doctors’ so that they would know what to say or do to get them to
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write prescriptions. They were savvy at picking up on verbal and nonverbal cues that they used
in their manipulation.

I’d go to a doctor and you know, complain about aches I didn’t have. You got to
be a good actress. You got to have a poker face. You got to know exactly what to
say and how to say it. You’ve got to learn how to read that doctor and what you
need to be for that doctor so the doctor will give you what you want. You got to fake it,
you got to fake whatever that injury is or whatever that health problem is. Addicts go
around and they test the doctor, they know the weak ones. (Sue).

You learn to lie, manipulate, connive and convince. You learn to read the doctors. I
about pretty much found what worked. I’d be nervous if he’s going to buy my story even
though the last 15 doctors have. You can call before you go and say, “do they write
narcotic pain meds?” They love to hand out drugs. (Mya).

Some participants were demanding to prescribers and launched false accusations if they
were not prescribed pain medication. Just as prescribers were noted to become uncomfortable
when participants cried or elaborated on their distress, the participants learned that prescribers
could be berated into prescribing them medications. They learned that prescribers would often
give in and prescribe them controlled drugs rather than deal with the participants’ vocal demands
or objections when prescribers attempted to refuse them.

All the manipulation and especially how bratty and ugly I would be. I would treat
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the doctors and nurses like I was above them and I was going to tell them how they were
going to do it. They were going to treat me. I treated the doctors and nurses absolutely
horrible. I was going to get what I wanted and I would cause as much trouble as I could
until it went my way and it always went my way. If not I’d file a grievance. I was going
to get what I wanted and it was easier just to give it to me and get me out of there because
I was going to throw a fit. They did it just to shut me up I think. It gave me a challenge.
(Jane).

Often the participants expressed a sense of pride and accomplishment when they were
able to secure prescriptions under false pretenses. In addition to feeling contentment about
getting drugs to abuse, the participants perceived the success of manipulating prescribers as
being particularly meaningful. Since many of them had not had many previous successes in their
lives, this sense of pride they felt over being successful at doctor shopping was especially
gratifying to them. The act of conning prescribers was seen as a challenge and was described as
being thrilling and exciting. This fun and positive experience was the only one that the
participants described. Using the drugs was something they had to do and was not described as
particularly enjoyable, whereas manipulating the prescribers was described as pleasurable.

You feel great when you’re doing it. You have all these pills and lots of money and
there’s a thrill in that. There’s a big thrill in that. You feel good. Always look
forward to doctor day. (Tammi).
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Overwhelmingly the participants expressed that doctor shopping was ‘easy’ as part of
their experience when it came to convincing prescribers to write them prescriptions for
controlled drugs. They were very successful with the manipulation and falsification of
symptoms. In comparison to playing the system, which involved a lot of work, baiting the
doctors was easy to accomplish. This was the only time during the interviews when the
participants expressed emotion. Their perception of baiting the doctors as being easy and fun
was reflected in the way they smiled and laughed when describing it.

Yeah, it really is easy to just get what you want if you know what you’re doing.
It works that simple. It’s very easy. I could talk ‘em into it, it’s so easy. (Jane).

It’s easily faked. That’s pretty much it, you know, it’s really not hard. It was easy
to get it. (Mya).

It wasn’t hard work. It was not a problem. I couldn’t believe how easy I thought
it was. It was like slicing cake, a piece of cake handed on a platter. (Desiree).

It’s not hard to get ‘em. They just gave ‘em to me. (Susan).

It’s not hard to do. (Becky).

It was pretty easy and I felt like I had that, you know, and it was pretty easy to
pull that off. (Tammi).
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A few participants described doctor shopping as something they loved and thrived on
even to the point of feeling addicted to it. The fear and danger were exhilarating. They seemed
to experience a physical high from their ability to bait the doctors. They would go into the
health care arena with fear and trepidation, but once they were successful at securing their
prescriptions, they became elated. This is likely an arousal seeking behavior where dopamine
levels are elevated causing a physically pleasing response.

It became like a big hobby for me to see who I could and couldn’t manipulate. It
just got really out of control and I would crave to doctor shop. Absolutely loved it.
I thrived off that. I paid all my bills that way, bought all my nice things that way, kept
myself high that way and had a lot of friends that way. It’s exciting and it’s kind of like
a person that is in a high speed chase that gets off on that, being chased, ‘I wonder if
they’re going to catch me.’ It’s just being on the edge. I thought at that point in time that
doctor shopping was going to be there for me always and take care of me and I really
depended on that and thought it was my friend. I miss the rush of doing it and the
abusing part of it of course. My drug of choice was doctor shopping. (Summer).

You do it once or twice and that right there is an addiction alone. I got addicted to
the excitement and danger of it. It was dangerous. It was on the edge and the closer
to the edge I could get the more I did it. It was fun and exciting. The excitement
was there but it was also a challenge. It was like, ‘let me see if I can break this new
doctor. Let me see if I could, how many times I can get this doctor to write.’ (Desiree).
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An aspect of the success the participants experienced when ‘baiting the doctors’ was that
many of the prescribers were either complacent with the act of doctor shopping, or in some cases
they were collaborative with the participants. Many times the participants described how they
were not checked for the accuracy of the information they provided, pill counts were not done,
nor were drug screens or examinations for needle marks. Even when needle marks were found,
some prescribers continued to prescribe the medication that was being abused. Participants
reported that seldom were PDMP reports checked. The participants perceived the complacency
of prescribers as common and something they expected and took for granted. The prescribers
were perceived as being uninterested, unconcerned, and as not being diligent in thwarting their
efforts. The participants were unconcerned with the fact that this could indicate that the
prescribers did not care, or were not considering the participants’ best interest. The fact that no
one tried to question them, or stop them, or offer them help, was inconsequential and not
perceived as significant by the participants.

I don’t know how I didn’t get caught. I think it’s because my doctor didn’t run that
narcotic check where they see what you have gotten since the last time you were there.
I think what it was is, I had a trust built with him that he felt maybe he didn’t need to do
that and my other doctor never did either. (Jane),

When I was sponsoring people and you can make a lot of money that way. I
bought a car (laughs). I sponsored people who were doctor shopping a lot.
Whenever you sponsor people we don’t really get called in that often for pill

106

counts or nothing. They’ll pretty much just send you out of there with whatever you
want, a lot of ‘em. (Becky).

The doctors would basically ask me, ‘what do you need?’ and I tell them. They
kept me well supplied. It’s like once you establish with them, you know, you get
something from them. It was so easy because it seemed like once they know you they
don’t really check anything. If they drug tested me, I would carry other people’s pee with
me. (Londie).

You go in and they’ll ask you what you want. Then they said, ‘do you need any more?’
They increased it and kept increasing it and increasing it. They’d say, ‘OK what do you
need?’ ‘What do you want?’ ‘How many do you need?’ and you just tell ‘em. You go in
and tell ‘em what’s wrong and they’d write ‘em that day without even going over your
records or anything. I’ve sat there waiting four hours before even going back to see the
doctor. Once you got back there, you wasn’t in there two minutes, two or three minutes.
You know, they just write out what you tell ‘em. They’re there to give you medicine
whether you need it or not, you know, because they want their money, especially if
you’re paying cash. Some do pill counts and some don’t. If they drug tested me I don’t
know how I passed. I think they just let me slide. (Susan).

In some cases participants developed relationships with prescribers, staff at prescribers’
offices or pharmacists in order to secure special favors or to prevent detection. This relationship
served to benefit both parties. In the case of sexual favors, the participants did not seem to
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recognize that they were being used similar to prostitution in securing their prescriptions. The
fact that the participants’ bodies were being used and disrespected by prescribers, who were
supposed to be protecting and helping them was not relevant to the participants’ experience.
Rather, the participants perceived the sexual favors as part of their manipulation of the
prescriber, which gave them power. They portrayed the prescriber as the one who was being
used.

I started doctor shopping for multiple reasons, to support a drug abuse habit, to
get them to sell, and um, eventually it became um, an intimate thing with the doctors.
I developed sexual relationships with them. If I flirted just right, I could get whatever
I wanted. I would make promises to the doctors and always got anything I wanted. That
doctor would introduce me to another shady doctor. I would befriend some of the
pharmacists to get refills in advance. The doctor would tell me what pharmacists to go to
fill them and I got a discount. (Desiree).

I dated a doctor and he would write anything I wanted. He would send me to one of
his friends that also prescribed to me. I became friends with a few other doctors I could
make house calls to. I got them right where I wanted them. (Summer).

In some cases the prescribers were described as also being addicts. The prescriber was
then perceived by the participant as an equal with whom to exchange favors for their mutual
benefit.
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The doctor that was writing them was trying to cover his ass as much as I was
trying to cover mine. He was using as well. He was trying to cover his tracks. He
would write me a prescription but it was going to his wife. (Melissa).

Summary
Weaving together the four themes found in this study in the experience of doctor
shopping as conceptualized by the existential grounds of world, time, body, and others, the
findings of this study are summarized in the following paragraphs.
The world in which the participants in this study interacted was limited. The only
locations they talked about frequenting were doctors’ offices, hospitals and pharmacies. Some of
the participants had jobs and they also attended NA meetings but the focus of their experience of
doctor shopping took place in healthcare environments. Their addiction to drugs was an allconsuming force and priority. This created a perceived need for feeding their addiction as a
result of cravings for the drugs as well as to prevent or treat severe withdrawal symptoms. When
discussing their addiction in their interviews, it was described as an entity outside themselves
which exerted dominance and control in their lives. In addition to the severe physical
withdrawal symptoms they experienced, they also experienced serious physical effects from their
drug use including infections, overdoses, seizures, and becoming comatose. The participants
apparently did not perceive the risks of abusing drugs to be significant enough to stop them from
doing it, although they had attended NA meetings either voluntarily or by court order.
The participants lived solo lives with a self-centered focus. Rarely were significant
others mentioned, and when the participants mentioned disturbing facts like their children being
removed from their custody, they did so with little emotion or expression of remorse which is
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evidence of emotional numbing. The primary people the addicts talked about having
relationships with were other addicts for the sole purpose of networking to obtain drugs.
Networking with addicts was done to obtain information as well as collaboration in the actual act
of doctor shopping. An addict ‘network’ or ‘circle’ was described as something the participants
relied on. Many of the participants also sponsored others or were sponsored by others to obtain
medications. This was often done when the participants either lacked money to doctor shop or
sponsorship of others was done as a method to make money which was used to support a drug
habit. Although the addicts networked with other addicts, this relationship appeared to lack the
care and concern that would normally be involved in interpersonal relationships. The
participants perceived the other addicts as a tool or instrument to be used to their benefit to
secure drugs.
Playing the system was part of the experience for the participants as they interacted in the
healthcare environment with prescribers, medical practices, hospitals and pharmacies. In some
cases when safeguards were implemented by prescribers, such as pill counts or urine drug
screens, the participants found ingenious ways to thwart these efforts. Using false names, fake
IDs and paying cash rather than using insurance were other ways that the participants were able
to play the system in order to remain undetected. The process of eluding detection involved a lot
of effort and work by participants and provoked fear in some of the participants, but fear did not
stop them from engaging in doctor shopping.
Baiting prescribers through conning and manipulating was essential to the act of
obtaining prescriptions when doctor shopping. Most often this involved falsifying or
exaggerating physical complaints such as pain or anxiety. The participants would read the
prescribers and figure out what to say or do to get prescriptions. They learned that causing a
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scene by crying or demanding medication made prescribers uncomfortable and more likely to
write them prescriptions for controlled drugs. Prescribers were complacent when they did not
check out patient’s histories, past records, PDMP reports, or ask for pill counts or drug tests.
Often participants waited long periods in waiting rooms to see prescribers but the amount of time
prescribers spent with the participants was very short. Several participants expressed their belief
that the prescribers did not care, looked the other way, and continued to prescribe them
controlled drugs to make money. In a few instances prescribers collaborated with participants in
doctor shopping in exchange for sex, profit, or to share the medication.
Conclusion
The thematic structure of the meaning of doctor shopping, which encompasses the four
figural themes can be synthesized as if it were told by a hypothetical participant: I am an addict.
I am a pill head and if I don’t take drugs I will get pill sick. My addiction rules my life. My
primary focus in life is feeding my addiction. I don’t care if my addiction causes me to get sick,
overdose, lose my kids, go to jail or die. One way I feed my addiction is through doctor
shopping. The only places I go are to the doctor to get prescriptions and to the pharmacy to get
them filled. The only people I have room for in my life are other addicts. Networking with
addicts helps me get information about where to go to doctor shop and we also help each other to
doctor shop and do it together. I play the system by going to numerous prescribers and
pharmacies to avoid detection which takes a lot of work. Sometimes I pay cash and sometimes I
use my insurance. I foil pill counts and drug screens. It’s easy to bait the doctors into
prescribing me drugs through conning and manipulating them. Most of the time they just go
along with it, whether they know what I’m doing, or not.
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Chapter 5
Discussion
The purpose of this study was to describe the meaning of the experience of doctor
shopping. Guided by existential phenomenological philosophy based on the works of MerleauPonty, I conducted 14 interviews with women who self-identified as having doctor shopped. All
the participants were asked to describe their experiences related to doctor shopping. The audio
recordings of the interviews were transcribed verbatim and analyzed using the UTK method of
phenomenology. Each interview was examined within the context of the entire set of interviews
to identify both the preliminary themes within each individual interview and then global themes
throughout the interviews. Finally a thematic structure was developed.
Thematic Structure
The themes of ‘feeding the addiction,’ ‘networking with addicts,’ ‘playing the system,’
and ‘baiting the doctors,’ form the thematic structure of the experience of doctor shopping. For
each theme there is a multidirectional association with the other. ‘Feeding the addiction’ caused
the participants to ‘network with other addicts’ to enable them to ‘play the system’ and ‘bait the
doctors.’ This in turn, fueled their need to ‘feed their addiction.’ Success at ‘playing the system,’
despite it being hard and scary, enabled them to ‘bait the doctors,’ which was easy, and provided
positive feedback. Success served as encouragement for them to continue doctor shopping, as
well as the impetus for them to share their experience with others when ‘networking with other
addicts.’ Success at doctor shopping also enabled them to secure more and more prescriptions
which they used to abuse or to sell to obtain other drugs to ‘feed their addiction.’
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Figure 1: Thematic structure of the meaning of doctor shopping
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For all the participants ‘feeding the addiction’ drove the phenomenon of doctor shopping.
In many cases the medications were sold but this was done to support a drug habit. The second
component in the experience of the meaning of doctor shopping is ‘networking with addicts.’
Just as in the meetings I attended where a sense of community was noted, the women heavily
relied on other addicts for information about which prescribers to target for doctor shopping.
Additionally, they networked together in the act of doctor shopping, by doing things such as
providing transportation to medical appointments, paying for another addicts’ appointments and
prescriptions in exchange for some of their medication as well as borrowing pills for pill counts
or urine for drug tests. After obtaining information from other addicts about where to go to
doctor shop, the participants ‘played the system’ of the health care arena, to foil detection. This
involved strategic timing of visits to prescribers, alternating using insurance or paying cash, and
traveling long distances to see prescribers or to have prescriptions filled.
Other ways they ‘played the system’ included carrying urine from other people or putting
drugs into urine, using false MRI’s and borrowing pills for pill counts. ‘Playing the system’
involved much hard work and effort by participants and often involved fear of being detected.
Finally, prescribers conned and manipulated prescribers by falsifying symptoms and acting like
they were in severe pain or in need of other controlled drugs when they were not. Dramatic
displays of distress were enacted as well as demands for prescriptions. This process of ‘baiting
the doctors’ was described as being easy and a piece of cake. Obtaining prescriptions often
involved prescriber complacency when prescribers either failed to take measures to decrease the
incidence of doctor shopping or looked the other way even when doctor shopping or prescription
drug abuse became evident. In some cases prescribers collaborated with the participants, such as
through an exchange for sexual favors, or profited from the doctor shopping scheme when other
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addicts were referred to them. To some extent pharmacies also played a role in complacency and
collaboration.
The world of the participants in their experience of doctor shopping was limited,
excluding other activities and people aside from those focused on doctor shopping. There was
little time for the participants for anything but doctor shopping and using drugs. The way the
participants described their bodies seemed as though they were empty vessels which needed
filling with drugs. They experienced bodily cravings and withdrawal symptoms when they
didn’t have drugs. Other people in their world consisted of other addicts for whom they had little
regard, and prescribers who they conned and manipulated to secure drugs.
Findings Related to Previous Literature
This phenomenological study has revealed many new findings about the meaning of the
experience of doctor shopping for women. The phenomenon previously has not been studied.
The phenomenon can now be better understood based on the findings from this study that the
participants experienced their world, time, and others as being limited and restricted primarily to
doctor shopping. Furthermore, the study adds to the literature an understanding that addiction
and its bodily effects, such as drug cravings and withdrawal symptoms, plays an integral role in
the engagement in doctor shopping. While networking with other addicts has been briefly noted
in existing literature, the extent to which people who engage in doctor shopping rely on each
other to obtain information and to work together while doctor shopping, along with the extent to
which specific tactics are employed, has not been previously understood or described. The
results of this study add to existing literature a further understanding of the act of conning and
manipulating prescribers, including a sense of it being easy and involving excitement. The
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extent to which prescribers are complacent or collaborative with the act of doctor shopping is
also better understood based on the findings from this study.
All the participants described a pattern or cycle of doctor shopping which resulted from
and perpetuated their addiction to drugs. They described the painful withdrawal symptoms they
experienced when they did not have the drugs. All but two of the women were IV drug users.
The drive to feed their addiction was overpowering despite great personal and financial costs.
Some women had lost custody of their children and others were estranged from their children or
other family members. Many had arrests related to substance abuse which resulted in time in
jail. Some women were homeless and were living with friends or in a half-way house. Almost
all the women reported serious physical consequences resulting from their addiction including
numerous overdoses, seizures and other hospitalizations.
Findings about serious health-related effects resulting from prescription drug abuse in
this study were consistent with previous literature, such as the study by Coben et al. (2010)
which found that poisoning by opioids, sedatives, and tranquilizers has increased, often
involving benzodiazepines. The majority of participants in this study mentioned abusing
benzodiazepines, specifically alprazolam, which Shah et al. (2012) showed to contribute to the
cause of overdose deaths. Coben et al. (2010) found that women over the age of 34 were more
likely hospitalized for poisoning by opioids, sedative and tranquilizers which is consistent with
this study, as the average age of participants was 34 years. However, since the majority of the
participants in this study were under age 34, it appears overdosing from poisoning of drugs
occurred at younger ages in this study. Doctor shopping clearly poses a serious health risk for
women who engage in doctor shopping due to prescription drug addiction. This is tantamount to
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a potentially deadly game being played by the women, as the study by Peirce at al. (2012) has
found that doctor shoppers have twice the odds of drug-related death.
While specific questions were not asked during the interviews, some information about
the participants was revealed about their characteristics, which can be used to compare to
findings from previous studies. Consistent with the findings of Hutchinson (1986), Grella and
Lovinger (2012) and Furrer (1991), co-morbidity of physical illness was noted in this study.
Nine of the fourteen women in the study reported having a physical health problem that at times
was the reason that prescription pain medication was initially prescribed, which they later began
abusing. Three participants had been declared disabled due to a physical illness.
Consistent with previous studies (Aston, 2009; Back et al., 2010; Bardhi et al., 2007;
Godlaski et al., 2009; Golder & Logan; 2011; Grella and Lovinger, 2012; Jamison et al., 2010;
McLarnon et al., 2011; Pant & Bagrodia, 2012; Passik et al., 2006; Shinebourne & Smith; 2011;
Tracy et al., 2012; Watson & Parke, 2011; Woodhouse; 1992), five of the women in this study
described mental illnesses, which was referred to as the reason for prescriptions for
benzodiazepines, which were then abused. One participant specifically stated the reason for her
disability was due to mental illness.
Contrary to previous studies, (Etherton, 2006; Furrer, 1991; Godlaski et al., 2009; Golder
& Logan, 2011; Jamison et al., 2010; McCauley, 2009; Pant & Bagrodia, 2003; Tracy et al.,
2012; Watson & Parke, 2001) history of abuse was not mentioned by the participants in this
study as being part of their experience of substance abuse. Similar to previous literature (Back et
al., 2010; Bardhi, et al., 2007; Green et al., 2009; McCabe et al. 2008; McCauley, 2009;
McLarnon, et al, 2011; and Passik et al., 2006) all participants in this study described
polysubstance abuse often including any controlled drug they were able to obtain, as well as
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alcohol. Six participants stated they had been in either outpatient or inpatient drug rehabilitation
for their addiction. Since all participants were recruited from NA meetings, they were all in
some way striving to recover from addiction, either voluntarily or under a court order.
Similar to the findings of Bardhi et al. (2007), the participants in this study believed that
obtaining prescription drugs from others was acceptable, they used prescription drugs with other
drugs, and obtained prescription drugs relatively easily. However, contrary to the findings of
Bardhi et al. (2007) the women in this study did not claim to avoid dependence on their
prescription drug use. Rather, abuse and addiction drove their doctor shopping and they
frequently referred to themselves as addicts or ‘pill heads.’ The participants in the study by
Bardhi et al. (2007) reported that general practitioners were more willing to write prescriptions
for controlled drugs than those in psychiatry. In the current study, the majority of prescribers the
participants mentioned who prescribed them controlled drugs were general practitioners,
although a few participants did also visit psychiatrists for controlled drugs. One participant
specifically mentioned that nurse practitioners and physician assistants were not as likely to
prescribe controlled drugs as physicians.
Similar to the findings of Inciardi et al. (2009), three participants in this study mentioned
patterns of drug diversion they engaged in aside from doctor shopping including forgery of
prescriptions. Also similar to Inciardi et al. in addition to doctor shopping, often participants
purchased prescriptions from friends, relatives or dealers.

As in the study by Fountain et al.

(1997), the women in this study described diversion techniques of multiple scripting,
overscripting, false identities, gaining sympathy, forgery, one off tactics, feigning symptoms, and
enjoying the game, by experiencing enjoyment from outwitting prescribers.
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Other similar patterns of prescription drug diversion were noted in this study compared to
the study by Rigg et al. (2012) in that special arrangements were sometimes made with
prescribers including recruiting additional patients, sexual favors, and exchanging prescription
drugs. Sponsorship was reported in this study similar to the Rigg et al. (2012) study involving
subsidizing another person’s trip to a pain clinic, cost of the visit, and transportation costs in
exchange for a percentage of the medication.

Targeting vulnerable persons such as veterans

and the elderly to sponsor to doctor shop was not noted by the participants in this study. Health
care fraud was committed with fake IDs, fake MRIs, and billing insurance for the cost of
prescriptions that were either abused or sold by women in this study, which was similar to the
Rigg et al. (2012) study.
Consistent with the findings of Green et al. (2013), participants in this study networked
together. Their collaboration involved sharing rides, pills, MRIs and information. However,
contrary to the findings from the study by Green (2013), coercion was not noted as being part of
the experience of women in this study. The participants did not mention coercing others to
engage in doctor shopping. Additionally, the women in this study did not report being coerced
or influenced by others in doctor shopping which is contrary to the findings by Pant and
Bagrodia (2003) and Woodhouse (1990).
Many findings from this study of female doctor shoppers are consistent with previous
studies done related to prescription drug abuse, diversion and doctor shopping. These
similarities and differences along with many new findings, helps shed light on a phenomenon
that is only recently being examined. In the following section I will discuss the implications of
the findings from this study related to the identified themes.
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Implications of the Study
Responsible Prescribing
Despite many years of education and training, and evidence of the severity of prescription
drug abuse, prescribers, for a variety of reasons, continue to write prescription for controlled
drugs to patients who abuse them. In general, health care providers are trained to help patients
and relieve their suffering. When patients present with dramatic complaints of pain or anxiety, a
natural instinct of the prescriber is to take them at their word, in an honest effort to provide them
help. A need exists to shift the focus of care to prevention and treatment of addiction, because if
prescribers write prescriptions for controlled drugs to people who are abusing them, prescribers
are actually contributing to a serious and potentially deadly disease.
Treating pain, anxiety, or other conditions with controlled drugs should be done on as
short term a basis as possible for the majority of cases. Current recommendations include that
greater clinical judiciousness is warranted when prescribing opioids due to a lack of evidence of
safety or effectiveness in long term use of opioids for chronic back pain and other nonmalignant
pain (Alexander, Kruszewski, & Webster, 2012). Long term use of benzodiazepines has also
come into question as some studies link it to a risk of increased falls, impaired memory, impaired
cognition, and a higher incidence of dementia (Galacher et al. 2012; Ilomaki, Johns, Shakib &
Bell, 2013; Uzan, Kozumplik, Jakovljevic, & Sedik, 2010).
Another problem prescribers face when trying to prescribe responsibly is that screening
patients for abuse based on their appearance, what they say, their actions, or even how they
complete screening instruments, is fraught with error because addicts are so good at deception
and manipulation. In practice, prescribers rely on their judgment and intuition when making
decisions about what treatments to endorse, and in the case of doctor shoppers, this is often
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ineffective. In most cases, people do not present to prescribers telling lies in an effort to deceive,
therefore this is an unexpected and often unrecognized occurrence. For some prescribers, it can
be perceived as being unsympathetic, negative, or unkind, to be suspicious of patients.
Prescribers often erroneously believe that they can a patient who is lying. This is contrary to a
meta-analysis of 206 studies done on deception judgments. The authors of that meta-analysis
determined a lie-truth discrimination rate of 54% which is only slightly better than could be
achieved by flipping a coin (Bond & DePaulo, 2006).
An article published by Gerhardt (2004) Identifying the Drug Seeker: The Advanced
Practice Nurse’s Role in Managing Prescription Drug Abuse outlines several red flags when
making a determination to prescribe a controlled drug: Evidence of escalated use is a warning
sign. This evidence includes patients reporting they have run out of their medication before
scheduled appointments and claiming their medications were lost or stolen, which were tactics
some of the participants in this study reported having told their prescribers. Prescribers should
be suspicious of patients who claim they have no regular provider, state they are from out of
town, request care after hours, or at emergency rooms. Other methods of scamming include
patients being overly complimentary, demanding, or threatening a lawsuit for failure to treat
when prescriptions are denied. Requesting specific controlled medications and refusing others,
stating they are allergic or they are ineffective, is another tactic that may signal addiction or
intent to divert medication. Other suspicious tactics include avoiding physical examination or
stating their previous prescriber has gone out of business (Gerhardt, 2004).
PDMP
The implementation of the PDMP is the most significant screening mechanism currently
in place to detect doctor shopping. Problems with the PDMP include that it is not a real time
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system and there is usually a few day delay in data being available to prescribers which varies
from state to state. Each PDMP is run independently and there are varying rules and regulations
about which drugs are entered. Only some states share information with each other, so doctor
shoppers can avoid detection by traveling to other states. A significant barrier to the
effectiveness of PDMPs to detect doctor shopping is the fact that they are not widely used. Only
eight states have statutes that require prescriber training of the PDMP (National Alliance of
Model States Drug Laws, 2012b). While few studies have examined prescriber use of PDMPs,
in one study of 23 hospices, 90% of respondents reported never using the PDMP (Blackhall,
Alfson, & Barclay, 2013).
Some states have imposed regulations requiring prescribers to check PDMPs when
prescribing controlled drugs, but these regulations have met resistance from some physicians
groups. Currently five states have some form of a law requiring prescribers to check the PDMP
at varying intervals (Dolan, 2012). The Tennessee Medical Association was successful at
loosening the requirements of their law requiring prescribers to check the PDMP. Initially the
law called for a check of the database every time a controlled substance is prescribed and every
six months after that. This was changed to require a check initially and then only annually
(Dolan, 2012). In response to a law passed in New York requiring prescribers to check the
PDMP, the New York Medical Association objected and released a statement that legislators are
placing too much of the blame on physicians for the prescription drug abuse problem (Dolan,
2012).
A sentiment of some physicians is that they should not have to police patients by
checking their prescription histories and they also resent government oversight (Schreiner,
2012). The American Medical Association published an article Prescription Abuse Laws Can
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Create a No-Win Situation for Doctors (Stack, 2012). The author argues that requiring
physicians to check PDMP data goes against a duty to treat pain. Furthermore an objection is
raised about requiring patients to provide a photo ID, and a recommendation to not routinely
administer or prescribe controlled drugs in emergency rooms. The author complains that if he
prescribes Percocet to an addicted patient, with a legitimate medical need, he could be liable if
that patient overdoses a month later. He also states that it is a widely held falsehood that patients
seen in emergency rooms are recklessly irresponsible or have criminal intent (Stack, 2012).
In an article on the legal response to America’s prescription drug epidemic, Schreiner
(2012), a medical attorney, advocates that courts should “impose a legal duty upon doctors to
check prescription databases prior to issuing prescriptions in order to strengthen potential tort
claims against those who fail to do so” (p. 536). His view is that requiring prescribers to check
PDMP databases will “provide clear direction to doctors on the professional standard of care of
an electronic monitoring program” (p. 536). Additionally, he states that prescribers may be
liable for damages that result from their failure to check a patient’s drug history prior to
prescribing “dangerous and addicting” (p. 536) drugs.
As evidence of physician resistance to being held liable for checking PDMP data, 17
states have laws in place that grant immunity to prescribers for failing to access PDMP data
(Schreiner, 2012). According to Schreiner, “granting civil immunity to physicians who fail to
check PDMP data can be seen as nothing more than an unacceptable example of legislatures
throwing a powerful lobby group a bone” (p. 537). Furthermore he states that “immunity
provisions are counterproductive and undermine the policy objectives of establishing a PDMP”
(p. 537).
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Checking the PDMP reports of patients prescription histories should be a standard policy
and protocol when controlled drugs are prescribed. This should be done at every visit in order to
detect doctor shopping. Mandating PDMP checks every six months or annually will allow the
possibility for patients to visit numerous prescribers within that time period.
Drug Testing
Once a decision has been made to prescribe a controlled drug, drug testing should be
done prior to writing the first prescription and then periodically while the patient is being
maintained on a controlled medication. Drug tests should be ordered to determine if a patient is
taking any illicit drug or a controlled drug other than what is prescribed. Secondly, drug testing
is done to determine that the patient is actually taking the controlled drug prescribed to them,
rather than selling it or taking it all at once, and then going without it. In that case, a negative
drug test, or one that did not have the prescription drug prescribed found in it, would indicate
aberrant use of the prescription. A common practice engaged in by doctor shoppers is fooling
drug tests when they were ordered. A national standard and requirement to screen patients for
drugs with the most accurate method available when controlled drugs are prescribed is needed.
Contrary to normal practice, drug screens need to be done prior to prescribing a controlled drug
as well as after, which would detect drug use which is either illicit or prescribed by another
prescriber.
Several professional organizations recommend periodic drug testing including the
American College of Preventive Medicine (2011), and the American College of Physicians
(n.d.). The most common form of drug testing is a urine drug screen (UDS). Recommendations
for frequency of urine drug screens were determined by Owen, Burton, Schade, and Passik
(2012) after pain experts reviewed best practices and the literature, as well as survey results from
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physician pain society members. They concluded that for patients receiving prescriptions for
controlled pain medication should be evaluated for risk, including behaviors, and through risk
assessment instruments, such as the ones previously mentioned. Other risk factors they
identified were co-occurrence of a mental health disorder, pain after a motor vehicle accident,
and pain involving three or more regions of the body. Their recommendation is that patients
who are prescribed controlled drugs who are at low risk should have a UDS done one to two
times a year. Patients at moderate risk should have them done three or four times a year, and
patients at high risk should have them done either four times a year, every month, every office
visit, or every drug refill (Owen et al., 2012).
There are two types of UDSs, dipstick enzyme immunoassays (EIS) and gas
chromatography mass spectroscopy (GC/MS). The most common way UDSs are done is with
dipstick EIS which is convenient and inexpensive, but not very accurate (Owen, et al. 2012).
This type of testing fails to distinguish drugs from the same class; therefore, patients could pass a
drug test for an opioid they are prescribed even if they are abusing an opioid which has not been
prescribed. Metabolites or levels are also not measured, which is why participants in this study
were able to put a small amount of the actual drug they were supposed to be taking as prescribed
into someone else’s clean urine to pass a UDS. Gas chromatography mass spectroscopy is a
more extensive, accurate, and expensive test for drugs in urine and is the gold standard for urine
drug testing (Owen et al. 2012). GT/MS testing can detect more drugs, distinguish one drug in
the same class from another, tests for metabolites, which only shows if the drug has been
ingested, and give drug levels, making it more difficult to fool. Nicotine is also tested which can
be useful to detect deception if the person being tested smokes and uses urine from someone who
does not or vice versa. Numerous products are on the market designed to help people fool urine
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drug screens which are likely ineffective. These include pills to take orally or put into urine, and
even fake penises with compartments to hold urine for men.
Other measures are needed to prevent adulterated urine from being used by patients to
avoid prescription drug abuse detection. Recommended measures include having the patient
observed while giving the specimen, having patients remove any unnecessary outer clothing or
personal belongings prior to entering the room to give the sample, placing a bluing agent in the
commode and turning off the water supply in the testing area so that water cannot be used to
dilute the specimen. Additionally, checking the temperature, pH, specific gravity, nitrates and
creatinine concentration of urine can also be done to detect adulterated urine (Standridge,
Adams, & Zotos, 2010).

Mandating regular urine drug screening with GS/MS and other

measures to detect adulterated urine provided for drug screens would reduce the ability of
patients to fool drug testing. Audits of documentation that these measures are being taken would
help ensure that there is compliance. Additionally, measures should be taken to make GS/MS
testing more available and affordable.
Other methods of drug testing include saliva testing, hair follicle testing, and serum blood
testing, are all more difficult to fool but more expensive. There may be some variability to the
findings from oral fluid tests as well as collection issues if there is a difficulty producing enough
saliva for the test (Drummer, 2006). Hair follicle tests reveal drug use in the last 90 days which
can be helpful and accurate (Huang, Liu, Huang & Chien, 2009). Both of these tests are
expensive and not widely done for regular screening. Commercial adulterants such as oral
tablets and techniques such as dying or using harsh chemicals in the hair are often used to try to
fool these tests, but their success rate is thought to be relatively low (Drummer, 2006; Hill,
Cairns & Shaffer, 2008). Serum drug screens can be done but each drug must be ordered
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individually, and a large amount of drug testing is hard to do on the small amount of blood
normally collected in blood testing. Additionally, there is a separate charge for each drug which
is expensive. Serum blood tests detect actual drugs in the blood rather than metabolites, so there
would need to be recent use for detection. One benefit of doing serum blood screens would be
that the patient’s arms would be examined when preparing for venipuncture, which could detect
needle marks indicating intravenous drug use.
Treatment Contracts
According to Bruckenthal (2007) key aspect of safe prescribing for pain management
include patient assessment and a treatment agreement or contract. A patient assessment should
include a thorough physical exam as well as a psychosocial assessment, which will help identify
patients who would be appropriate for opioid therapy. A treatment agreement should be signed
by the patient and include policies on refills, frequency of office visits, monitoring, including pill
counts and drug screens, and verification that medications are stored securely. Additionally,
contracts require a single prescriber policy, where patients are not permitted to seek pain
medication from another prescriber and only one pharmacy is permitted as well. This type of
contract should also be implemented when patients are prescribed benzodiazepines or other
controlled drugs.
Physical Examination
Other recommendations include ongoing physical assessment of patients for signs of drug
abuse such as appearing sedated, intoxicated, impaired or physically unkempt. Unlike other
objective examinations which can be fooled, the presence of needle marks, also called tracks, in
people who use drugs intravenously cannot be hidden. While the exact number of people who
engage in doctor shopping and abuse prescription drugs intravenously is not known, it is likely
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that the number is significant. Some participants in this study did report that they were checked
for IV needle marks. Patients who are prescribed controlled drugs should be checked for needle
marks which would involve disrobing and putting on an examination gown so that their legs as
well as their arms could be examined. While this may be inconvenient, it should be part of
routine screening of patients who are prescribed controlled drugs. Other physical examination
techniques to screen for prescription drug abuse are nasal examination for redness or bleeding
from snorting drugs, examining fingers for burns or lesions from smoking drugs, and an eye
examination for pin point pupils which indicates acute intoxication.
Screening Instruments
To aid in screening for substance abuse, instruments to assess inappropriate drug use
should be utilized, including those that patients complete as well as those for prescribers to
complete. The Addiction Behavior Checklist (ABC) completed by the prescriber to document
and assess for drug seeking behavior provides a valuable tool to help prescribers assess their
patients behaviors which could indicate abuse. Patient response instruments such as the Patient
Version Prescription Drug use Questionnaire (PDUQp) and the Revised Screener and Opioid
Assessment for Patients with Pain (SOAPP-R) should be used to attempt to detect addiction,
despite the fact that patients can lie when completing these instruments, because studies have
shown them to be effective in many cases.
The PDUQp is a 31-item questionnaire which patients complete, which was developed to
help clinicians identify opioid abuse or dependence in patients with chronic pain (Compton, Wu,
Schieffer, Pham, & Naliboff, 2008). Questions included in this instrument are: ‘have you used
the pain medication to help other symptoms such as problems sleeping, anxiety or depression?’
and ‘have you ever borrowed pain medication from a friend or family member?’ The PDUQp
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showed statistically significant validity based on t-test results (p < 0.001). The instrument was
able to distinguish between patients whose medications were stopped due to problematic use
compared to those who continued on them or who discontinued for other reasons. Additionally,
logistic regression results were used to determine that the PDUQp score was a significant
predictor of medication agreement violation–related discontinuation.
The SOAPP-R is a self-report questionnaire designed to predict aberrant medication
behaviors among chronic pain patients (Butler, Fernandez, Benoit, Budman, & Jamison, 2008).
This 24-item questionnaire includes questions about behavior that have occurred in the last 30
days, including: ‘how often have you run out of pain medication early,’ ‘how often have you
counted pain pills to see how many are remaining,’ and ‘how often have you attended an AA or
NA meeting?’ Stability and internal consistency of this scale was statistically significant (p <
.001). Testing of this screening tool found an 80% success rate at identifying people at high risk
for aberrant medication behaviors.
The ABC is a 20-item instrument developed to assess behaviors characteristic of
addiction related to prescription opioid medications in patients with chronic pain using items
focused on observable behaviors of the prescriber during and in between clinic visits (Wu et al.,
2006). The scale also includes questions for patients prescribed sedative analgesics along with
their narcotic pain medication. Items assessing addiction behaviors observed by the prescriber
since last visit include: ‘patient has hoarded meds,’ ‘patient ran out of meds early’ ‘patient
received narcotics from more than one provider’ and ‘patient bought meds on the street.’ Items
assessing addiction behaviors within the current visit include: ‘patient appears sedated or
confused,’ ‘patient misrepresented analgesic prescription or use,’ ‘patient indicated she or he
‘needs’ or ‘must have’ analgesic meds,’ and ‘patient expressed a strong preference for a specific
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type of analgesic or a specific route of administration.’ Interrater reliability for this instrument
was statistically significant p < 0.01. Concurrent validity of the instrument was also significant
(p <0.001) when compared to the global judgment of the clinician (p < 0.01) and when compared
to the PDUQ. A cut-off score of three or more on the ABC showed a good general estimate of
appropriate versus inappropriate opioid use, which therefore warrants more careful monitoring of
patients.
Documentation Flow Sheet
The implementation of a flow sheet when controlled prescription drugs are prescribed to
document responsible and necessary measures that must be taken should become the standard of
care which may need to involve mandatory use by statute. This flow sheet would allow a
prescriber to document when steps such as physical exam, UDS, pill counts, checking PDMP,
checking for needle marks, checking pupils, nasal exams, documenting patient’s meds are stored
securely, and completion of screening instruments. Prescribers could be audited to produce this
flow sheet to ensure that responsible measures of prescribing are being taken. The extra effort
and time which would be required to responsibly monitor patients who are prescribed controlled
drugs should be reflected in a higher reimbursement rate for services.
Prescriber Education
In order for responsible prescribing to occur, adequate training must take precedence.
Mandatory training on the use of controlled drugs and issues related to addiction would ensure
that all prescribers who write prescriptions for controlled drugs are provided with the
information and tools they need to make responsible decisions about patient care. Use of the
PDMP, identifying drug seekers, principles of medication safety and risks, signs of addiction and
addiction treatment need to be included. Training on how to counsel patients about non-
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pharmacological treatment for conditions that are treated with controlled drugs should also be
provided.
Another important area where prescribers need training is how to handle the situation
when doctor shopping or abuse is detected. In some cases prescribers may avoid implementing
measures to detect abuse because they feel uncomfortable confronting patients. In a study of
palliative medicine fellows “I Feel Uncomfortable ‘Calling a Patient Out’: Educational Needs
of Palliative Medicine Fellows in Managing Opioid Misuse (Childers & Arnold, 2012), 77% of
the 57 participants in that study had seen at least one patient with substance abuse and 47% had
concerns about a patient having a substance abuse disorder. Despite this, only half felt they had
a working knowledge of addiction, 41% felt that their training prepared them to manage opioid
misuse, and 36% felt they knew how to differentiate pain from addiction. Only 21% were
satisfied with how they treat symptoms in patients who misuse opioids. Detecting and treating
addiction or drug misuse needs to be included as part of the training of prescribers.
Addiction Treatment
The United States government continues in its efforts to address the problem of substance
abuse, however, it devotes comparatively little resources to treat addiction as compared to other
health conditions. The results of a five-year study from the National Center on Addiction and
Substance Abuse at Columbia (2012) include that 40 million Americans age 12 and older have
some form of addiction involving drugs, alcohol or nicotine. Additionally, in 2010 only $28
billion was spent to treat addiction affecting that large segment of the American population, as
compared to $44 billion to treat diabetes, which affects 26 million people, or $107 billion to treat
heart disease, which affects 27 million people. In 2012, the Substance Abuse Prevention and
Treatment block grant received an increase of $20.9 million; however, the Substance Abuse and
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Mental Health Services Administration (SAMSA) has requested cuts to substance abuse
prevention for the second year in a row (Budget, prescription drug abuse, workforce, parity main
concerns, 2013). With budget shortfalls in all areas of government, battles over expenditures
continue.
Parity
Another area of controversy relates to coverage of addiction treatment in this country. In
2008, the Mental Health Parity and Addiction Equity Act was signed. This is a federal law that
requires group health insurance plans with more than 50 employees that offers coverage for
substance use disorders, to provide those benefits in no more of a restrictive way than coverage
for all other medical and surgical procedures (Substance Abuse and Mental Health Services
Administration, 2013). Unfortunately, after four years, final rule for the law has not been
determined on issues such as non-quantitative treatment limits, and whether residential treatment
is included (Budget, prescription drug abuse, workforce, parity main concerns, 2013). How the
Affordable Care Act (ACA) will affect the parity law is not certain.
Substance Abuse Treatment Workforce
Workforce issues need to be addressed concerning the professionals in this county who
treat substance abuse. Currently there is no consensus on whether addiction treatment counselors
should be required to hold a Master’s degree, and the educational requirement is presumed to be
a matter that will be resolved on a state-by-state basis. This issue is relevant, as a report from the
Addiction Technology Transfer Center network recommends that the substance abuse treatment
workforce needs to be more diverse and better trained. Furthermore, they predict that more
professionals will be needed in 2014 when the ACA takes effect and more Americans are insured
(Budget, prescription drug abuse, workforce, parity main concerns, 2013).
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Nurses often work with patients with addictions in a variety of settings including
inpatient and outpatient treatment. Addictions nursing is a subspecialty of nursing with
certification offered in this specialty through the International Nurses Society on Addictions.
Psychiatric mental health nurse practitioners (PMHNPs) are advanced practice nurses who treat
mental illness, including substance abuse disorders.

According to the American Psychiatric

Nurses Association (n.d.), there is a shortage of nurses working in mental health, including
PMHNPs. Salaries for PMHNPs in 2011 were over $90,000, representing the seventh highest
paid specialty for nurse practitioners, but for unknown reasons, the salary rate dropped by 8%
from the previous year (Perron-Pronsati, 2012).
While the exact nationwide numbers of the psychiatric nurse practitioner workforce is
unknown, a shortage is particularly meaningful given the shortage of psychiatrists in this
country. According to a U.S. World & News Report (“Fewer U.S. medical students choose
psychiatry,” 2012) there are about 50,000 psychiatrists in the United States, described as being
too few to serve all the patients who need help. Additionally, there has been a downward trend
over the past six years of medical students choosing psychiatry as a specialty. Although the
exact reason for the decline is not known, it may have to do with the relatively low salary of
psychiatrists who have the fifth lowest salary of all physician specialties (Physician
Compensation Report 2012, 2013). Efforts to increase the overall workforce of professionals
providing care for people suffering from drug addiction should be employed such as increasing
the availability of scholarships and grants for education and training, tuition reimbursement,
ensuring adequate compensation, and increasing recruitment and public awareness of needed
professionals in this field.
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Detox and Rehab
Treatment options for people with addiction focus on detoxification and rehabilitation.
These treatments are often compartmentalized and not offered at the same location. Detox units
are often found within traditional inpatient psychiatric units and involve a fairly short four to five
day stay. During this time, patients are administered medications to safely wean them off drugs
of abuse, and to treat the withdrawal symptoms. Most insurance plans cover detox unit stays
which average a cost of $1,700 per day (Choose Help, 2011). When discharged, patients are
generally set up with treatment options such as outpatient drug treatment programs which last an
average of 10 weeks at a cost of $7,000 (Choose Help, 2011). Rarely are patients willing to go,
or do they have insurance coverage or the ability to privately pay for inpatient rehab programs
which typically involve a 28-day stay at a residential facility with an average cost of $19,000
(Choose Help, 2011). Insurance plans that do cover these services often have limits on the
number of substance abuse treatments which is problematic, considering the incidence of
numerous relapses and repeated treatment needs for most addicts. Most patients are discharged
from detox back to the same environments from which they came, often resulting in relapse
within days. There is a need to compel insurance companies to cover rehabilitation as well as for
addicts to participate in them.
It may be that addicts would be more inclined to enter a rehabilitation program if it is
directly located within a detox unit facility. Court orders for rehabilitation participation are
common when a person has been charged with a drug-related crime. Since prescription drug
abuse is a crime, a feasible recommendation would be to court order patients who undergo detox
to comply with rehab. Judges routinely hold sessions on psychiatric units for involuntary
admissions, so they would be readily accessible to order rehabilitation. This measure, however,
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may lead to fewer addicts voluntarily agreeing to admission for detox if they knew they will then
be court ordered to rehab. Additionally the rights of the individuals are limited when
involuntarily admission to rehab is ordered, which poses an ethical dilemma. Another problem
with short term detox is that many addicts will voluntarily enter a detox unit if they run out of
drugs or money since they know they will be given controlled drugs to wean them off drugs as
well as being provided a safe place to stay which includes meals. Often they leave detox only to
immediately resume abusing drugs. Currently there are no mandates for detox or rehab units to
check PDMPs or notify prescribers of the patient’s prescription drug abuse status. Because of
this, many patients leave treatment units and go immediately back to a prescriber or pharmacy to
obtain prescription drugs to abuse. Offering an incentive, such as a monetary one, may be
effective to encourage people who abuse prescription drugs to participate in rehab. Considering
the skyrocketing costs of prescription drug abuse, it would likely be cost effective to offer
addicts a small sum such as a $250 gift card to successfully complete rehab. The savings from
the successful treatment of those who are able to remain off drugs would offset the additional
cost of rehab.
Treatment Issues for Women
As was described by the participants in this study, relapse from recovery to abuse in
addiction is common, and is estimated to be at a rate of 60% (National Institute on Drug Abuse,
2008). Due to this high failure rate of treatment, innovative approaches should be considered.
Gender differences are evident in the phenomenon of substance abuse, therefore treatment and
recovery needs specific to women must be addressed. Gender specific substance abuse services
were recommended following a meta-synthesis of 30 qualitative studies on substance abuse
treatment views and recommendations of substance abusing women (Hines, 2011). The findings
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from this study also indicate that gender specific aftercare for women is needed due to
dissatisfaction with current programs as well as reports of unmet needs.
After Care
Often when patients leave detox units or rehab they do not have a safe drug free
environment to return to. Half-way houses, sometimes called recovery houses, or sober living
houses, can provide a safe structured environment for people suffering from addiction during the
initial phase of their recovery. These houses typically charge rent of approximately $100 per
week. Most states require these houses to be licensed by the Department of Health. Often there
is a shortage of halfway houses for a variety of reasons. Many times if there are zoning laws,
communities or neighborhoods will oppose a halfway house from opening within their
parameters. Running a halfway house can be difficult and it is often hard to maintain adequate
staffing.
The Center for Behavioral Health Statistics and Quality at SAMHSA gathers data on
treatment facilities, and reports that in the United States there are a total of 1,290 halfway houses
affiliated with a treatment facility, and 200 non-treatment halfway houses (C. Alderks, personal
communication, February 19, 2013). Gender information is not gathered on non-treatment
halfway houses. For the 1,290 treatments facilities that also have a halfway house, 897 indicated
that they accept adult women; however, it is not known if they house men and women together
or women alone. In the geographical location where the study participants were recruited, there
was only one halfway house for women within a 60 mile radius. For the entire state where the
study took place, there are only four independent halfway houses, gender served is unknown.
There are 36 treatment facilities in that state that have a halfway house, 30 of which accept
women (C. Alderks, personal communication, February 19, 2013).
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Support Groups
It is generally recommended that people suffering from addiction attend support groups
to aid in their recovery. According to the Substance Abuse Mental Health Service
Administration (SAMHSA) (2008), the most widely available mutual support groups are 12-step
groups. According to a report by SAMHSA, research has shown that active participation in
support groups significantly increases the likelihood of abstinence from drugs and alcohol.
Attending the groups provides a forum to talk about recovery with other people sharing the same
journey. Another aspect of 12-step groups is the concept of sponsorship, where a person with
greater time in sobriety will sponsor another addict with less time and be available to them for
support. This concept of support is seen as important because rather than using drugs when a
person experiences cravings, they are urged to call their sponsor instead.
A few times at meetings I attended, when a person voiced that they were struggling, a pad
of paper was passed around for people of the same gender to write their name and phone number
as an option to call if needed. A principle in NA is that only women sponsor women, and men
sponsor men, to avoid any relationships which could take the emphasis off of recovery. Since
sponsorship is common in doctor shopping, a term referring to addicts working together to obtain
prescription drugs to abuse, it is interesting that this same term is used to help another person
maintain abstinence in recovery. Before recovery sponsorship leads to further addiction. During
recovery, sponsorship is a tactic to eradicate addiction. In both cases it involves a relationship
and clearly relationship plays an important role not only in addiction, but also in recovery.
Narcotics Anonymous was founded in 1953 and sprang out of the Alcoholics Anonymous
program of the 1940s. The organization is a community-based organization that offers recovery
from addiction through working the 12 steps and attending group meetings. There are more than
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58,000 weekly meetings in 131 countries (Narcotics Anonymous, 2012). Each group runs itself
based on the principles of NA, with no formal organization association or oversight; therefore
statistics about demographics are not certain.
The effectiveness of 12-step support groups such as NA has come into question. The
Cochrane Library published a review on the results of a meta-analysis which indicated that
available experimental studies did not show the effectiveness of Alcoholics Anonymous or other
12-step approaches in reducing alcohol use or achieving abstinence (Ferri, Amato, Davoli, 2009).
A similar review on the evidence for the effectiveness of psychosocial interventions for people
with opioid dependence revealed that experimental studies are lacking and therefore there is
insufficient evidence at this time to draw any conclusions (Mayet, Farrell, Amato, & Davoli,
2010).
A survey was taken of the attendees at the annual world convention which was held in
San Diego California, in 2011. Of those in attendance, which is likely not entirely
representative, 47% of respondents were female, 53% male. Additional demographics include
that 74% of respondents were Caucasian and the average age was 43 (Narcotics Anonymous
2011 membership survey, 2012).
Another study, which probably more accurately represents NA demographics, was done
by Galanter, Dermatis, Post and Santucci (2013) who surveyed 396 members of 10 NA meetings
in three states. The purpose of their study was to determine abstinence from drugs of abuse in
community-based members of NA. The participants had been abstinent an average of 5.7 years.
The percentage of males in this study was 71.5% and the mean age was 38. The percentage of
Caucasian respondents in that study was 68.2%. The gender differences with a much higher
percentage of men being present are more approximate to what I witnessed and was told by
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participants during my study. The age of participants and percentage of Caucasians in this study
is similar to the survey done at the NA convention.
The fact that women are a minority may be a significant reason why women do not feel
as comfortable attending. The format of the meetings where cross talk between attendees is
discouraged may also leave women feeling disconnected and unsupported. Additionally, the
older age of the average participants of 43, as compared to the younger age of participants in the
present study, and the growing incidence of prescription substance abuse in people at younger
ages, may indicate that a greater variety of support groups geared toward younger women could
have a positive effect on the lives of women in their recovery. Since Caucasians are
overwhelmingly overrepresented in NA, a need exists to identify the needs of people with
substance abuse from a variety of racial backgrounds to increase their participation in support
groups.
During the field work spent attending NA meetings to recruit participants for this study, I
noted a scarcity of women attending the groups. In one meeting this was discussed and several
people pointed out that NA meetings have always been better attended by men than women.
Noted in the experience of doctor shopping by the women in the present study, a sense of
community and camaraderie with other addicts was important. Some women pointed out that the
friendships they made while using drugs ended once they stopped using drugs. Providing the
option of a network of support for women in recovery where they could experience camaraderie
to promote abstinence may be beneficial.
There are a few mutual support groups geared at women such as Women for Sobriety
(WFS), but this organization is primarily centered on alcohol abuse. Formed in 1976, the
program is based on a 13 statement ‘New Life’ program. These statements include, ‘I have a
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life-threatening problem that once had me,’ ‘negative thoughts destroy only myself,’ ‘happiness
is a habit I will develop,’ ‘problems bother me only to the degree I permit them to,’ ‘I am what I
think,’ ‘love can change the course of my world,’ and ‘the fundamental object of life is
emotional and spiritual growth’ (Women for Sobriety, 2011). The program is based on positive
thinking, metaphysics, meditation, group dynamics, and pursuit of health through nutrition.
There are nearly 300 WFS groups held weekly worldwide (Substance Abuse Mental Health
Service Administration, 2008). This type of group for women suffering from drug abuse would
likely be an asset to the repertoire of options available. Other groups, which are also less
plentiful, include SMART Recovery, Save Ourselves (SOS), which has an online E-Support
group for women, and LifeRing Secular Recovery, with worldwide meetings estimated at 100 to
500 a week (Substance Abuse Mental Health Service Administration, 2008).
Interventions to improve access to and availability of support groups for women in
recovery are needed. Grants to expand the availability of these groups might include
assessments of those in the community to identify their needs, start-up money for group
development, and paid positions for group leaders. Support groups are generally run by people
who have experienced addiction, but in some cases it may be appropriate for healthcare
professionals to start and run these groups if needed. Studies of the appropriateness and
effectiveness of health care professionals starting and running support groups are needed.
Addiction Prevention
Since addiction is the central key factor that drives doctor shopping related to
prescription drug abuse, steps to improve prevention and treatment are warranted. Determining
successful strategies to prevent and treat the complex, multifaceted problem of substance abuse
has been elusive for centuries. Because substance abuse is so resistant to treatment, efforts
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aimed at prevention should be a primary focus. Education based at prevention is warranted
targeted at children to prevent prescription drug abuse. The White House Office of National
Drug Control Policy (2011) emphasizes education on the hazards of prescription drug abuse
including a recommendation for parents to talk to their kids about this problem. They
recommend the Time to Talk Toolkit published by the Partnership for a Drug Free America
(2013) and offer a link to download this free from their website. This toolkit offers tips for
parents on how to talk to their preschool through teenage children about drug abuse prevention,
including prescription drugs.
Further recommendations include proper storage and disposal of prescription drugs.
According to a report on prescription drug abuse in adolescents by the National Center for
Mental Health Promotion and Youth Violence (2013) children often access prescription drugs to
abuse in their own homes from medicine cabinets. This behavior is sometimes referred to as
“pharming.” This report highlights the fact that easy access combined with the common
misconception that prescription drugs are a “safe high,” calls for the increased attention of
educators, parents, law enforcement officials, policy makers, health professionals, and
prevention specialists. To deal with easy accessibility which also leads to controlled prescription
drugs being taken by others outside the home from medicine cabinets to abuse or sell, proper
safe storage is also recommended. Several types of medication safes or lock boxes are on the
market at a nominal cost of approximately $25. Use of such devices should be included as a
general recommendation as part of child proofing one’s home for all parents as well as a general
safety recommendation for every household for any controlled drug prescriptions. Public service
announcements about the need to keep controlled drugs in locked boxes could impact access to
prescription drugs within homes which often leads to prescription drug abuse which could lead to

141

doctor shopping. Prescribers and pharmacists should routinely advise patients with prescriptions
for controlled drugs to keep them in locked boxes.
System Change and Safeguard Recommendations
Doctor shoppers succeed in securing prescription drugs through playing the system.
Safeguards to close loopholes in the system are needed to decrease the incidence of prescription
drug abuse. People who doctor shop are ingenious and creative; they are finding numerous
clever ways of outwitting measures to prevent abuse. It is unlikely that all loopholes can ever be
closed, but all possible measures should be taken to decrease the incidence of prescription drug
abuse and its devastating consequences.
Terminology
A variety of terms are currently used to describe the phenomenon of prescription drug
abuse. A need exists for agreed upon terminology related to prescription drug abuse both for
professionals and the public. According to the American College of Preventive Medicine (2011)
consensus on terminology is needed because currently terms such as abuse, misuse, addiction,
and nonmedical use are used interchangeably. The terms misuse and nonmedical are often used
to describe aberrant or unintended use or abuse of medications that have been prescribed to a
person, but these terms are also used when referring to people accessing drugs from others such
as friends, family members or dealers. Making a distinction between people who abuse
medications that are prescribed to them, versus those who abuse medications they obtain from
others is important in regards to tailoring interventions for prevention, detection, and treatment.
Identification
Accurately verifying a patient’s identity (ID) is necessary to prevent doctor shopping.
Since fake IDs or using alternate names is a strategy used when doctor shopping, the policy of

142

verifying identification solely through an ID is not adequate. More than one document to verify
ID is needed, similar to measures taken when applying for a driver’s license, such as requiring
utility bills or other mail verifying identity through their address or passports or social security
cards. People who require long term use of controlled drugs could also be required to have a
special tamper resistant photo identification card to show when presenting for medical visits or at
pharmacies. This controlled drug recipient card could be issued at a health department.
Information which has been thoroughly verified and contained on this card could be included in
the patients PDMP profile.
Geographical location of prescribers
People who engage in doctor shopping often travel great distances to visit prescribers and
pharmacies to obtain controlled drugs to abuse. A regulation could be instituted where patients
are required to obtain and fill prescriptions within a specified geographical location in which
they reside such as within a 30-mile radius. This could be verified through their controlled drug
recipient card. In the vast majority of cases there would be an available prescriber or pharmacy
within 30 miles. Exceptions could be made for persons residing in remote locations.
Additionally, exceptions would need to be made to see prescribers, if specialists were not
available in the geographic location of the patient. Patients could be required to have a waiver
for this requirement, but only one per specialist, prohibiting them from traveling far distances to
visit more than one pain clinic, for example. Information regarding a patient’s geographical
radius restriction and exceptions could be available on their PDMP profile.
Method of payment
Another way that doctor shoppers avoid detection is by paying cash rather than using
their insurance, or they alternate between using their insurance and paying cash. With the onset
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of the ACA in 2014, there will be a requirement for Americans to have health insurance or pay a
tax. This should decrease the potential for abuse through cash payments, but a certain
percentage of patients will remain without insurance in place at the time of their visit. This
would be due to a variety of reasons, such as a delay in it getting instated, not being willing or
able to pay for it, or being in between coverage. Some states, such as Tennessee, have enacted
statutes that disallow cash payments for visits at pain clinics other than insurance co-pays, in an
attempt to decrease abuse, and to ensure that a paper trail of payments can be tracked (Tennessee
State Capital, 2012). This would not preclude patients from paying cash at other locations, and
the only way a paper trail would prevent abuse is if someone had reason to track it. Surveillance
of prescribers in clinics, hospitals, and office settings, as well as at pharmacies is seldom done.
Occasionally the top prescribers of controlled drugs in individual states will be identified and
contacted by government regulators, such as officials at the DEA. Often, only if crimes are
suspected involving prescribers or pharmacists is an investigation done. A nationwide regulation
prohibiting cash payments for medical visits when controlled drugs are prescribed or to pay for
controlled drugs would be another measure to take. Audits of prescribers and pharmacies could
be done to verify method of payment.
The use of a controlled drug recipient debit card could also be required for patients to pay
for visits to prescribers or prescriptions for controlled drugs. This card could be issued at a
health department and could be coded to match the ID card. Kiosks where patients could upload
cash or other forms of payment to the controlled drug debit card could be placed in convenient
locations such as pharmacies, hospitals and health departments. Prescribers and pharmacists
would swipe this card when patients pay for services or medications and this data could also be
included in a patient’s PDMP profile in real time similar to electronic banking transactions.
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When payment is not necessary, such as when insurance is covering the entire cost, a code could
be entered prior to swiping the card indicating that there was not an exchange of money but
rather insurance was used, including the amount.
Standardized fees for services
Some participants in this study reported they were required to pay inflated charges to
prescribers or pharmacies to secure controlled prescription drugs. Paying $500 for a visit at a
pain clinic or having to pay double the normal cost for prescriptions was reported. This practice,
which clearly serves as monetary incentive for prescribers to write prescriptions for controlled
drugs, and for pharmacists to fill them, should be outlawed, to prevent a conflict of interest. This
would serve as a measure to prevent unscrupulous prescribers and pharmacists from profiting
from writing or filling prescriptions for controlled drugs.
Insurance status
Some method for determining which patients have insurance and then requiring them to
use that insurance rather than cash, would help close the loophole where patients use cash, or
claim to not have insurance, in order to prevent detection. Currently insurance status can be
verified by contacting individual insurance companies such as Medicare and Blue Cross and
Blue Shield through an automated system. This information could be available through a
national database with a call center for prescribers. This information could also be included in
the patients PDMP report.
Visit Monitoring
Another loophole in the system is that the current use of PDMPs involves collecting and
recording data on prescriptions filled at pharmacies. However, this does not preclude doctor
shoppers from visiting more than one prescriber in a short time frame without filling the
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prescriptions they obtain that day. Because in most states, pharmacists are only required to enter
the prescriptions but not monitor them, those prescriptions can be filled at a later time. One
possible recommendation to track and dissuade patients from visiting numerous prescribers
would be to include these visits in the PDMP data. Prescribers could be required to enter in date
of service whenever a controlled drug was prescribed within an established time frame such as
60 minutes. Prescribers could log on to the PDMP when considering prescribing a controlled
drug to a patient and see if they had recently visited another prescriber for a prescription for
controlled drugs regardless of whether it had been filled or not.
Monitoring Arrests and Substance Abuse Treatment
Currently patients may be arrested on a drug-related charge or hospitalized or treated for
substance abuse, and their prescriber who is prescribing them controlled drugs may not be aware.
Drug-related arrests and substance abuse treatments could be entered into the patients’ PDMP
profiles. Law enforcement or treatment facilities should be mandated to report to prescribers
drug related arrests or treatment. This may or may not affect treatment practice but it provides
the prescriber information that should be considered when making decisions about prescribing.
Prescription Pill Identification
Pill counts to determine that prescribed medications are being taken as directed should
become part of standard measures in place when controlled drugs are prescribed. These should
be done at random, when patients are contacted randomly and asked to bring their medications in
to be counted within a short period of time. For patients who are taking more of their medication
than prescribed or who are selling their medication, they will not have enough pills in their bottle
when they are counted. It was learned in this study that addicts will often call around and
borrow pills from other addicts to use for pill counts the rare times they were requested. Some
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method of marking the medications to match that specific patient’s medication bottle could be
developed to verify that the pills are the correct ones that the patient was dispensed from the
pharmacy. This would also help track prescription medications that are confiscated in arrests to
determine how they were diverted.
Abuse deterrent prescription formulations
One strategy that is currently being employed and studied, is the development and
production of abuse deterrent formulations of controlled drugs. The FDA has identified the
development of abuse-deterrent formulations as a public health priority and is encouraging their
development (U.S. Food and Drug Administration, 2013). These preparations include hard
gelatin capsules which cannot be extracted with a needle; tablets that contain niacin, designed to
produce flushing and other unpleasant side effects if taken in excessive quantities, or other
formulations which are compromised if chewed or crushed (Raffa & Pergolizzi, 2010).
Currently these products are not widely available and addicts are known to be ingenious at
thwarting efforts to prevent them from abusing prescription drugs, therefore the success rate of
these abuse deterrent formulations is not known.
Controlled Drug Recipient Office
A problematic feature of implementing effective system safeguards is that they largely
rely on prescribers and pharmacists for their implementation. In a certain amount of instances,
these healthcare professionals are either complacent with doctor shopping or collaborate with
patients when prescribing them controlled drugs. Relying on the very people who have been
party to the phenomenon of doctor shopping to date, to safeguard the system, will likely involve
a certain amount of failure. The development of an established office staffed with objective
adequately trained personnel, who could play a role in assessing and monitoring patients, and

147

assisting with their care related to controlled prescription use, would be an asset to the current
system.
As previously stated, debit cards to pay for services to obtain or to fill prescriptions for
controlled drugs, as well as an ID verifying the identity of patients in need of ongoing controlled
drugs, could be made available at a local health department. An office which could be called a
controlled drug recipient office (CDRO) could be set up within these departments to provide
these services, as well as screening and ongoing assessment of patients who are prescribed
controlled prescription drugs. Patients in need of acute pain management, such as for an
unexpected injury or surgery; or controlled anxiety medication, such as following a severe
trauma, could initially receive a three day supply of controlled medication from a prescriber. A
similar strategy is already being implemented in New York City public hospital emergency
rooms, where a policy was instated which prohibits more than a three day supply of prescription
painkillers, in an effort to crack down on prescription drug abuse (Hartocollis, 2013). In most
cases, a three day supply would be adequate treatment with a controlled drug as
recommendations are for short term use when possible to prevent tolerance or dependence.
Patients would be told that they should follow up with their primary care provider or specialist if
they need ongoing treatment with controlled drugs and that in order for this to occur, they would
need to be seen at a proposed CDRO.
Patients could be seen at a CDRO by a professional such as a counselor, social worker, or
nurse, with special training in addictions, pain management and mental health. A thorough
assessment would be done including a psychosocial assessment, UDS, screening instruments, a
PDMP check, physical assessment for needle marks and other signs of abuse. Patients would
receive regular counseling on non-pharmacological management of pain and anxiety symptoms.
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Patients would be required to be seen at a CDRO on a periodic basis as long as they are being
prescribed controlled drugs, such as every two to three months. If at any time abuse or addiction
is suspected, the CDRO would be in charge of recommending treatment and assisting patients to
obtain treatment or other services such as referrals to half way houses, counselors, or support
groups. A certificate verifying they are being seen at the CDRO, would need to accompany
patients to prescribers as well as pharmacies in order to be prescribed controlled drugs or have
them filled. The CDRO staff could also be involved in periodic audits of prescribers to verify
that practices related to responsible prescribing are being utilized. This safeguard of an outside
agent to monitor, assist, and intervene in a system that has so far been fraught with problems and
failure, would be beneficial to the safety and well-being of patients. The implementation of a
CDRO office could also prevent prescribers from unwittingly prescribing controlled drugs to
patients who abuse them. Given the resistance of some prescribers to checking the PDMP and
the existence of statutes granting immunity to prescribers when they do not check it, outside
partnership to combat this problem in warranted. The costs of the CDRO office would be offset
by savings from less fraud and abuse of the system.
Implications for Nursing
Advanced practice nurses, being a significant proportion of prescribers, need to
implement measures to ensure responsible prescribing, as well as advocate for systematic
changes to decrease the incidence of doctor shopping. Nurses in a variety of specialties and
settings can use these findings to increase their understanding of women who engage in doctor
shopping related to prescription drug abuse. Nurses are often in key positions to detect abuse
and to intervene when addiction is suspected. Additionally, Nurses are well suited to design
treatment interventions and recovery support options for women that would be more appealing
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than traditional programs. Gender specific program interventions both in inpatient hospital units
and residential programs are needed. Psychiatric nurses are already employed in these settings
and therefore would be in an optimal position to recommend, design, and implement changes.
Support group options for women are particularly needed that would meet the needs of
women, unlike NA groups, which usually follow a male model and attract mainly men. Nurses
could play a role in the development, implementation and facilitation of support groups for
women who abuse substances. Since support groups are associated with a higher incidence of
abstinence, the addition of gender specific groups for women could result in a lowered incidence
of doctor shopping. Community assessments could be performed by nurses to identify the needs
of women in their community in order to develop appropriate programs and groups.
The fact that there is a lack of safe and recovery focused housing for women in this
country is a problem that could also be addressed by nurses. Through grants, and other sources
of funding, such as private and business collaboration, nurses could establish and staff halfway
houses in their communities so that women leaving treatment programs could have somewhere
to stay during recovery. The availability of gender specific programs and treatments available at
these houses for women would further meet the needs of women in recovery and thus help curb
the cycle of addiction.
Strengths and Limitations of the Study
Strengths of this study include that it was conducted in accordance with ethical standards
and using several methods to achieve rigor and validity. The UTK method of phenomenology
requires the input and feedback of an interdisciplinary phenomenology group, which is a major
strength of this study. Another strength is that data saturation was achieved in 14 informative
interviews, which were done with women who self-identified as doctor shoppers. The findings
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are significant and illuminating including four themes which have been used to increase
awareness and understanding of the meaning of doctor shopping as well as to determine
implications and recommendations for change in this phenomenon. Another strength of this
study is that no previous qualitative studies have been done with women who engage in doctor
shopping, so the results of this study are groundbreaking and original. The use of the method of
phenomenology is also a strength because it highlights the experience of the participants
including an emphasis on various aspects of their world, body, time, and others, which reveals
illuminating findings about the meaning of the phenomenon of doctor shopping. Because I
attended numerous NA meetings which involved lengthy interactions with many individuals
suffering from drug addiction, I was able to further glean insight into their world and experience.
Limitations of this study include that it was conducted in a specific geographical region
and the findings may not be reflected in other regions. The majority of the women on the study
were Caucasian, which is typical of the region but the findings may not be representative of
women from other racial groups. A possible limitation is that my being a prescriber in the same
geographical area as the participants, this could have affected the participants responses.
However, I only addressed myself as a PhD student and as far as I know, none of the participants
or people at the NA groups I attended were aware that I am a prescriber. The present study was
done with women participants; therefore the results may not be generalizable to men.
Additionally, the participants for this study were recruited from NA meetings, therefore, their
experience may not reflect women who engage in doctor shopping who are not participating in
an addiction support group.
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Unintended Consequences
Unintended consequences of this study would be that if the recommendations proposed
are implemented and the incidence of prescription drug abuse is reduced, addicts may resort to
abusing illicit drugs such as heroin, which would also be a significant problem. To combat this,
resources currently directed at combatting prescription drug abuse could be focused on illicit
drug abuse. Savings to the healthcare and legal system from a decrease in prescription drug
abuse could be used to help pay for costs related to illicit drug abuse.
Another possible unintended consequence of this study would be that if the
recommendations set forth in this study are implemented, they in some cases, could be perceived
as barriers for people in legitimate need of controlled drugs to obtain them. It is not the intention
of this study to prevent patients who need pain medication or other controlled drugs from being
treated. Rather, the measures recommended should lead to an improvement in the ability of
patients to be treated with controlled drugs when indicated, because prescribers should be less
hesitant to prescribe them when causes for suspicion are eliminated. Some of the measures
proposed in this study would incur a hardship on patients in need of controlled drugs for instance
if they would have to undergo more in depth screening. Some screening, such as examinations
and producing urine drug screens may be embarrassing or inconvenient for patients. Some of the
recommendations would result in an increased cost to the health care system, such as a CDRO
office or an increase in laboratory screening. These costs would be offset by the savings to the
system from a decrease in doctor shopping.
Future Research
Since there has been so little research done in the area of prescription drug abuse and
specifically doctor shopping, a plethora of research is still needed in this area. The present study
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was done with women. Since no similar study has been conducted with men, research is needed
to understand the experience of men who engage in doctor shopping. The experience of
prescribers in their role in prescribing controlled drugs or with doctor shopping is another area in
need of study. This study should include a variety of professionals who prescribe controlled
drugs such as both physicians and APNs so that differences and similarities could be examined.
A grounded theory study to formulate a theory of doctor shopping is needed.
Quantitative studies are needed to measure doctor shopping and prescribing practices.
Instruments need to be developed in order for these studies to be done. Interventions to prevent
or reduce the incidence of doctor shopping are needed such as testing the effectiveness of
training programs for prescribers and the use of more stringent screening. A flow sheet to
document responsible prescribing practices needs to be developed and tested.
Currently there are screening instruments for patients once they have been started on
opioids but similar instruments need to be developed for other controlled drugs such as
benzodiazepines, stimulants, and hypnotics. Instruments to assess risk of abuse or addiction
prior to starting a controlled drug which could be used by prescribers in their decision making
process when considering controlled drugs are also needed.
Studies of women who engage in doctor shopping to assess their personality traits, selfesteem, emotional intelligence and other characteristics would be helpful to identify risk factors,
and develop effective interventions for them. Similar studies of prescribers could help identify
those prescribers who are risk of inappropriate prescribing. Additionally, development and
testing of effectiveness of new and innovative treatment programs including support groups are
needed for women. Research is also needed to develop more accurate and fool proof drug
testing methods and tamper proof prescription pill formulations. Another area for future research
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is the role of pharmacists in doctor shopping. Studies are needed on the experiences of
pharmacists who dispense controlled drugs to patients and their experience when they encounter
doctor shopping. Interventions aimed at prescription drug abuse prevention are also needed.
Conclusion
Prescription drug abuse is a serious problem in the United States which adversely affects
people and society involving huge financial cost. Prescription drug abuse often involves doctor
shopping where individuals visit numerous prescribers and pharmacies to secure controlled drugs
to abuse. Women are more likely to engage in doctor shopping than men, and are more likely to
have physical and mental health co-morbidities related to addiction. This is the first study of its
kind to examine in depth the experience of people who engage in doctor shopping. This
qualitative phenomenology study revealed four themes evident in the meaning of the experience
of women who doctor shop; (1) feeding the addiction, (2), networking with addicts, (3), playing
the system, and (4) baiting the doctors. Other findings include an analysis of the meaning of the
doctor shopping experience related to existential grounds. Findings from this study have been
used to propose several innovative recommendations for practice. Changes in policy,
procedures, practice, and future research need to be implemented to reduce the incidence of
doctor shopping related to prescription drug abuse and its devastating effects.
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INFORMED CONSENT STATEMENT
Consent Form
You are invited to participate in a research study about the experiences related to
doctor shopping. The study is being conducted by Julie Worley, a PhD student at the
University of Tennessee, College of Nursing. The study involves answering questions in
an interview that will take about one to two hours in which you will be asked general
questions about your experiences related to doctor shopping, that is obtaining controlled
prescription drugs from numerous prescribers and filling them at more than one
pharmacy for non-medical use such as for abuse, recreational use or to sell. Interviews
will be recorded and then typed out by a professional transcriptionist who will sign an
agreement to keep all information in the interview confidential. You are asked not to
name any names of yourself or others during the interview. Approximately 6 to 12
participants are estimated to be included in this study.
A risk of this study is that there is a chance that you will experience stress when
sharing your story in this study. If need be the interview will be paused or discontinued.
If you experience distress that may warrant treatment you will be given a referral to a
licensed counselor and/or referred to contact the Plateau Mental Health Center crisis line.
Injury is not expected during this study but if it occurs you will be referred to your
primary care provider or the emergency room. The University of Tennessee does not
"automatically" reimburse subjects for medical claims or other compensation. If injury is
suffered in the course of research, or for more information, please notify the investigator
in charge (Julie Worley, 931-260-2738). Participation may also involve risks to
participants that are unforeseeable. Participants who appear acutely intoxicated may be
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terminated from the study without regard to the participants consent. Significant new
findings developed during the course of the research that may related to your willingness
to continue participation will be provided to you. The interview will last approximately
60 to 90 minutes. After the interview you will be asked to write answer some questions
about some general information about yourself such as age, race, education level and type
of employment. Participation is optional and voluntary and you are free to leave the
study at any time. If you leave the study before completing the interview, your
incomplete interview recording will be destroyed. Discontinuing participation in the
study at any time is without penalty or loss of benefits or services you are otherwise
entitled or receiving.
One benefit of participation in the study is that the results from this study will
help others to understand the experience of women who engage in doctor shopping.
All information collected about you will be kept confidential. The information will not
be shared with anyone who is not directly related to the research study other than the fact
that some of the data, without names, may be used for future research studies. No one
will have access to the materials of this study or any future studies using these data
except Julie Worley (the principal investigator), and Dr. Thomas (Advisor). The
Institutional Review Board of the University of Tennessee may also request access to the
study data if indicated. The transcripts, consent forms, and question answers will be
stored securely in the office of the advisor, Dr. Thomas, for three years. No reference
will be made in oral or written reports which could link you to the study. The tape
recordings of the interviews will be destroyed after the study is completed. No
information will be kept on computer files
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If you have questions at any time about the study or the procedures, you may contact the
researcher, Julie Worley at 2370 Quinland Lake Rd. Cookeville, TN 38506 and 931-2602738. If you have questions about your rights as a participant, contact the Office of
Research Compliance Officer at (865) 974-3466.

I have read the above information. I have received a copy of this form. I agree to
participate in this study.
Participant’s name (Print) ____________________________

Participant’s signature _______________________________ Date___________

Investigators signature _______________________________ Date ___________
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DEMOGRAPHIC QUESTIONS FOR PARTICIPANTS

Participant Name (Pseudonym) ________________________

1.

Age___________________________

2.

Race __________________________

3.

Marital Status___________________

4.

Education Level _________________

5.

Occupation ______________________
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CONFIDENTIALITY PLEDGE OF TRANSCRIPTIONIST

I understand that the material I am transcribing from interviews must be held in
complete confidence. This means that no words, phrases, or other segments of the
material can be discussed with anyone. All names of places, such as schools or hospitals,
will be replaced in the typed text by blanks or pseudonyms. All names of persons will
also be replaced with pseudonyms.

_______________________________________ (Signature)

________________(Date)
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CONFIDENTIALITY PLEDGE OF PHENOMENOLOGY GROUP
I understand that the information from the transcripts from interviews presented and
discussed must be held in complete confidence. This means that no words, phrases, or
other segments of the material can be discussed with anyone.

_______________________________________ (Signature)

________________(Date)

186

VITA
Julie A. Worley was born and raised in Barrington, Illinois and after high school attended
Ravenswood Hospital School of Nursing in Chicago where she earned a registered nurse
diploma in 1984. She worked as a nurse in a variety of settings in Chicago and went on to
complete a bachelor of nursing degree from Northern Illinois University in 1992. She then
completed a master’s degree in nursing with specialization as a family nurse practitioner from
University of Illinois Chicago in 1994. She moved to Tennessee and worked as a family nurse
practitioner in a variety of settings and then completed a post master’s certificate in a psychiatric
mental health nurse practitioner program from the University of South Alabama in 2004. She
has worked at a mental health clinic and in private practice as a psychiatric mental health nurse
practitioner and has been on the medical staff of two inpatient psychiatric units. She has also
taught nursing at the bachelors and doctorate level. She has published two articles on
psychotropic medication adherence, one review of literature on prescription drug monitoring
programs, and one concept analysis on doctor shopping. She belongs to a variety of professional
organizations and is a member of the nursing honor society Sigma Theta Tau and the Phi Kappa
Phi honor society for all disciplines. She completed her doctorate of philosophy at the
University of Tennessee College of Nursing in May, 2013.

187

